Sentence,class,file
"J Neurosci 2014;34:8219-30; PMID:24920626; http://dx.doi.org/10.1523/JNEUROSCI.0936-14.2014 [5] Marrion NV, Tavalin SJ.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Nature 1998; 395:900-5; PMID:9804423; http://dx.doi.org/10.1038/27674 [ 6 ] B o w d e nS E ,F l e t c h e rS ,L o a n eD J ,M a r r i o nN V .",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"JNeurosci 2004; 24:5301-6; PMID:15190101; http://dx.doi.org/10.1523/JNEUROSCI.0182-04.2004 [8] Gu N, Hu H, Vervaeke K, Storm JF.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Neurophysiol 2008; 100:2589-604; PMID:18684909; http://dx.doi.org/10.1152/jn.90433.2008 [ 9 ] G u l l e d g eA T ,D a s a r iS ,O n o u eK ,S t e p h e n sE K ,H a s s e JM, Avesar D. A sodium-pump-mediated afterhyper-polarization in pyramidal neurons.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Neurosci 2013;33:13025-41; PMID:23926257; http://dx.doi.org/10.1523/JNEUROSCI.0220-13.2013 [10] Joiner WJ, Wang LY, Tang MD, Kaczmarek LK.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Proc Natl Acad Sci U S A 1997; 94:11651-6; PMID:9326665; http://dx.doi.org/ 10.1073/pnas.94.21.11651 [12] Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
J Biol Chem1997; 272:32723-6; PMID:9407042; http://dx.doi.org/10.1074/jbc.272.52.32723 [13] Lein ES.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
Nature 2007; 445:168-76; PMID:17151600; http://dx.doi.org/10.1038/nature05453318 R. W. TURNER ET AL.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Neurophysiol 2004;92:2346-56; PMID:15190096; http://dx.doi.org/10.1152/jn.00977.2003 [16] Nguyen TV, Matsuyama H, Baell J, Hunne B, Fowler CJ, Smith JE, Nurgali K, Furness JB.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Neurophysiol2007; 97:2024-31; PMID:17229825; http://dx.doi.org/10.1152/jn.00935.2006 [17] Wulff H, Gutman GA, Cahalan MD, Chandy KG.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
J Biol Chem 2001; 276:32040-5; PMID:11425865; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Br J Pharmacol 2013; 168:432-44; PMID:22891655; http://dx.doi.org/10.1111/ j.1476-5381.2012.02143.x [19] Visan V, Fajloun Z, Sabatier JM, Grissmer S. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1channels.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Mol Pharmacol 2004; 66:1103-12; PMID:15286210; http://dx.doi.org/10.1124/mol.104.002774 [20] Nolting A, Ferraro T, D ’Hoedt D, Stocker M. An amino acid outside the pore region in ﬂuences apamin sensitivity in small conductance Ca 2C-activated K Cchannels.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Biol Chem 2007; 282:3478-86; PMID:17142458; http://dx.doi.org/10.1074/jbc.M607213200 [21] Wulff H, Kohler R. Endothelial small-conductance and intermediate-conductance KCa channels: anupdate on their pharmacology and usefulness ascardiovascular targets.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
Curr Med Chem 2007; 14:1437-57; PMID:17584055; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Blood 2008; 111:3991-7;PMID:18192510; http://dx.doi.org/10.1182/blood-2007- 08-110098 [24] Vogalis F, Furness JB, Kunze WA.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Physiol 2002; 538:421-33; PMID:11790810; http://dx.doi.org/10.1113/jphysiol.2001.012952 [26] Vogalis F, Harvey JR, Furness JB.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"J Physiol 2003;548:801-14; PMID:12640013; http://dx.doi.org/10.1113/jphysiol.2002.037325 [27] Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
Methods MolBiol 2007; 403:123-39; PMID:18827991; http://dx.doi.org/10.1007/978-1-59745-529-9_8CHANNELS 319,Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Oncotarget 2015; 6(39):41783-93; PMID: 26496025; http://dx.doi.org/10.18632/oncotarget.6157© 2016 Tatiana Kilch, Sven Kappel, and Christine Peinelt.",OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
"3, 170 –171 http://dx.doi.org/10.1080/19336950.2015.1137176",Non-OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
Sci Signal 2010; 3:115 ra24; PMID:20354224; http://dx.doi.org/10.1126/scisignal.2000672 [3] Alansary D et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
BBA 2015; 1853:1541-50; PMID:25791427; http://dx.doi.org/10.1016/j.bbamcr.2015.03.007 [4] Holzmann C et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
Oncotarget 2013; 4:2096-2107; PMID:24240085; http://dx.doi.org/10.18632/oncotarget.1483 [5] Holzmann C et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
Biophys J 2015; 109:1410-9; PMID:26445441; http://dx.doi.org/10.1016/j.bpj.2015.08.006 [6] Dubois C et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
Cancer Cell 2014; 26:19-32; PMID:24954132; http://dx.doi.org/10.1016/j.ccr.2014.04.025 [7] Holzmann C et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
Oncotarget 2015; 26:19-32; PMID:26496025; [Epub ahead of print] http://dx.doi.org/10.18632/oncotarget.6157 [8] Kilch et al.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
JBC 2013; 288:1653-64; PMID:23212906; http://dx.doi.org/10.1074/jbc.M112.417246 Figure 1.,OADS,/arxiv_data1/oa_pdf/09/f5/kchl-10-03-1137176.PMC4954580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/66/emss-69115.PMC4954606.pdf
"http://clinicaltrials.gov/show/ NCT00896077 , NLM Identiﬁer: NCT00896077.",Non-OADS,/arxiv_data1/oa_pdf/94/86/13318_2015_Article_260.PMC4954844.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"The exosomal fusion with the plasma membrane of the recipient cell, or phagocytosis followed by membrane fusion, leads to the release of miRNA cargo into the cytosol and translational repression.Arron Thind and Clive Wilson 2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"(22).Exosomal miRNAs as cancer biomarkers Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"Although it has been shown that some miRNAs are selectively loadedor retained in exosomes, there often is little difference between the cellular miRNA expression profile of tumour cells and the expression profile of their secreted exosomes; therefore, exosomal profiles are potentially suitable as aArron Thind and Clive Wilson 4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"RT-PCRmiR-598 (2 ¡), miR-148a (2.4 ¡), miR-34a (11 ¡) and miR-146a (3 /C160 ) Fold changes in miRNAs are included in right-hand column where known.Exosomal miRNAs as cancer biomarkers Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"Thus far, there islimited knowledge about the biology of ex-miRNA, andit is important that similar studies are performed todetermine whether this is a general phenomenon.Arron Thind and Clive Wilson 6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"The activation of these and other pathways in distant sites generates a pre-metastatic niche that facilitates metastasis.Exosomal miRNAs as cancer biomarkers Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"Furthermore, modulatingthe activities of molecules like Rabs and ESCRTs, that have key roles in multiple cell biological events, is very likely to affect processes other than ex-miRNA secretion.Whilst the pathways for exosome biogenesis and loadingArron Thind and Clive Wilson 8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"1999;94:3791 /C19.Exosomal miRNAs as cancer biomarkers Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"2014;3: 24858, doi: http://dx.doi.org/10.3402/jev.v3.24858 23.",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"2015;4:27269, doi:http://dx.doi.org/10.3402/jev.v4.27269 29.",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"Endothelial exosomes contribute to the antitumorArron Thind and Clive Wilson 10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"2011;12:1659 /C168.Exosomal miRNAs as cancer biomarkers Citation: Journal of Extracellular Vesicles 2016, 5: 31292 - http://dx.doi.org/10.3402/jev.v5.31292 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/0b/JEV-5-31292.PMC4954869.pdf
"Key Words : Adult spinal deformity · Idiopathic scoliosis · Classification · Spinal fusion · Selective fusion · Algorithm.Review Article • Received : February 24, 2015  • Revised : March 3, 2016  • Accepted : April 5, 2016 • Address for reprints : Seung-Jae Hyun, M.D., Ph.D.  Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil,    Bundang-gu, Seongnam 13620, Korea   Tel : +82-31-787-7164,  Fax : +82-31-787-4097,  E-mail : hyunsj@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 327-333, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.327 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkns-59-327.PMC4954878.pdf
• Supplementary Materials The online-only Data Supplement is available with this article  at http://dx.doi.org/10.3340/jkns.2016.59.4.327.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkns-59-327.PMC4954878.pdf
"348 De Xiang Road, Heilongjiang Province, Jiamusi City 154003, PRC, China  Tel : +86-15774546828,  Fax : +86-454-8617486,  E-mail : zipromax@163.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 334-340, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.334 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/d5/57/jkns-59-334.PMC4954879.pdf
Available  from : http://oro.open.ac.uk/9064/ 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/57/jkns-59-334.PMC4954879.pdf
"Department of Neurosurgery, Liuzhou Workers’ Hospital, 1st Liushi Road, Yufeng District, Liuzhou, Guangxi, PR China  Tel : +86-0772-3815284,  Fax : +86-0772-381258,  E-mail : CJKDOCTORLGY@163.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 341-345, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.341 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e5/2f/jkns-59-341.PMC4954880.pdf
"Key Words : Acute ischemic stroke · Cerebral blood volume · Hemodynamic failure · Magnetic resonance imaging · Middle cerebral artery occlusion.Clinical Article • Received : August 20, 2015  • Revised : December 24, 2015  • Accepted : February 26, 2016 * Move to : Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University, Seoul, Korea • Address for reprints : Seung Ho Yang, M.D., Ph.D.  Department of Neurosurgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea  Tel : +82-31-249-8304,  Fax : +82-31-245-5208,  E-mail : 72ysh@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.3340/jkns.2016.59.4.346 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr J Korean Neurosurg Soc 59  (4) : 346-351, 2016",Non-OADS,/arxiv_data1/oa_pdf/f2/32/jkns-59-346.PMC4954881.pdf
"Department of Radiology and the Research Institute of Medical Science, Chonbuk National University Medical School and Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju    54907, Korea  Tel : +82-63-250-2582,  Fax : +82-63-272-0481,  E-mail : kwak8140@jbnu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 352-356, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.352 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/3a/e1/jkns-59-352.PMC4954882.pdf
"Key Words : Anaplastic · Meningioma · Papillary · Prognosis · Rhabdoid.Clinical Article • Received : September 30, 2015  • Revised : January 14, 2016  • Accepted : April 6, 2016 • Address for reprints : Tae-Young Jung, M.D., Ph.D.  Department of Neurosurgery, Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea  Tel : +82-61-379-7666,  Fax : +82-61-379-7673,  E-mail : jung-ty@chonnam.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 357-362, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.357 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/40/a5/jkns-59-357.PMC4954883.pdf
"Key Words : Hydroxyapatite · Autograft · Fusion · CT scan.Clinical Article • Received : November 9, 2015  • Revised : January 31, 2016  • Accepted : February 26, 2016 • Address for reprints : Yoon Ha, M.D., Ph.D.  Department of Neurosurgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea  Tel : +82-2-2228-2150,  Fax : +82-2-393-9979,  E-mail : hayoon@yuhs.ac • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 363-367, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.363 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/84/a6/jkns-59-363.PMC4954884.pdf
"Key Words : Cervical · Laminoplasty · Lamina · Hinge · Fracture · Risk factors.Clinical Article • Received : January 5, 2015  • Revised : March 14, 2016  • Accepted : March 20, 2016 • Address for reprints : Youn-Kwan Park, M.D., Ph.D.  Department of Neurosurgery, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea  Tel : +82-2-2626-3095,  Fax : +82-2-863-1684,  E-mail : ykapa76@yahoo.co.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 368-373, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.368 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/cf/b0/jkns-59-368.PMC4954885.pdf
"Key Words : Cervical · Posterior · Foraminotomy · Cervical spondylosis · Radiculopathy.Clinical Article • Received : January 18, 2016  • Revised : March 16, 2016  • Accepted : March 20, 2016 • Address for reprints : Jae Chil Chang, M.D., Ph.D.   Department of Neurosurgery, Soonchunhyang University Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 04401,  Korea  Tel : +82-2-709-9270,  Fax : +82-2-792-5976,  E-mail : j7chang@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.3340/jkns.2016.59.4.374 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr J Korean Neurosurg Soc 59  (4) : 374-378, 2016",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/jkns-59-374.PMC4954886.pdf
"Departments of Radiology and Neurosurgery, Cerebrovascular Center, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, 130  Dongdeok-ro, Jung-gu, Daegu 41944, Korea  Tel : +82-53-420-6246,  Fax : +82-53-423-0504,  E-mail : kdhdock@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 379-384, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.379 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/jkns-59-379.PMC4954887.pdf
"Key Words : Anterior cervical discectomy and fusion · Stand-alone cage · Subsidence · Long-term outcomes · Intervertebral height · Odom’s criteria.Clinical Article • Received : March 25, 2016  • Revised : March 25, 2016  • Accepted : May 6, 2016 • Address for reprints : Seung-Jae Hyun, M.D., Ph.D.  Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil,    Seongnam 07061, Korea  Tel : +82-31-787-7169,  Fax : +82-31-787-4097,  E-mail : hyunsj@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 385-391, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.385 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ef/7a/jkns-59-385.PMC4954888.pdf
"Key Words : Gynecologic cancer · Brain metastases · Gamma Knife Radiosurgery · Prognostic factor · Survival.Clinical Article • Received : December 2, 2015  • Revised : February 21, 2016  • Accepted : April 7, 2016 • Address for reprints : Do Hoon Kwon, M.D., Ph.D.  Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  Tel : +82-2-3010-3550,  Fax : +82-2-476-6738,  E-mail : ykwon@amc.seoul.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 392-399, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.392 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e7/83/jkns-59-392.PMC4954889.pdf
"Department of Neurosurgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan  Tel : +81-78-382-5966,  Fax : +81-78-382-5979,  E-mail : taichiro.imahori@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 400-404, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.400 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/66/e8/jkns-59-400.PMC4954890.pdf
"Key Words : 7.0 T MRI · Meningioma.Case Report • Received : April 9, 2015  • Revised : October 21, 2015  • Accepted : October 27, 2015 • Address for reprints : Sun Ha Paek, M.D., Ph.D.  Department of Neurosurgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea  Tel : +82-2-2072-3993,  Fax : +82-2-744-8459,  E-mail : paeksh@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 405-409, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.405 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/5a/fa/jkns-59-405.PMC4954891.pdf
"Department of Neurosurgery, Kent Hospital, 8229/1 Sokak No : 56 35630 Cigli-Izmir, Turkey  Tel : +90-5066892909,  Fax : +90-2323767071,  E-mail : goktug_akyoldas@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 410-413, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.410 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/bf/99/jkns-59-410.PMC4954892.pdf
"Department of Neurosurgery, Institute of Neurological sciences, Southern General Hospital, 1345 Govan Road, GLASGOW G51 4TF, United Kingdom  Tel : +44 0 1 412 327 696,  Fax : +44 0 1 412 012 995,  E-mail : charles.champeaux@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 414-419, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.414 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/4d/7f/jkns-59-414.PMC4954893.pdf
"Brain Tumor Institute, Novalis Stereotactic Radiosurgery Center,  Department of Neurosurgery, College of Medicine, Dong-A University, 26 Daesingongwon-ro, Seo-gu,    Busan 49201, Korea  Tel : +82-51-240-5241,  Fax : +82-51-242-6714,  E-mail : kukim@donga.ac.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (4) : 420-424, 2016http://dx.doi.org/10.3340/jkns.2016.59.4.420 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/80/fd/jkns-59-420.PMC4954894.pdf
458 458 DOI of original article: http://dx.doi.org/10.1016/j.neo.2016.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/30/99/main.PMC4954930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/99/main.PMC4954930.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.06.006,OADS,/arxiv_data1/oa_pdf/30/99/main.PMC4954930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2016.05.002,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1016/S0140-6736(09)61196-X .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1245/s10434-010-0985-4 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/jid.2010.266 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/nature07083 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1002/path.2605 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/jid.2013.83 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/nm.2545 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1096/fj.10-179788 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1128/MCB.02214-07 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/nprot.2009.120 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1016/j.intimp.2010.12.020 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1186/1471-2466-10-26 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1084/jem.20071978 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1016/j.semcancer.2008.03.004 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.3389/fimmu.2014.00276 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-12-4539 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-07-3059 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1111/j.1600-0714.2009.00792.x .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.103/jid.2011.9 .,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1038/nri3175 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.4049/jimmunol.1201454 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1084/jem.20100559 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1002/jcp.21494 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.1182/blood-2011-01-332049 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
"Eur J Cardiothorac Surg 38,2 6 0 –267.http://dx.doi.org/10.1016/j.ejcts.2010.01.061 .",OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.3109/00313025.2010.522174 .,Non-OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
http://dx.doi.org/10.3892/or.2013.2821 .446 VEGF-D modulates tumor inflammation and reduces tumor growth Honkanen et al.,OADS,/arxiv_data1/oa_pdf/c8/90/main.PMC4954931.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.008,Non-OADS,/arxiv_data1/oa_pdf/c0/c1/main.PMC4954932.pdf
nov. MALDI-TOF-MS spectrum accession number The MALDI-TOF-MS spectrum of ‘Peptoniphilus vaginalis ’is available at http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/c0/c1/main.PMC4954932.pdf
Available online at: http://www.bacterio.net/peptoniphilus.html .,Non-OADS,/arxiv_data1/oa_pdf/c0/c1/main.PMC4954932.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,6 5 –66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c0/c1/main.PMC4954932.pdf
457 457 DOI of original article: http://dx.doi.org/10.1016/j.neo.2016.03.003 .,OADS,/arxiv_data1/oa_pdf/5a/53/main.PMC4954933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/53/main.PMC4954933.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.06.005The authors regret that one of the funding sources was inadvertently omitted: National Cancer Institute Lung Cancer Specialized Programof Research Excellence P50CA70907.The authors would like to apologize for any inconvenience caused.,Non-OADS,/arxiv_data1/oa_pdf/5a/53/main.PMC4954933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/6d/main.PMC4954934.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.06.003,OADS,/arxiv_data1/oa_pdf/07/6d/main.PMC4954934.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/aa/main.PMC4954935.pdf
His http://dx.doi.org/10.1016/j.ijscr.2016.07.003 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/dd/aa/main.PMC4954935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/0e/main.PMC4954936.pdf
http://dx.doi.org/10.1016/j.idcr.2016.06.005 2214-2509/ ã2016 The Authors.,OADS,/arxiv_data1/oa_pdf/72/0e/main.PMC4954936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 43 –45 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/72/0e/main.PMC4954936.pdf
http://dx.doi.org/10.1016/j.idcr.2016.06.006 2214-2509/ ã2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/73/main.PMC4954937.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 40 –42 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/ff/73/main.PMC4954937.pdf
MALDI-TOF-MS spectrum accession number The MALDI-TOF-MS spectrum of ‘Phocea massiliensis ’is avail- able at http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/f0/0c/main.PMC4954938.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.009,Non-OADS,/arxiv_data1/oa_pdf/f0/0c/main.PMC4954938.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,6 7 –68 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f0/0c/main.PMC4954938.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/83/main.PMC4954939.pdf
Abdominal exploration  revealed  dilated  small  bowel  loops  due  to  a  stenotic http://dx.doi.org/10.1016/j.ijscr.2016.06.023 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ab/83/main.PMC4954939.pdf
"362  (June  (24))  (2010)  2389–2398, http://dx.doi.org/10.1056/NEJMcp1000274 .",Non-OADS,/arxiv_data1/oa_pdf/ab/83/main.PMC4954939.pdf
"(June  (18))  (2014), http://dx.doi.org/10.1159/000365329 .",Non-OADS,/arxiv_data1/oa_pdf/ab/83/main.PMC4954939.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/a3/main.PMC4954940.pdf
"In  the  ﬁrst  web  space,  it  was  sepa- http://dx.doi.org/10.1016/j.ijscr.2016.06.036 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/71/a3/main.PMC4954940.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/16/main.PMC4954941.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.06.002,OADS,/arxiv_data1/oa_pdf/99/16/main.PMC4954941.pdf
"Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.neo.2016.06.002 .",OADS,/arxiv_data1/oa_pdf/99/16/main.PMC4954941.pdf
ISBN: 3-900051-07-0; 2011 .A v a i l a b l eo n l i n ea t http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/99/16/main.PMC4954941.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/1c/main.PMC4954942.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.05.001,OADS,/arxiv_data1/oa_pdf/89/1c/main.PMC4954942.pdf
"He also had dysarthria and head tremor (3 Hz) at rest, as well as a postural tremorFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/0c/a1/tre-06-400-7522-1.PMC4954943.pdf
Bilateral Olivary Degeneration and Holmes Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/0c/a1/tre-06-400-7522-1.PMC4954943.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/0c/a1/tre-06-400-7522-1.PMC4954943.pdf
Bilateral Olivary Degeneration and Holmes Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/0c/a1/tre-06-400-7522-1.PMC4954943.pdf
World Population 2012. http://www.un.org/en/ de- velopment/desa/population/publications/pdf/trends/WPP2012_  Wallchart.pdf (accessed May 25th 2015 ).,Non-OADS,/arxiv_data1/oa_pdf/0b/b2/CG-17-343.PMC4955028.pdf
http://www.fao.org/docrep/017/i 1688e/  i1688e.pdf (accessed May25th 2015 ).,Non-OADS,/arxiv_data1/oa_pdf/0b/b2/CG-17-343.PMC4955028.pdf
"https://tos.nias.affrc.go.jp/  (Accessed march 26, 2015 )  [54] Eamens, a.; Wang, M.-B.",Non-OADS,/arxiv_data1/oa_pdf/0b/b2/CG-17-343.PMC4955028.pdf
"http://wmd3.weigelworld.org/  cgi-bin/webapp.cgi (Accessed April 5, 2015 ).",OADS,/arxiv_data1/oa_pdf/0b/b2/CG-17-343.PMC4955028.pdf
http://irri.org/news/119-wild-parent-spawns- super-salt-tolerant-rice.,Non-OADS,/arxiv_data1/oa_pdf/0b/b2/CG-17-343.PMC4955028.pdf
"For example, the genomes of 142 s pecies of l and  plants have be en sequenced (a s of 07 Ma y 2015)  (http://www.ncbi.nlm.nih.gov/genome/brows e/).",OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
4    359  able: Phytozome (http://phytozome.jgi.doe.gov/pz/portal.,Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
html) and Ensembl Plants (http://plants.ensembl.org/index.,OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"For example,  >124,000 accessions of rice, including modern and tradi- tional varieties, and wild relatives of rice are stored at the International Rice Gene Bank (http://irri.org/our-work/research/genetic-diversity/international-rice-genebank), which is maintained by the International Rice Research Insti-tute (http://irri.org/), and these are used by researchers  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"Furthermore, >30,000 and >10,000 accessions of  maize ( Zea mays ) and wheat ( Triticum aestivum ), respec- tively, are stocked and maintained at the International Maize  and Wheat Improvement Center (http://www.cimmyt.org/  en/).",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"1,746 accessions of potato ( Solanum tuberosum ), 8,177  accessions of tomato ( Solanum lycopersicum ), 20,183 acces- sions of soybean ( Glycine max ), and 30,604 accessions of  barley ( Hordeum vulgare ) are stocked and widely available  from the National Plant Germplasm System of USDA-ARS  (as of 13 July 2015) (http://www.ars-grin.gov/npgs/).",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"For example, 5,695 stocks of Arabidopsis thaliana , a  model species, are available (as of 08 May 2015;  https://www.arabidopsis.org/abrc/catalog/natural_accession_1.html) from the Arabidopsis Biological Resource Center (https://abrc.osu.edu/home).",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"For studies on the whole- genome sequence of natural accessions, the 1001 Genome Project (http://1001genomes.org/) was launched in 2008 in  order to elucidate genetic variations among 1,001 natural  accessions in A. thaliana  [30].",OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"In the case of the model temperate grass Brachypo- dium distachyon , 179 natural accessions are stocked and  available from the National Plant Germplasm System of USDA-ARS (http://www.ars-grin.gov/npgs/).",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"Moreover, AmpliSeq has been receiving increasing attention in clinical  studies because a commercially available system, Ion Am- pliSeq Cancer Hotspot Panel v2, has been designed to am- plify 207 amplicons covering approximately 2,800 muta- tions, in 50 cancer-related genes, listed in the Catalogue of  Somatic Mutations in Cancer (http://www.lifetechnolo-gies.com/order/catalog/product/4475346).",Non-OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
"The online Ion  AmpliSeq Designer tool (https://www.ampliseq.com/) is preloaded with the reference genome of crops (e.g., maize,  rice, soybean, and tomato) and is freely available for creating  custom panels.",OADS,/arxiv_data1/oa_pdf/18/7c/CG-17-358.PMC4955029.pdf
Galaxy (http://galaxyproject.org) is one of the  software systems in which researchers can easily use analy-sis tools through web-based interfaces comprised of enor-mous free-accessed biological data [28].,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
"Another software is  Artemis, which is freely available from Sanger institute  (http://www.sanger.ac.uk/).",Non-OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
Type of Database URL  General Plant Genome Database  NCBI Genome http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
gov/genome/  Phytozome v10.2 http ://phytozome.jgi.doe.gov/pz/portal.html  PLAZA http://pl aza.psb.ugent.be/  PlantGDB http://www.plant gdb.org/  Ensembl Plants http://plants.ensembl.org/index.html  ChloroplastDB http://chloroplast.cbio.psu.edu/  KEGG http://www.genome.jp/kegg/  GOLD v.5 https://gold.jgi-psf.org/  CoGepedia https://genomevolution.org/wiki/index.php/Main_Page  Species-specific sequence databases  TAIR ( Arabidopsis ) http://www.arabi dopsis.org/  SIGnAL ( Arabidopsis ) http://signal.salk.edu/  RARGE ( Arabidopsis ) http://rarge.psc.riken.jp/  RGAP v.7 (Rice) http://rice.plantbiol ogy.msu.edu/  RAP-DB (Rice) http://ra pdb.dna.a ffrc.go.jp/  SGN ( Solanaceae ) http://solgenomics.net/solanaceae-project/index.pl  Gramene ( Gramineae ) http://www.gramene.org/  GrainGenes ( Triticeae  and Avena ) http://wheat.pw.usda.,Non-OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
"gov/GG3/  SoyBase (Soybean) http://s oybase.org/  MaizeGDB (Maize) http://www.maize gdb.org/  CyanoBase (Cyanobacteria) http://genome.microbedb.jp/cya nobase/  GDR ( Rosaceae ) https://www.rosaceae.org/  Brassica Genome Gateway ( Brassica ) http://brassica.nbi.ac.uk/  Cucurbit Genomics Database ( Cucurbitacea e) http://www.icugi.org/cgi-bin/ICuGI/index.cgi  Comparative genomics analysis databases  Golm transcriptome db http://cs bdb.mpimp-golm.mpg.de/csbdb/dbxp/ath/ath_xpmgq.html  ATTED-II http://atted.jp/  Other database and tools resources  Galaxy http://gala xyproject.org  Sanger institute http://www.sanger.ac.uk/  GSAP http://www.broadinstitute.org/    method performs by considering an unknown gene that is co- expressed with various genes from a metabolic pathway which is expected to have a function in that particular path-way [80, 81].",Non-OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
One of the largest comparative databases for  plant species (http://phytozome.jgi.doe.gov/pz/portal.html).,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
"Being known as the most comprehensible plant  comparative genomics online platform, PLAZA integrates  functional and structure annotation of all currently published  crop plant genomes (http://plaza.psb.ugent.be/).",OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
A web resource belongs to South Green  Bioinformatics Platform (http://southgreen.cirad.fr/) and is open to public access.,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
This is one of the most commonly used plant  database resources for integrative and comparative plant  genome research (http://mips.helmholtz-muenchen.de/plant/  genomes.jsp).,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
BHIT is  freely available at http://digbio.missouri.edu/BHIT/ for aca- demic users [133].,OADS,/arxiv_data1/oa_pdf/6f/df/CG-17-368.PMC4955030.pdf
"Using ATTED ver7.1  (http://atted.jp/), the co-expression relationship of AtLPR1  (At1g23010) and AtLPR2 (At1g71040) and AtPDR2  (AT5G23630) can be investigated.",OADS,/arxiv_data1/oa_pdf/1d/13/CG-17-308.PMC4955032.pdf
"http://irri.org/news/hot-topics/international- land-acquisition-for-rice-production (A ccessed July 18, 2015 )  [3] Sparks, A.; Nelson, A.; Castilla, N. Where rice pests and diseases  do the most damage.",Non-OADS,/arxiv_data1/oa_pdf/a0/9f/CG-17-297.PMC4955034.pdf
"In Expert Meeting on  How to Feed the World in 2050, 2009 , 1-33. http://gfs.wur.nl/  docs/Bruinsma_pres.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"PLoS one , 2014 ,  http://dx.plos.org/10.1371/journal.pone.0111402 [9] Trenberth, K.E.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"J. Bot ., 2012 ,  http://www.hindawi.com/jour nals/jb/2012/217037/abs/.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"Plant Sci ., 2014 , 5.  http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"Physiol ., 2012 , 3.  http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"Sci ., 1977 , http://agris.fao.org/agris- search/search.do?recordID=AU19780321350.",OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"PLoS Biology , 2014 ,  http://dx.plos.org/10.1371/journal.pbio.1001883.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"PLoS Genetics ,  2011 , http://dx.plos.org/10.1371/journal.pgen.1002383.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"PLoS , 2013 ,  http://dx.plos.org/10.1371/journal.pone.0062795.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
"PLoS , 2013 , http://dx.plos.org/10.1371/journal.pone.0064062.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/CG-17-330.PMC4955035.pdf
Neuroimaging was performed in all patients except one because ofFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/e6/3b/tre-06-402-7522-1.PMC4955070.pdf
Chorea/Ballism associated with hyperglycemia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/e6/3b/tre-06-402-7522-1.PMC4955070.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/e6/3b/tre-06-402-7522-1.PMC4955070.pdf
Chorea/Ballism associated with hyperglycemia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/e6/3b/tre-06-402-7522-1.PMC4955070.pdf
Available from:  http://www.nccn.org/professionals/physician_gls/pdf/ genetics_screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/56/AJA-18-530.PMC4955175.pdf
"Figure 2: Top 20 genes mutated in prostate carcinoma as January 31,  2016 (http://www.sanger.ac.uk/genetics/CGP/cosmic).",Non-OADS,/arxiv_data1/oa_pdf/0b/8f/AJA-18-533.PMC4955176.pdf
Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ ucm427554.htm.,Non-OADS,/arxiv_data1/oa_pdf/a9/d3/AJA-18-592.PMC4955184.pdf
Available from:  https://www.clinicaltrials.gov/ct2/show/study/ NCT02438007?term=ARMOR3 and rank=1 and  show_locs=Y#locn.,Non-OADS,/arxiv_data1/oa_pdf/a9/d3/AJA-18-592.PMC4955184.pdf
Available from: http://www.bvsms.saude.gov.br/bvs/ saudelegis/anvisa/2011/res0023_27_05_2011.,OADS,/arxiv_data1/oa_pdf/39/27/AJA-18-596.PMC4955186.pdf
"Now offering: Neurology®Resident & Fellow Editorial team information “Search by subcategory ”option E-pearl of the Week RSS Feeds Direct links to Continuum®, Career Planning, and AAN Resident & Fellow pages Recently published Resident & Fellow articles Podcast descriptions Find Neurology®Residents & Fellows Section on Faceb ook: http://tinyurl.com/o8ahsys Follow Neurology®on Twitter: http://twitt er.com/GreenJournal Neurology 87 July 19, 2016 313 ª2016 American Academy of Neurology.",Non-OADS,/arxiv_data1/oa_pdf/8d/86/NEUROLOGY2015692616.PMC4955275.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/58/jev211.PMC4955290.pdf
"18 In previous work in our laboratory, we detected the expression of cytoplasmic Hp within the tumors of patients with ovariancarcinoma, whereas this protein was absent from cancer-free © OL Garibay-Cerdenares, VI Hern /C19andez-Ramírez, JC Osorio-Trujillo, D Gallardo-Rinc /C19on, and P Talam /C19as-Rohana *Correspondence to: P Talam /C19as-Rohana; Email: ptr@cinvestav.mx Submitted: 12/18/2013; Revised: 03/13/2015; Accepted: 03/25/2015 http://dx.doi.org/10.1080/19336918.2015.1035504 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Br J Cancer 2004; 91:129-140; PMID:15199385;http://dx.doi.org/10.1038/sj.bjc.6601882 3.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Gene 1997; 195(1):19-27; PMID:9300815;http://dx.doi.org/10.1016/S0378-1119(97)00123-6 5.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Clin Chem 2008; 54(4):697-704; PMID:18258668; http://dx.doi.org/10.1373/clinchem.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Hum Hered1987; 37(5):290-293; PMID:3499374; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Hum Hered 1988; 38(3):144- 150; PMID:3397067; http://dx.doi.org/10.1159/ 000153775 9.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Clin Chim Acta 2004; 341(1):17-21; PMID:14967153; http://dx.doi.org/10.1016/j.cccn.2003.10.032 10.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Pathol Oncol Res 1998; 4(4):271-276; PMID:9887357; http://dx.doi.org/10.1007/BF02905217 11.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
BMC Biol 2009; 7:87;PMID:20017911; http://dx.doi.org/10.1186/1741- 7007-7-87 15.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Cancer 1993; 71(12):3938-3941; PMID:8389656; http://dx.doi.org/ 10.1002/1097-0142(19930615)71:12%3c3938::AID- CNCR2820711223%3e3.0.CO;2-Q 16.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
CA Cancer J Clin 2013; 63(1):11-30; PMID:23335087; http://dx.doi.org/10.3322/caac.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Lancet Oncol2006; 7(11):925-934; PMID:17081918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
J Ovarian Res 2014; 7 (1):27; PMID:24576319; http://dx.doi.org/10.1186/ 1757-2215-7-27 20.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Eu J Cancer Clin Oncol 1984; 20(5):625-630;PMID:6539699; http://dx.doi.org/10.1016/0277- 5379(84)90007-5 21.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Nature 1968; 218 (5143):736-741; PMID:4172407; http://dx.doi.org/ 10.1038/218736a0 22.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Int J Lab Hematol 2007; 29(2):92-110; PMID:17474882; http://dx.doi.org/10.1111/j.1751- 553X.2007.00898.x 23.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
J Proteomics 2010; 73(10):1864- 1872; PMID:20561909; http://dx.doi.org/10.1016/j.jprot.2010.05.013 25.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Elec- trophoresis 2007; 28:1989-1996; PMID:17503403; http://dx.doi.org/10.1002/elps.200600629 26.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Int J Cancer 2008; 122(1):39-49; PMID:17803183; http://dx.doi.org/10.1002/ijc.22958 27.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Curr Op Cell Biol 2005; 17(5):559-564; PMID:16098726; http://dx.doi.org/10.1016/j.ceb.2005.08.002 28.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Proteomics 2004;4(8):2221-2228; PMID:15274115; http://dx.doi.org/ 10.1002/pmic.200300787 29.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Biochem Biophys ResCommun 1995; 209(1):250-256; PMID:7726843; http://dx.doi.org/10.1006/bbrc.1995.1496 30.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Cancer Lett 1992; 14(66):43-48; PMID:1451094; http://dx.doi.org/10.1016/0304-3835(92)90278-4 33.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Proteomics 2005; 5(17):4625-4636; PMID:16220531; http://dx.doi.org/10.1002/pmic.200401321 35.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Nature 2001; 409 (6817):198-201; PMID:11196644; http://dx.doi.org/ 10.1038/35051594 37.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
BMC Biology 2009; 7(1):87-87; PMID:20017911; http://dx.doi.org/ 10.1186/1741-7007-7-87 38.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
Neopla-sia 2007; 9(1):1-7; PMID:17325738; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
J CellSci 2003; 116(22):4615-4628; PMID:14576355; http://dx.doi.org/10.1242/jcs.00755 43.,OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
PLoS One 2012; 7(1):e28305; PMID:22279523; http://dx.doi.org/10.1371/journal.pone.0028305 44.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
PLoS One 2011; 6(11):e27593; PMID:22096600;http://dx.doi.org/10.1371/journal.pone.0027593 45.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
(7):2004-2013; PMID:17568021; http://dx.doi.org/ 10.1681/ASN.2006111292 46.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
J Clin Invest 2009; 119(6):1420-1428; PMID:19487818; http://dx.doi.org/10.1172/ JCI3910447.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
BMC Cancer2011; 12(11):130; PMID:21486440; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/kcam-09-05-1035504.PMC4955374.pdf
"6, e1145333 (15 pages)http://dx.doi.org/10.1080/2162402X.2016.1145333",Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
CA Cancer J Clin 2011; 61:69-90; PMID:21296855;http://dx.doi.org/10.3322/caac.20107 2.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Treat Rev 2015;41:170-8; PMID:25498841; http://dx.doi.org/10.1016/j.ctrv.2014.11.003 3.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Med 2013; 19:1423-37; PMID:24202395; http://dx.doi.org/10.1038/nm.3394 5.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Clin Invest 2012; 122:787-95; PMID:22378047; http://dx.doi.org/10.1172/JCI59643 6.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Cell 2013; 23:277-86; PMID:23518347;http://dx.doi.org/10.1016/j.ccr.2013.02.013 7.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Rev Immunol 2009; 9:162-74;PMID:19197294; http://dx.doi.org/10.1038/nri2506 8.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Biochim Biophys Acta 2013; 1835:100-9; PMID:23123827; http://dx.doi.org/10.1016/j.bbcan.2012.10.003.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Exp Med 2008; 205:2235-49;PMID:18809714; http://dx.doi.org/10.1084/jem.20080132 10.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Nucl Med 2015; 56:450-6; PMID:25678492; http://dx.doi.org/ 10.2967/jnumed.114.146688 11.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Science 2015; 348:74-80; PMID:25838376; http://dx.doi.org/10.1126/science.aaa6204 12.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Immunol 2014; 193:3835-41; PMID:25281753; http://dx.doi.org/ 10.4049/jimmunol.1401572 13.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Ann Oncol 2014; 25:2433-42;PMID:25223485; http://dx.doi.org/10.1093/annonc/mdu452 14.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Lab Invest2014; 94:107-16; PMID:24217091; http://dx.doi.org/10.1038/labinvest.2013.130 15.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer 2007; 109:1499-505; PMID:17340590; http://dx.doi.org/10.1002/cncr.22588ONCOIMMUNOLOGY e1145333-13,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Genet Mol Res 2015; 14:1277-86;PMID:25730066; http://dx.doi.org/10.4238/2015.February.13.6.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Semin Oncol 2015; 42:363-77; PMID:25965355; http://dx.doi.org/10.1053/j.seminoncol.2015.02.015 19.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
PLoS One 2012; 7:e34207; PMID:22470535;http://dx.doi.org/10.1371/journal.pone.0034207 20.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Res2013; 73:172-83; PMID:23135911; http://dx.doi.org/10.1158/0008-5472.CAN-11-3843 21.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Prostate 2006; 66:1768-78; PMID:16955399; http://dx.doi.org/10.1002/pros.20509 22.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Onco Targets Ther 2014; 7:223-34; PMID:24600234; http://dx.doi.org/ 10.2147/OTT.S53524.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Oncoimmunology 2012; 1:1404-5; PMID:23243608; http://dx.doi.org/10.4161/onci.21027 24.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
PLoS Biol 2009; 7:e97; PMID:19402754; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Eur J Biochem 2000; 267:560-5;PMID:10632726; http://dx.doi.org/10.1046/j.1432-1327.2000.01040.x 27.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Immunology2011; 133:221-38; PMID:21453419; http://dx.doi.org/10.1111/j.1365- 2567.2011.03429.x 28.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Rev Immunol 2013; 13:777-89;PMID:24113868; http://dx.doi.org/10.1038/nri3536 29.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Rev Cancer 2008;8:535-45; PMID:18548086; http://dx.doi.org/10.1038/nrc2400 30.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Med 2013; 19:1264-72; PMID:24056773; http://dx.doi.org/ 10.1038/nm.3337 31.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cytokine Growth Factor Rev 2014; 25:377-90; PMID:25200249;http://dx.doi.org/10.1016/j.cytogfr.2014.07.018 32.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Eur J Cancer 2014; 50:1829-35; PMID:24726733; http://dx.doi.org/10.1016/j.ejca.2014.03.278.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Oncotar-get 2015; 6:28401-24; PMID:26315114; http://dx.doi.org/10.18632/ oncotarget.4951 34.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Immunol Res 2015; 3:136-48;PMID:25370534; http://dx.doi.org/10.1158/2326-6066.CIR-14-0036 35.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Immunol 2013; 14:1014-22; PMID:24048123; http://dx.doi.org/10.1038/ni.2703 36.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Oncoimmunology 2014; 3: e27878; PMID:24800173; http://dx.doi.org/10.4161/onci.27878 38.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cell Death Differ 2014; 21:39-49; PMID:23832118; http://dx.doi.org/10.1038/cdd.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Cell 2015; 27:437-8; PMID:25873170; http://dx.doi.org/10.1016/j.ccell.2015.03.015 40.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Clin Invest 2014; 124:687-95;PMID:24382348; http://dx.doi.org/10.1172/JCI67313 42.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Semin Oncol 2015; 42:429-35; PMID:25965361; http://dx.doi.org/10.1053/j.seminoncol.2015.02.010 43.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nature2014; 515:558-62; PMID:25428503; http://dx.doi.org/10.1038/ nature13904 44.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Oncotarget 2014; 5:12472-508; PMID:25537519; http://dx.doi.org/10.18632/ oncotarget.2998 45.,OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J Clin Oncol 2011; 29:4022-8; PMID:21931019; http://dx.doi.org/10.1200/JCO.2011.35.6295 46.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Nat Rev Cancer 2013; 13:365-76; PMID:23535846; http://dx.doi.org/10.1038/nrc3498 48.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Res 2014; 74:5057-69; PMID:25082815; http://dx.doi.org/10.1158/0008-5472.CAN-13-3723 49.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Crit Rev Immunol 2008; 28:325-39; PMID:19166383; http://dx.doi.org/10.1615/ CritRevImmunol.v28.i4.40 50.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancers (Basel) 2011; 3:3856-93; PMID:24213115; http://dx.doi.org/10.3390/ cancers3043856 51.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
J ImmunoTher Cancer 2014; S3-131; http://dx.doi.org/10.1186/2051-1426-2-S3-P131 52.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Oncoimmunology 2015; 4: e974399; PMID:26155432; http://dx.doi.org/10.4161/2162402X.2014.974399 53.,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Cancer Res 2015; 75:2139-45; PMID:25977340; http://dx.doi.org/10.1158/0008-5472.CAN-15-0255ONCOIMMUNOLOGY e1145333-15,Non-OADS,/arxiv_data1/oa_pdf/08/10/koni-05-06-1145333.PMC4955379.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.06.010 2451-8654/ ©2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC4955389.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 4 (2016) 14 e24,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC4955389.pdf
"[52] National Committee for Quality Assurance, HEDIS &Quality Measurement, Available at, http://www.ncqa.org/tabid/59/Default.aspx .",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC4955389.pdf
Available from: http://www.pediatrie-pratique.com/journal/ article/004889-tuberculosepelvienne-simulant-un-cancer-de-lovaire- chez-lenfant-propos-dun.,Non-OADS,/arxiv_data1/oa_pdf/30/03/AJPS-12-155.PMC4955410.pdf
Available from: http://www.nhsemployers.org.,Non-OADS,/arxiv_data1/oa_pdf/bc/3c/AJPS-12-114.PMC4955416.pdf
Available from:  http://www.champprogram.com/question/19a.shtml.,Non-OADS,/arxiv_data1/oa_pdf/eb/01/AJPS-12-161.PMC4955427.pdf
Available from: http://www.posterng.,Non-OADS,/arxiv_data1/oa_pdf/eb/01/AJPS-12-161.PMC4955427.pdf
Available from: http://www.wikiradiography.com/page/ Pneumoperitoneum.,Non-OADS,/arxiv_data1/oa_pdf/eb/01/AJPS-12-161.PMC4955427.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/58/fe/AJPS-13-63.PMC4955439.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/72/5d/AJPS-13-9.PMC4955451.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/72/5d/AJPS-13-9.PMC4955451.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/53/b8/AJPS-13-36.PMC4955455.pdf
: Saline colostomy distension study in ARM31 January-March 2016 / Vol 13 / Issue 1 African Journal of Paediatric SurgeryAvailable from: http://www.cancer.gov/cancertopics/causes/ radiation/radiation-risks-pediatric-CT. [Last reviewed on 2012 Jul 06;  Last accessed on 2014 Jan 09].,Non-OADS,/arxiv_data1/oa_pdf/c0/f0/AJPS-13-26.PMC4955457.pdf
Available at  http://www.schn.health.nsw.gov.,Non-OADS,/arxiv_data1/oa_pdf/c0/f0/AJPS-13-26.PMC4955457.pdf
Available from: http://www.isradiology.org.,Non-OADS,/arxiv_data1/oa_pdf/c0/f0/AJPS-13-26.PMC4955457.pdf
Available from:  http://www.dx.doi.org/10.4236/ojped.2014.43025.,Non-OADS,/arxiv_data1/oa_pdf/a7/e6/AJPS-12-261.PMC4955472.pdf
Available from:  http://www.wjgnet.com/1007-9327/full/v19/i47/9077.htm.,Non-OADS,/arxiv_data1/oa_pdf/a7/e6/AJPS-12-261.PMC4955472.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/d5/40/AJPS-12-251.PMC4955474.pdf
(http://www.pediatricurologybook.com/ urethral_valves.html) 4.,Non-OADS,/arxiv_data1/oa_pdf/91/00/AJPS-12-270.PMC4955479.pdf
Available from:  http://www.data.worldbank.org/about/country-classifications.,OADS,/arxiv_data1/oa_pdf/52/e4/AJPS-12-1.PMC4955493.pdf
Available from: http://www.urology-textbook.com/hypospadias.,Non-OADS,/arxiv_data1/oa_pdf/21/6e/AJPS-12-41.PMC4955496.pdf
Available from: http://www.emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/21/6e/AJPS-12-41.PMC4955496.pdf
Available from:  http://www.nice.org.uk/IPG149.Ankyloglossia (tongue-tie) Access this article online Quick Response Code: Website:    www.afrjpaedsurg.org DOI:    10.4103/0189-6725.151010  PMID:   *** Figure 1: Image depicting scar tissue (arrow) on ventral surface of tongue,Non-OADS,/arxiv_data1/oa_pdf/20/bd/AJPS-12-101b.PMC4955500.pdf
Available from:  http://www.nice.org.uk/IPG149.Ankyloglossia (tongue-tie) Access this article online Quick Response Code: Website:    www.afrjpaedsurg.org DOI:    10.4103/0189-6725.151010  PMID:   *** Figure 1: Image depicting scar tissue (arrow) on ventral surface of tongue,Non-OADS,/arxiv_data1/oa_pdf/1e/61/AJPS-12-101a.PMC4955501.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/52/nihms799836.PMC4955854.pdf
Available at: https://www.vdh.virginia.gov/epidemiology/DiseasePrevention/documents/pdf/ THISFINALREPORTVol1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/90/qai-72-s248.PMC4955862.pdf
THIS IS A N OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.03.005,Non-OADS,/arxiv_data1/oa_pdf/d4/43/main.PMC4955869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/43/main.PMC4955869.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/48/gzw022.PMC4955872.pdf
"In order to include the effects of the missingcharged residues, we built the atomic models for the other residueswith electron densities that were not observed in the crystal structures,listed in Table I, by the spanner modeling server (Lis et al., 2011) (http://sysimm.ifrec.osaka-u.ac.jp/spanner/).",OADS,/arxiv_data1/oa_pdf/34/48/gzw022.PMC4955872.pdf
The partial atomic chargesof ADP and ATP were taken from the AMBER parameter database(http://www.pharmacy.manchester.ac.uk/bryce/amber).,OADS,/arxiv_data1/oa_pdf/34/48/gzw022.PMC4955872.pdf
All of the productive runs were performed using theHA-PACS supercomputer system at Tsukuba University (http://www.ccs.tsukuba.ac.jp/eng/research-activ ities/projects/ha-pacs/).,OADS,/arxiv_data1/oa_pdf/34/48/gzw022.PMC4955872.pdf
Available at: https://careacttarget.org/sites/ default/ ﬁles/ﬁle-upload/resources/PrEP%20and%20Transgender%20Women %20NCIHC%20Brief.pdf2015.,Non-OADS,/arxiv_data1/oa_pdf/1d/87/qai-72-s230.PMC4955879.pdf
"Available at: http://www.wpath.org/ uploaded_ ﬁles/140/ ﬁles/Standards%20of%20Care,%20V7%20Full% 20Book.pdf2012.",Non-OADS,/arxiv_data1/oa_pdf/1d/87/qai-72-s230.PMC4955879.pdf
Availabl e at: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/DrugInteractions Labeling/ucm093664.htm.,Non-OADS,/arxiv_data1/oa_pdf/1d/87/qai-72-s230.PMC4955879.pdf
Available at: http://www.questdiagnostics.,Non-OADS,/arxiv_data1/oa_pdf/1d/87/qai-72-s230.PMC4955879.pdf
"Quality of life [Short Health  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/32/jjw032.PMC4955912.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Birthweight and prostate cancer 848 www.bjcancer.com | DOI:10.1038/bjc.2016.38,Non-OADS,/arxiv_data1/oa_pdf/9b/19/bjc201638a.PMC4955914.pdf
"24-26 ©Anastasiya V Snigireva, Veronika V Vrublevskaya, Vladimir N Afanasyev, and Oleg S Morenkov *Correspondence to: Anastasiya V Snigireva; Email: snigireva.s@gmail.comSubmitted: 03/09/2015; Revised: 09/23/2015; Accepted: 09/30/2015 http://dx.doi.org/10.1080/19336918.2015.1103421 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Biomed J 2013; 36:106-17; PMID:23806880; http://dx.doi.org/10.4103/2319- 4170.113230 3.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
EMBO J 2007; 26:1221-33; PMID:17304217; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Future Oncol 2009; 5:679-88; PMID:19519207; http://dx.doi.org/10.2217/fon.09.30 5.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Mol Cell Biol 2008; 28:3344-58; PMID:18332123; http://dx.doi.org/10.1128/MCB.01287-07 7.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Biochem Biophys Res Com- mun 1998; 253:283-7; PMID:9878529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Biol Chem 2004; 279:45379-88; PMID:15302889; http://dx.doi.org/10.1074/jbc.M405486200 11.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Clin Invest 2011; 121:4348-61;PMID:22019588; http://dx.doi.org/10.1172/JCI46475 12.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Int Rev Cell Mol Biol 2013; 303:203-35; PMID:23445811; http://dx.doi.org/10.1016/B978-0- 12-407697-6.00005-2 13.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Exp Dermatol 2004; 13:27-32;PMID:15009113; http://dx.doi.org/10.1111/j.0906- 6705.2004.00114.x 14.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
BMC Can- cer 2010; 10:294; PMID:20553606; http://dx.doi.org/ 10.1186/1471-2407-10-294 15.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Biol Chem 2008; 283:2031-41;PMID:18056992; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
BMC Cell Biol 2010; 11:51; PMID:20602761; http://dx.doi.org/10.1186/1471- 2121-11-51 17.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Cell Cycle 2004; 3:1098-1100;PMID:15326368; http://dx.doi.org/10.4161/ cc.3.9.1088 18.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Immunity 2001; 14:303-13; PMID:11290339; http://dx.doi.org/ 10.1016/S1074-7613(01)00111-X 19.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Genes Dev 2013; 27:805-17; PMID:23592797; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
PLoS ONE 2014; 9:e86842; PMID:24466266; http://dx.doi.org/ 10.1371/journal.pone.0086842 22.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Biol Chem 2010; 285:40039-49; PMID:20937816; http://dx.doi.org/10.1074/jbc.M110.181941 23.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Biochem Biophys Res Commun 2010; 398:525-31; PMID:20599762; http://dx.doi.org/10.1016/j.bbrc.2010.06.112 24.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Cold Spring Harb Perspect Biol 2011;3:a004952; PMID:21690215; http://dx.doi.org/ 10.1101/cshperspect.a004952 25.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Int J Biochem Cell Biol 2000;32:263-384; PMID:10716624; http://dx.doi.org/ 10.1016/S1357-2725(99)00116-8 27.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Biochemistry 1989; 28:8100-7; PMID:2532538; http://dx.doi.org/10.1021/bi00446a021 29.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Handb Exp Pharmacol 2012; 207:159-76; PMID:22566225; http://dx.doi.org/10.1007/978-3-642-23056-1_8 30.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Biol Chem 1995; 270:24442-50; PMID:7592659; http://dx.doi.org/10.1074/jbc.270.41.24442 31.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Cell Sci 2003; 116:2875-83;PMID:12771183; http://dx.doi.org/10.1242/jcs.00597 33.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Immunol 2010; 185:6819-30; PMID:21048103; http://dx.doi.org/10.4049/jimmunol.1000448 34.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Eur J Immunol 2008; 38:809-17;PMID:18266273; http://dx.doi.org/10.1002/ eji.200737722 35.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Biol Chem 2003; 278:15758-64; PMID:12598530; http://dx.doi.org/ 10.1074/jbc.M208786200 36.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
J Neurosci 2011; 31:1644-51; PMID:21289173; http://dx.doi.org/10.1523/JNEUROSCI.5491-10.2011 38.,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Int J Cell Biol 2012; 2012:676731; PMID:22505933; http://dx.doi.org/10.1155/2012/ 676731 39.,OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
Biomed Chromatogr 2009; 23:1208-16; PMID:19488974; http://dx.doi.org/10.1002/bmc.1245 468 Volume 9 Issue 6 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/19/c9/kcam-09-06-1103421.PMC4955955.pdf
"Once activated and © Noritaka Saeki, Shingo Nishino, Tomohiro Shimizu, and Kazushige Ogawa *Correspondence to: Kazushige Ogawa; Email: kogawa@vet.osakafu-u.ac.jpSubmitted: 08/19/2015; Revised: 10/06/2015; Accepted: 10/07/2015 http://dx.doi.org/10.1080/19336918.2015.1107693 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Immunity 2014; 41:694-707; PMID:25517612; http://dx.doi.org/10.1016/j.immuni.2014.10.008.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Cell Adh Migr 2014; 8:67-75; PMID:24621576; http://dx.doi.org/10.4161/ cam.28244.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Curr Opin Hematol 2010; 17:43-52; PMID:19996887; http://dx.doi.org/10.1097/ MOH.0b013e3283333949.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Annu Rev Immunol 2007; 25:619-47; PMID:17201681; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141618.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Genome Biol 2007; 8:215; PMID:17543136; http://dx.doi.org/ 10.1186/gb-2007-8-5-215.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Nat Rev Immunol 2007; 7:678-89; PMID:17717539; http://dx.doi.org/10.1038/nri2156.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Cell 2008; 133:38-52; PMID:18394988; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Nat Rev Mol Cell Biol 2005; 6:462- 75; PMID:15928710; http://dx.doi.org/10.1038/ nrm1662.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Nat Rev Cancer 2010; 10:165-80; PMID:20179713; http://dx.doi.org/ 10.1038/nrc2806.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Cell Mol Life Sci 2014; 71:3685-710;PMID:24794629; http://dx.doi.org/10.1007/s00018- 014-1633-0.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Nat Rev Mol Cell Biol 2002; 3:475-86; PMID:12094214; http://dx.doi.org/10.1038/nrm856.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Mol Immunol 2008; 45:1208-20; PMID:17980912; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Blood 2009; 114:5081-90; PMID:19828693; http://dx.doi.org/10.1182/blood-2009-03-210617.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Blood 2003; 102:4431-40; PMID:12907451; http://dx.doi.org/ 10.1182/blood-2003-02-0500.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Mol Cell Biol 2001; 21:4579-97;PMID:11416136; http://dx.doi.org/10.1128/ MCB.21.14.4579-4597.2001.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Biophys J 2010; 98:881-9; PMID:20197042; http://dx.doi.org/10.1016/j.bpj.2009.11.008.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
J Biol Chem 2005; 280:29355-63;PMID:15955811; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Sci- ence 1995; 268:567-9; PMID:7536959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Am J Pathol 2012; 181:1493-503; PMID:23021982; http://dx.doi.org/10.1016/j.ajpath.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Nat Rev Drug Discov 2014; 13:39-62; PMID:24378802;http://dx.doi.org/10.1038/nrd4175.25.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Oncogene 2000; 19:6043-52;PMID:11146556; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
Histochem Cell Biol 2013; 140:659-75; PMID:23881165; http://dx.doi.org/10.1007/s00418-013-1129-2.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/kcam-09-06-1107693.PMC4955956.pdf
"It is considered as © Emanuala Barletta, Matteo Ramazzotti, Florinda Fratianni, Daniela Pessani, Donatella Degl ’Innocenti *Correspondence to: Donatella Degl ’Innocenti; Email: donatella.deglinnocenti@uni ﬁ.it Submitted: 09/22/2014; Revised: 11/07/2014; Accepted: 01/12/2015 http://dx.doi.org/10.1080/19336918.2015.1008330 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Nat Rev Mol Cell Biol 2007; 8:221-33;PMID:17318226; http://dx.doi.org/10.1038/nrm2125 2.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Trends Cell Biol 2008; 18:560-74; PMID:18848450; http://dx.doi.org/ 10.1016/j.tcb.2008.08.007 3.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Onkologie 2012; 35:49-53; PMID:22310347; http://dx.doi.org/10.1159/000336304 4.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cancer Treat Res 2009;148:43-66; PMID:19377918; http://dx.doi.org/ 10.1007/978-0-387-79962-9_4 5.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Nat Rev Drug Dis-cov 2007; 6:480-98; PMID:17541420; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Nat Rev Cancer 2007; 7:800-8; http://dx.doi.org/10.1038/nrc2228 7.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cell 2011; 147:992-1009; PMID:22118458; http://dx.doi.org/10.1016/j.cell.2011.11.016 8.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
"Kessenbrock K, Plaks V, Werb Z. Matrix metallopro- teinases: regulators of the tumor microenvironment.Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Arch Oral Biol 2007; 53:287- 94; PMID:17936716; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Expert Rev Anticancer Ther 2005; 5:149-63; PMID:15757447; http://dx.doi.org/10.1586/14737140.5.1.149 12.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
J AgricFood Chem 2012; 60:12451-7; PMID:23210512; http://dx.doi.org/10.1021/jf300964f 14.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Mar Pollut Bull 2013; 75:157-67; PMID:23953894; http://dx.doi.org/10.1016/j.marpolbul.2013.07.044 16.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
J Environ Monit 2011; 14:187-92; PMID:22101939; http://dx.doi.org/ 10.1039/c1em10575b 17.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
PLoS One 2013; 8:e76870; PMID:24204692; http://dx.doi.org/ 10.1371/journal.pone.0076870 19.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
J Ethnopharmacol 2007; 115:122- 30; PMID:17977678; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Botanica Marina 1979; 22:129-31; http://dx.doi.org/ 10.1515/botm.1979.22.6.359 23.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Botanica Marina 1989; 32:85-88; http://dx.doi.org/10.1515/ botm.1989.32.2.85 24.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
JChem Ecol 2007; 33:1083-8; PMID:17404815; http://dx.doi.org/10.1007/s10886-007-9290-5 25.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Sci Total Environ 2006; 370:91-8; PMID:16890273; http://dx.doi.org/ 10.1016/j.scitotenv.2006.07.016 27.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Nat Prod Res 2012; 27:1265-70; PMID:22978670; http://dx.doi.org/10.1080/14786419.2012.725401 29.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Pharm Biol 2007; 45: 745-8; http://dx.doi.org/ 10.1080/13880200701585717 30.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Clin Chim Acta 2005; 362:57-64; PMID:16004979; http://dx.doi.org/10.1016/j.cccn.2005.05.009 32.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Am J Physiol Heart Circ Physiol 2012; 302: H1330-9; PMID:22268108; http://dx.doi.org/10.1152/ajpheart.01044.2011 33.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Int J Dermatol 2010; 49:276-82;PMID:20465664; http://dx.doi.org/10.1111/j.1365- 4632.2009.04269.x 34.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cancer Metastasis Rev 2006; 25:695-705; PMID:17160708; http://dx.doi.org/10.1007/s10555- 006-9037-8 35.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
BMC Complement Altern Med 2014; 14:133; PMID:24712558; http://dx.doi.org/10.1186/1472- 6882-14-133 37.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Clin Chim Acta 2007; 381:69-77; PMID:17382921; http://dx.doi.org/10.1016/j.cca.2007.02.022 38.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cancer Metastasis Rev 2012; 31:323-51; PMID:22314287; http://dx.doi.org/10.1007/s10555-012-9347-y 39.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cancer Cell Int 2006; 6:7; PMID:16566826; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Int Immunopharmacol 2010; 11:23-8; PMID:20951230; http://dx.doi.org/ 10.1016/j.intimp.2010.09.021 44.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Methods Enzymol 2001; 335:190-203; PMID:11400368; http://dx.doi.org/10.1016/S0076- 6879(01)35243-6 46.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Cancer 2001; 91:822-32; PMID:11241252; http://dx.doi.org/ 10.1002/1097-0142(20010215)91:4%3c822::AID-CNCR1070%3e3.0.CO;2-G 47.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
J Med Food 2011; 14:957- 63; PMID:21476926; http://dx.doi.org/10.1089/ jmf.2010.0170 49.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Anal Bio- chem 2005; 339:69-72; PMID:15766712; http://dx.doi.org/10.1016/j.ab.2004.12.001 50.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
in human subjects.Br J Nutr 2008; 101:79-85; http://dx.doi.org/ 10.1017/S000711450899475751.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
J Agric Food Chem 2000; 48:3597-604; PMID:10956156; http://dx.doi.org/10.1021/jf000220w 52.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Biol Chem 2002; 383:189-97; PMID:11928813; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
Methods 2002; 25:402-8; http://dx.doi.org/10.1006/meth.2001.1262 www.tandfonline.com 431 Cell Adhesion & Migration,OADS,/arxiv_data1/oa_pdf/e9/0c/kcam-09-06-1008330.PMC4955962.pdf
"5,7FERM domain is considered as the binding site for membrane components, phosphatidyl-inositide *Correspondence to: Kouichi Tachibana; Email: kouichi-tachibana@aist.go.jp Submitted: 07/07/2015; Revised: 09/11/2015; Accepted: 10/22/2015 http://dx.doi.org/10.1080/19336918.2015.1113366 502 Volume 9 Issue 6 Cell Adhesion & MigrationCell Adhesion & Migration 9:6, 502--512; November/December 2015; © 2015 Taylor & Francis Group, LLCRESEARCH PAPER",Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Cell Biol 1997; 138:1409-23; PMID:9298994; http://dx.doi.org/ 10.1083/jcb.138.6.1409 2.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Blood 2003; 102:3890-9; PMID:12907449; http://dx.doi.org/10.1182/blood-2002-12-3807 3 .,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Immunity 2001; 15:691-701; PMID:11728332;http://dx.doi.org/10.1016/S1074-7613(01)00231-X 4.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Immunity 2001; 15:715- 28; PMID:11728334; http://dx.doi.org/10.1016/ S1074-7613(01)00225-4 5.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Biochem Bio- phys Acta 2007; 1772:653-60; http://dx.doi.org/ 10.1016/j.bbamcr.2006.06.013 6.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Int J Biochem Cell Biol 2008; 40: 344-9; PMID:17419089; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
FEBS Lett 1994; 376:172-6; http://dx.doi.org/10.1016/0014- 5793(95)01270-1 10.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Cell 2000; 101:259-270; PMID:10847681; http://dx.doi.org/ 10.1016/S0092-8674(00)80836-3 12.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Biol Chem 2012; 287:16311-23; PMID:22433855; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Curr Opin CellBiol 1999; 11:109-16; PMID:10047517; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Biol Chem 1999; 274:34507-10; PMID:10574907; http://dx.doi.org/10.1074/jbc.274.49.34507 16.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Biol Chem 1995; 270:31377-85; PMID:8537411; http://dx.doi.org/10.1074/jbc.270.52.31377 17.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Biochem Biophys Res Commun 1996; 226: 650-6; PMID:8831671; http://dx.doi.org/10.1006/bbrc.1996.1410 19.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Mol Biol Cell1999; 10:2669-85; PMID:10436021; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Biol Cell 2000; 92:305-16; http://dx.doi.org/10.1016/S0248-4900(00)01078-9 21.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Curr Biol 2008; 18:91-101; PMID:18207738;http://dx.doi.org/10.1016/j.cub.2007.12.051 22.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Cell Biol 2008; 180:739-46; PMID:18283112; http://dx.doi.org/10.1083/jcb.200709161 23.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Cell Adh Migr 2011;5:119-32; PMID:21045567; http://dx.doi.org/ 10.4161/cam.5.2.13908 2 4 .,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Cell Adh Migr 2013; 7:426-33; PMID:24036614; http://dx.do i.org/10.4161/cam.25957 25.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Cell Motil Cyto- skeleton 1991; 18:26-40; PMID:1848484; http://dx.doi.org/10.1002/cm.970180104 26.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Br J Pharmacol 1993; 109:703-12; PMID:8395295; http://dx.doi.org/10.1111/j.1476-5381.1993.tb13631.x 27.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Immunity 2001; 15:683-6; PMID:11728330; http://dx.doi.org/10.1016/S1074-7613(01)00237-0 2 8 .,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Bio- chem Biophys Acta 2001; 1589:93-103; http://dx.doi.org/ 10.1016/S0167-4889(02)00161-1 29.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Biophys J 1999; 77:3363-70;PMID:10585959; http://dx.doi.org/10.1016/S0006- 3495(99)77168-7 30.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Biophys J 2008; 94:1836-53; PMID:17921219; http://dx.doi.org/ 10.1529/biophysj.107.113605 31.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
Nat Rev Mol Cell Biol 2007; 8:633-44; PMID:17643125; http://dx.doi.org/10.1038/nrm222234.,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
J Biosci Bioeng 2013; 116:380-5; PMID:23567154; http://dx.doi.org/10.1016/j.jbiosc.2013.03.003 512 Volume 9 Issue 6 Cell Adhesion & Migration,OADS,/arxiv_data1/oa_pdf/58/b1/kcam-09-06-1113366.PMC4955964.pdf
"genome sequence from UCSC database (UCSC hg19, http://genome.ucsc.edu/).16To explore single nucleotide polymorphisms (SNPs) and insertions-deletions (indels),high-quality alignment was called to assure variant call-ing accuracy.",OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
"The analysis-ready BAM alignment resultswere procured after removing duplicated reads, conduct-ing local alignment, and recalibrating base quality byPicard (http://sourceforge.net/projects/picard/), Genome Analysis Toolkit and SAMtools.",OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
"A 100.83 /C2mean sequencing depth provided adequate depth and guaran-teed 99% variant calling accuracy of each targeted exome.Given that the variant of interest is rare in the normalpopulation, all variants were ﬁltered against public data-bases, including 1000 Genomes Project (2012 Aprilrelease, http://www.1000genomes.org/), database ofSNPs build 137 (dbSNP137, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
"15-17 Annotate Variation (ANNOVAR) software was used to annotate potential variants.18Nonsynonymous SNPs were evaluated using Sorting Intolerant from Tolerant(SIFT, http://sift.jcvi.org/, variant with a score less than0.05 is predicted to be deleterious) and PolymorphismPhenotyping version 2 (PolyPhen-2, http://gen-etics.bwh.harvard.edu/pph2/).",OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
MutationTaster (http://www.mutationtaster.org/) wasused to test amino acid substitution impact on proteinfunction.,OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
Multiple protein sequence alignment was carriedout across diﬀerent species using the NCBI BLAST (http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
At least 85 mutations in the CLCN7 gene are recorded in the Human Gene Mutation Database(http://www.hgmd.cf.ac.uk/ac/all.php).,Non-OADS,/arxiv_data1/oa_pdf/0e/c8/10.1177_1744806916652628.PMC4955969.pdf
Available from: (http://mouse.brain-map.org/static/atlas).,OADS,/arxiv_data1/oa_pdf/33/91/10.1177_1744806916648153.PMC4955973.pdf
NM_001004062) was designed and subjected to a Blast-Search (http://blast.ncbi.nlm.nih.gov) to ensurethat only one gene was being targeted.,OADS,/arxiv_data1/oa_pdf/3f/3b/10.1177_1744806916641679.PMC4955996.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 217–223Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 217 Original reSearch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S103972 real-world glycemic outcomes in patients with  type 2 diabetes initiating exenatide once weekly  and liraglutide once daily: a retrospective cohort  study William B Saunders1 hiep nguyen2 iftekhar Kalsekar2 1Department of Public health  Sciences, college of health and  human Services, The University  of north carolina at charlotte,   charlotte, nc, 2astraZeneca, Fort  Washington, P a, USaAim: The glucagon-like peptide-1 receptor agonists exenatide once weekly (QW) and liraglutide  once daily (QD) have demonstrated improvements in glycemic outcomes in patients with type  2 diabetes mellitus in randomized clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
"correspondence: William B Saunders Department of Public health Sciences, college of health and human Services, The University of north carolina at charlotte, 9201 University city Blvd, charlotte, nc 28223, USa email william.saunders@uncc.eduJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: Original ResearchY ear: 2016V olume: 9Running head verso: Saunders et alRunning head recto: Real-world glycemic outcomes in patients with type 2 diabetesDOI: http://dx.doi.org/10.2147/DMSO.S103972",Non-OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 223 real-world glycemic outcomes in patients with type 2 diabetes References  1.,Non-OADS,/arxiv_data1/oa_pdf/69/42/dmso-9-217.PMC4956055.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/e2/ott-9-4301.PMC4956058.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4301–4305OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4301Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10941 5 Lung cancer with concurrent EGFR mutation and  ROS1  rearrangement: a case report and review of  the literature Y ou-cai Zhu1,2,* Chun-wei Xu3,* Xiao-qian Ye4 Man-xiang Yin4 Jin-xian Zhang2 Kai-qi Du2 Zhi-hao Zhang2 Jian Hu1 1Department of Thoracic surgery,   The First affiliated Hospital of  Medical school of Zhejiang University,   Hangzhou, 2Department of Thoracic  surgery, Chinese people’s armed  police Force, Zhejiang Corps Hospital,   Jiaxing, Zhejiang, 3Department of  pathology, affiliated Hospital of  academy of Military Medical sciences,   Beijing, 4Department of p athology,   Chinese people’s armed police Force,   Zhejiang Corps Hospital, Jiaxing,   Zhejiang, people’s republic of China *These authors contributed equally  to this workAbstract:  ROS1  rearrangement has recently emerged as a new molecular subtype in non-small  cell lung cancer, and is predominantly found in lung adenocarcinomas compared with other  oncogenes such as EGFR , KRAS , or ALK .",Non-OADS,/arxiv_data1/oa_pdf/ac/e2/ott-9-4301.PMC4956058.pdf
"Case report A 50-year-old female who had never smoked was evaluated for persistent cough and  shown by computed tomography (CT) scanning to have a 32 mm tumor in the right lower Correspondence: Jian Hu Department of Thoracic surgery, The  First Affiliated Hospital of Medical School  of Zhejiang University, No 79 Qingchun  road, Hangzhou, Zhejiang province  310003, people’s republic of China Tel +86 571 8723 6841 Fax +86 571 8723 6843 email 780171493@qq.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: Lung cancer with a concurrent EGFR  mutation DOI: http://dx.doi.org/10.2147/OTT.S109415",Non-OADS,/arxiv_data1/oa_pdf/ac/e2/ott-9-4301.PMC4956058.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/e2/ott-9-4301.PMC4956058.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/e2/ott-9-4301.PMC4956058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dddt-10-2289.PMC4956059.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2289–2297Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2289Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9394 1 Galeterone for the treatment of advanced  prostate cancer: the evidence to date Diogo A Bastos1 emmanuel S Antonarakis2 1Department of Oncology,   Hospital Sirio-Libanes, Sao Paulo,   Brazil; 2Department of Oncology  and Urology, Sidney Kimmel  Comprehensive Cancer Center,   Johns Hopkins University School of  Medicine, Baltimore, MD, USAAbstract:  Major advances have been achieved recently in the treatment of metastatic castration- resistant prostate cancer, resulting in significant improvements in quality of life and survival with  the use of several new agents, including the next-generation androgen receptor (AR)-targeted  drugs abiraterone and enzalutamide.",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dddt-10-2289.PMC4956059.pdf
"Keywords:  galeterone, AR splice variants, AR-V7, castration-resistant prostate cancer Introduction Despite significant recent advances in the treatment of advanced prostate cancer,  most patients with metastatic spread will ultimately die of progressive disease, and  prostate cancer remains one of the leading causes of cancer-related deaths in men  worldwide.1,2 Over the last decade, there has been an increasing understanding of mechanisms of  disease progression after androgen deprivation therapy, which has led to the develop - ment of multiple new androgen receptor (AR)-directed drugs with promising activity  for patients with metastatic castration-resistant prostate cancer (mCRPC).3–5 Of those,  abiraterone (an oral CYP17 inhibitor), and enzalutamide (an oral AR-antagonist), have  demonstrated significant clinical activity and have been approved by the US Food and  Drug Administration (FDA) and the European Medicines Agency (EMA) based on  notable improvements in median overall survival (OS), radiographic progression-free  survival (rPFS), and quality of life.6,7 Nonetheless, these trials also demonstrate that  about 10% to 20% of all patients with mCRPC show primary resistance to abirater - one or enzalutamide, and most of the remaining patients who have an initial clinical  benefit will eventually develop disease progression later.8–11 Since patients progress - ing on abiraterone or enzalutamide often present with a rising PSA, it has become  evident that many resistance mechanisms are related to persistent androgen/AR Correspondence: emmanuel S  Antonarakis Sidney Kimmel Comprehensive Cancer  Center, Johns Hopkins University  School of Medicine, 1650 Orleans St,  CRB1-1M45, Baltimore, MD, USA email eantona1@jhmi.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Bastos and Antonarakis Running head recto: Galeterone for the treatment of prostate cancer DOI: http://dx.doi.org/10.2147/DDDT.S93941",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dddt-10-2289.PMC4956059.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dddt-10-2289.PMC4956059.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/89/dddt-10-2289.PMC4956059.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4307–4315OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4307Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9097 6Microrna-194 promotes the growth, migration,  and invasion of ovarian carcinoma cells by targeting  protein tyrosine phosphatase nonreceptor type 12 Tian liang liru li Yan cheng chengcheng ren guangmei Zhang Department of gynecology and  Obstetrics, The first affiliated  hospital of harbin Medical University,   nangang District, harbin, hei  longjiang, People’s republic of chinaAbstract:  Ovarian carcinoma is the most lethal gynecologic malignancy among women.",Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"MicroRNAs (miRNAs) are a class of small (19–25 nt in length), endogenous,  noncoding RNAs that play regulatory functions by binding imperfectly complemen - tary to the 3 ′-untranslated region (3 ′UTR) of their target messenger RNAs (mRNAs),  controlling the translation of mRNA to protein.4,5 miRNAs are involved in regulating  cellular processes, such as proliferation, differentiation, and apoptosis.5 Moreover,  increasing evidence indicated that miRNAs play a significant role in tumor occurrence correspondence: guangmei Zhang Department of gynecology and  Obstetrics, The First Affiliated Hospital of  harbin Medical University, 23 Youzheng  street, nangang District, harbin, hei  longjiang, People’s republic of china email guangmeizhang194@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liang et al Running head recto: miR-194 promotes ovarian carcinoma cells by targeting PTPN12 DOI: http://dx.doi.org/10.2147/OTT.S90976",Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"Then we predicted the  putative targets of miR-194 by three web-based algorithms,  miRWalk, TargetScan, and PicTar ( http://www.umm.uni - heidelberg.de/apps/zmf/mirwalk2/index.htm l, http://www.",OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"targetscan.or g, and http://pictar.mdc-berlin.de /).",Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/14/ott-9-4307.PMC4956060.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/ijn-11-3225.PMC4956062.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3225–3237International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3225OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10240 6 Synthesis, characterization, and efficacy of  antituberculosis isoniazid zinc aluminum-layered  double hydroxide based nanocomposites Bullo saifullah1 Mohamed ezzat el  Zowalaty2,3 Palanisamy arulselvan3 sharida Fakurazi3,4 Thomas J Webster5–7 Benjamin Mahler geilich5,6 Mohd Zobir hussein1 1Materials synthesis and  characterization laboratory, Institute  of advanced T echnology, (ITM a),   Universiti Putra Malaysia, serdang,   selangor, Malaysia; 2school of health  sciences, University of KwaZulu- Natal, Westville campus, Durban,   south africa; 3laboratory of Vaccines  and Immunotherapeutics, Institute of  Bioscience, 4Department of human  anatomy, Faculty of Medicine and  health science, Universiti Putra  Malaysia, serdang, selangor, Malaysia;   5Department of chemical engineering,   6Department of Bioengineering,   Northeastern University, Boston,   Ma, Usa; 7center of excellence  for advanced Materials research,   King abdulaziz University, Jeddah,   saudi arabiaAbstract:  The chemotherapy for tuberculosis (TB) is complicated by its long-term treatment,  its frequent drug dosing, and the adverse effects of anti-TB drugs.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/ijn-11-3225.PMC4956062.pdf
"The emergence of the resistance of M. tuberculosis  against INH is a multifactorial correspondence: Mohd Zobir hussein Materials synthesis and characterization  laboratory, Institute of advanced  Technology, (ITMa), Universiti Putra  Malaysia, PO Box 43400 UPM, serdang,  selangor 43400, Malaysia Tel +60 3 89 466 801 Fax +60 3 89 435 380 email mzobir@upm.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Saifullah et al Running head recto: Isoniazid zinc aluminum-layered double hydroxide based nanocomposites DOI: http://dx.doi.org/10.2147/IJN.S102406",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/ijn-11-3225.PMC4956062.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/ijn-11-3225.PMC4956062.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/ijn-11-3225.PMC4956062.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1113–1131Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1113ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11223 6 an overview of the effect of sodium glucose  cotransporter 2 inhibitor monotherapy on  glycemic and other clinical laboratory parameters  in type 2 diabetes patients Yaowen Wang1 Xueting hu2 Xueying liu3 Zengqi Wang2 1Department of Clinical laboratory,   Weifang People’s hospital,   2Department of Clinical laboratory,   Weifang Traditional Chinese hospital,   Weifang, 3Department of Clinical  laboratory, The Third hospital of  Jinan, Jinan, People’s Republic of ChinaObjectives:  We aimed to determine the effect of sodium glucose cotransporter 2 (SGLT2)  inhibitor monotherapy on glycemic and other clinical laboratory parameters versus other antidi - abetic medications or placebo therapy in patients with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
"Keywords:  SGLT2 inhibitor, diabetic ketoacidosis, type 2 diabetes mellitus, hyperglycemia,  dyslipidemia, weight loss Introduction The worldwide prevalence of type 2 diabetes mellitus (T2DM) is expected to increase  by 89% in the next 2 decades, and the role of the renal system in this context has been  studied only recently.1,2 In the kidneys, the glomeruli filter ~180 g of glucose from Correspondence: Zengqi Wang Department of Clinical laboratory,  Weifang Traditional Chinese hospital,  1055 Weizhou Road, Weifang 261041,  People’s Republic of China Tel +86 158 6459 9659 email wangzengqiop@sohu.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: Effect of SGLT2 inhibitor monotherapy in T2DM patients DOI: http://dx.doi.org/10.2147/TCRM.S112236",Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm446845.,Non-OADS,/arxiv_data1/oa_pdf/63/29/tcrm-12-1113.PMC4956063.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/71/f2/nsa-9-029.PMC4956064.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/71/f2/nsa-9-029.PMC4956064.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Nanotechnology, Science and Applications 2016:9 29–45Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  29OrigiNAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S9974 7A role of ZnO nanoparticle electrostatic  properties in cancer cell cytotoxicity Denise Wingett1–3 Panagiota louka1 catherine B Anders2 Jianhui Zhang4 Alex Punnoose2,4 1Department of Biological Sciences,   2Biomolecular Sciences PhD Program,   Boise State University, Boise, iD,   3Department of Medicine, Division of  gerontology and geriatric Medicine,   University of Washington, Seattle, WA,   4Department of Physics, Boise State  University, Boise, iD, USA correspondence: Denise Wingett   Department of Biological Sciences,  Mail Stop 1515, Boise State University,  1910 University Drive, Boise,   iD 83725, USA   T el +1 208 426 2921   email denisewingett@boisestate.ed uAbstract:  ZnO nanoparticles (NPs) have previously been shown to exhibit selective cytotoxicity  against certain types of cancerous cells suggesting their potential use in biomedical applications.",Non-OADS,/arxiv_data1/oa_pdf/71/f2/nsa-9-029.PMC4956064.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer ­reviewed, open  access journal that focuses on the science of nanotechnology in a wide range of  industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/71/f2/nsa-9-029.PMC4956064.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/f2/nsa-9-029.PMC4956064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 297–301Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 297 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S107346Prevalence and perception of smoking habits  among the Palestinian population in the Gaza Strip Ahmed S Eldalo Department of Pharmacology and  T oxicology, College of Pharmacy, Taif University, Taif, Kingdom of Saudi ArabiaBackground: The Gaza Strip is a densely populated place with ~2 million inhabitants in an  area of 365 km2.",Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
"5 The Palestinian Legislative Council  Public Health Law states that, “The ministry should take the suitable measures to limit Correspondence: Ahmed S Eldalo   Department of Pharmacology and  Toxicology, College of Pharmacy, Taif University, Al-Haweiah, PO Box 888, Taif 21974, Kingdom of Saudi Arabia   Tel +966 5 5525 0840   Email ahmed_dalo@tu.edu.saJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: EldaloRunning head recto: Prevalence and perception of smoking habits among Palestinian populationDOI: http://dx.doi.org/10.2147/JMDH.S107346",Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 301 Prevalence and perception of smoking habits among Palestinian population as the center and the meeting place for all family members.,Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
Available from: http://ash.org/wp-content/uploads/2014/01/full-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
Available from: http://www.pcbs.gov.ps/Portals/_PCBS/Downloads/book1941.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/7a/jmdh-9-297.PMC4956068.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 173–180Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  173 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S111693Safety of polyethylene glycol 3350 solution  in chronic constipation: randomized,  placebo‑controlled trial Thomas McGraw Global Medical Affairs, Merck & Co.,   Inc., Kenilworth, NJ, USAPurpose: To evaluate the safety and tolerability of aqueous solution concentrate (ASC) of  polyethylene glycol (PEG) 3350 in patients with functional constipation.",Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
"3 Variation in the inci- dence of constipation exists due to several reasons such as differences in constipation definitions, whether constipation is physician or patient reported, and the population Correspondence: Thomas McGraw Clinical Research & PM Consulting LLC, 928 Long Hill Road, Millington, NJ 07946‑0231, USA Tel +1 908 604 4202   Email thomas_p_mcgraw@yahoo.comJournal name: Clinical and Experimental Gastroenterology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: McGrawRunning head recto: Tolerance of polyethylene glycol 3350 solutionDOI: http://dx.doi.org/10.2147/CEG.S111693",Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical‑and‑experimental‑gastroenterology‑journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 180 McGraw and in the decision to submit the article for publication.,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/022015s000_ClinPharmR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f4/6b/ceg-9-173.PMC4956069.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 947–959Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  947OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10719 7 Daily home gardening improved survival for older  people with mobility limitations: an 11-year  follow-up study in Taiwan Chhian Hu ˉi Lêng1,2 Jung-Der Wang3–5 1Institute of Allied health sciences,   College of Medicine, national  Cheng Kung University, Tainan,   2school of Medical sociology and  social Work, Chung shan Medical  University, Taichung, 3Department  of Public health, College of Medicine,   4Department of Occupational and  environmental Medicine, 5Department  of Internal Medicine, national Cheng  Kung University hospital, Tainan,   TaiwanAims:  To test the hypothesis that gardening is beneficial for survival after taking time-dependent  comorbidities, mobility, and depression into account in a longitudinal middle-aged (50–64 years)  and older ( 65 years) cohort in Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
"It is thus of interest to examine whether home gardening without much physical  exertion yields a beneficial effect on survival similar to that reported for the Danish  Diet, Cancer and Health cohort,3 a New Haven elderly cohort,4 and a Finnish cohort  in 1980.5 It is also possible that there are some reservations about the benefits, as in  the Whitehall II cohort study.6Correspondence: Jung-Der Wang Department of Public health, College  of Medicine, national Cheng Kung  University, 1 University road,  Tainan 701, Taiwan Tel +886 6 235 3535 ext 5600 Fax +886 6 235 9033 email jdwang121@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lêng and Wang Running head recto: Daily gardening benefits survival of mobility limited DOI: http://dx.doi.org/10.2147/CIA.S107197",Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
"However, additional  research is needed to explore whether the social interactions  and outdoor psychological advantages of gardening in an  allotment (ie, working in a community garden primarily for growing vegetables: http://www.allotment-garden.org /)   or large private garden confer significantly more protection  than tending to small, inside-the-house flowerpot “gardens”  against chronic depression on mortality.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
Available from: https://olap.hpa.gov.tw/en_US/search/ ListHealth1.aspx?menu =1&mode =5&year=96&sel=0&mid=3.,OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/cia-11-947.PMC4956070.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 229–255International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 229 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S102819Human serum albumin homeostasis: a new look  at the roles of synthesis, catabolism, renal and  gastrointestinal excretion, and the clinical value of  serum albumin measurements David G Levitt1,* Michael D Levitt2,* 1Department of Integrative Biology  and Physiology, University of  Minnesota, 2Research Service, Veterans  Affairs Medical Center, Minneapolis,  MN, USA   *These authors contributed equally to this workAbstract:  Serum albumin concentration (CP) is a remarkably strong prognostic indicator of  morbidity and mortality in both sick and seemingly healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
"For  example, post-surgical mortality in 54,000 Veterans Administration (V A) Hospital Correspondence: David G Levitt Department of Integrative Biology and Physiology, University of Minnesota, 6-125 Jackson Hall, 321 Church Street South East, Minneapolis, MN 55455, USATel +1 612 625 7649Fax +1 612 625 5149Email levit001@umn.eduJournal name: International Journal of General Medicine Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Levitt and LevittRunning head recto: Serum albumin homeostasisDOI: http://dx.doi.org/10.2147/IJGM.S102819",Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 255 Serum albumin homeostasis,Non-OADS,/arxiv_data1/oa_pdf/a9/61/ijgm-9-229.PMC4956071.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b7/8f/ijn-11-3023.PMC4956072.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3023–3034International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3023OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10364 8cerium oxide nanoparticles inhibit the migration  and proliferation of gastric cancer by increasing  DhX15 expression Yu-Feng Xiao1 Jian-Mei li2 su-Min Wang1 Xin Y ong1 Bo Tang1 Meng-Meng Jie1 hui Dong1 Xiao-chao Yang2 shi-Ming Yang1 1Department of gastroenterology,   Xinqiao hospital, Third Military  Medical University, chongqing,   People’s republic of china; 2school of  Biomedical engineering, Third Military  Medical University, chongqing,   People’s republic of chinaAbstract:  Gastric cancer is one of the leading causes of tumor-related deaths in the world.",Non-OADS,/arxiv_data1/oa_pdf/b7/8f/ijn-11-3023.PMC4956072.pdf
"Gold-coated FeO nanoroses, gold nanoclusters,  and SiO2@GN-serum composites have been directly used as anticancer reagents.11–13 correspondence: Xiao-chao Yang school of Biomedical engineering,  Third Military Medical University,  Number 30, gaotanyan street,  shapingba District, chongqing 400038,  People’s republic of china Tel +86 23 6877 2482 email xcyang@tmmu.edu.c n  shi-Ming Yang Department of gastroenterology,  Xinqiao hospital, Third Military  Medical University, Xinqiao street,  shapingba District, chongqing 400037,  People’s republic of china Tel +86 23 6875 5604 email shimingyang@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xiao et al Running head recto: Inhibition of migration and proliferation of gastric cancer by CNPs DOI: http://dx.doi.org/10.2147/IJN.S103648",Non-OADS,/arxiv_data1/oa_pdf/b7/8f/ijn-11-3023.PMC4956072.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b7/8f/ijn-11-3023.PMC4956072.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/8f/ijn-11-3023.PMC4956072.pdf
"Keywords Oligodendrocyte, myelin, spinal dorsal horn, pain, HIV-1 gp120 Date received: 20 January 2016; revised: 11 May 2016; accepted: 2 June 2016 Background There are around 35 million HIV/AIDS patients world- wide (WHO: http://www.who.int/gho/hiv/en/).",Non-OADS,/arxiv_data1/oa_pdf/ad/65/10.1177_1744806916656845.PMC4956145.pdf
37–39We assessed expression of ion channels and GPCRs with putative therapeutic import-ance based on classiﬁcation obtained from IUPHAR(http://www.guidetopharmacology.org).,Non-OADS,/arxiv_data1/oa_pdf/95/be/10.1177_1744806916646111.PMC4956150.pdf
Supplementary Material The online data supplements are available at http://mpx.sage-pub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/95/be/10.1177_1744806916646111.PMC4956150.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/a9/ott-9-4295.PMC4956153.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4295–4299OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4295Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10710 6 Clinical study on the influence of motion  and other factors on stereotactic radiotherapy  in the treatment of adrenal gland tumor Jingsheng Wang Fengtong li Yang Dong Y ongchun song Zhiyong Yuan Department of Radiation Therapy,   Tianjin Medical University cancer  Institute and Hospital, National  Clinical Research Center of Cancer,   Key Laboratory of Cancer Prevention  and Therapy, Tianjin, People’s  Republic of ChinaBackground:  The aim of this study was to investigate the adrenal tumor motion law and influ - ence factors in the treatment of adrenal gland tumor and provide a reference value basis for  determining the planning target volume margins for therapy.",Non-OADS,/arxiv_data1/oa_pdf/af/a9/ott-9-4295.PMC4956153.pdf
"Uncertainty regarding the degree  of the resulting adrenal displacement greatly impacts the ability to accurately direct correspondence: Fengtong li Department of Radiation Therapy, Tianjin  Medical University cancer institute and  Hospital, National Clinical Research  Center of Cancer, Key Laboratory of  Cancer Prevention and Therapy, Tianjin  300060, People’s Republic of China Tel +86 22 2334 1405 Fax +86 22 2334 1405 email ftong_li@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Influence of motion and other factors of adrenal gland tumor DOI: http://dx.doi.org/10.2147/OTT.S107106",Non-OADS,/arxiv_data1/oa_pdf/af/a9/ott-9-4295.PMC4956153.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/af/a9/ott-9-4295.PMC4956153.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/a9/ott-9-4295.PMC4956153.pdf
"https://newdrugapprovals.org/2016/01/ 23/what-was-the-drug-in-clinical-trial-tragedy-in-france-jan-2016/ (2016, accessed 9 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/ba/6e/10.1177_1744806916649192.PMC4956176.pdf
Acknowledgment The authors thank Inter-Biotech (http://www.inter-biotech.,Non-OADS,/arxiv_data1/oa_pdf/4f/84/10.1177_1744806916643082.PMC4956177.pdf
SUPPLEMENTARY MATERIALS Supplementary materials for this article are available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600274/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/da/d0/1600274.PMC4956185.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600089/DC1movie S1.,Non-OADS,/arxiv_data1/oa_pdf/54/c7/1600089.PMC4956186.pdf
"Ana lysis and 3D reconstruction of the image Z stack were accomplished using NIS-Elements AR (Nikon),Volocity (PerkinElmer), and Fiji (http://fiji.sc/Fiji) software.",OADS,/arxiv_data1/oa_pdf/1e/3d/1600087.PMC4956187.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600087/DC1Supplementary Materials and MethodsRESEARCH ARTICLE Usmani et al .,Non-OADS,/arxiv_data1/oa_pdf/1e/3d/1600087.PMC4956187.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600021/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/1600021.PMC4956188.pdf
VBM protocol and analysis We used VBM8 toolbox revision 435 (http://dbm.neuro.,OADS,/arxiv_data1/oa_pdf/3f/c8/10.1177_1744806916652408.PMC4956386.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600557/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/2d/1600557.PMC4956390.pdf
Data and materials availability: The SDO/HMI data used to obtain the conclusions in this paper are available at http://jsoc.stanford.edu.,OADS,/arxiv_data1/oa_pdf/a7/2d/1600557.PMC4956390.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600427/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/64/c3/1600427.PMC4956391.pdf
"The undischarged cathodes were assembled in exactly the same way as the discharged cathodes, soaked in the electrolyte system, and exposed to a mixtureof CO 2and O 2before they were washed with acetonitrile.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600968/DC1table S1.",Non-OADS,/arxiv_data1/oa_pdf/67/3a/1600968.PMC4956394.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600320/DC1Perturbed equations at high current densitiesPerturbed equations at low current densities fig.,Non-OADS,/arxiv_data1/oa_pdf/df/8a/1600320.PMC4956395.pdf
"Annual Report 2014, http://www.tsu mura.co.jp/English/ir/library/annual/index.htm.",Non-OADS,/arxiv_data1/oa_pdf/e2/3d/10.1177_1744806916656382.PMC4956397.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600341/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/61/17/1600341.PMC4956398.pdf
Image analysis and post- processing were carried out with Imag eJ (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/5d/e7/1600500.PMC4956400.pdf
1.1 (http://r-project.org/) for the time series analysis described below.RESEARCH ARTICLE Muranaka and Oyama Sci.,OADS,/arxiv_data1/oa_pdf/5d/e7/1600500.PMC4956400.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/7/e1600500/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/e7/1600500.PMC4956400.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/63/nihms796103.PMC4956499.pdf
").9Co-first author SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, four tables, and one movie and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2016.06.032 .",Non-OADS,/arxiv_data1/oa_pdf/5c/63/nihms796103.PMC4956499.pdf
"Known immune-related candidates in these LD blocks, based on ImmPort classi ﬁcation (https://immport.niaid.nih.",Non-OADS,/arxiv_data1/oa_pdf/47/49/gene201623a.PMC4956564.pdf
The GWAS-NR algorithm (version 2) was executed asa Matlab script and is available from http://hihg.med.miami.edu/software-download/gwas-nr-version-2.0.,OADS,/arxiv_data1/oa_pdf/47/49/gene201623a.PMC4956564.pdf
"Candidate genes were classi ﬁed as immune- related based on reported involvement in immune function, or inclusionin the Comprehensive List of Immune-Related Genes maintained by The Immunology Database and Analysis Portal (ImmPort https://immport.niaid.",OADS,/arxiv_data1/oa_pdf/47/49/gene201623a.PMC4956564.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on G enes and Immunity website (http://www.nature.com/gene).GWAS implicates NF- κB-mediated T cell induction in MS JP Hussman et al 312 Genes and Immunity (2016) 305 –312 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/47/49/gene201623a.PMC4956564.pdf
"Post-transcriptional modification includes a shift from  the compliant N2BA isoform to the stiffer N2B isoform.6 Post- translational modification is mainly regulated via phosphoryla- tion of titin by the protein kinases A (PKA), G, and C. Titin  phosphorylation by PKA7 and protein kinase G8 reduce myo- fibril stiffness, whereas protein kinase C–mediated titin phos- phorylation results in increased RV diastolic stiffness.9–11 We  have previously demonstrated that in end-stage PAH, no altera-tions in titin isoform composition are observed, 2 whereas PKA- mediated titin phosphorylation was significantly reduced.4Original Article Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAILURE.115.002636Background—The purpose of this study was to determine the relative contribution of fibrosis-mediated and myofibril- mediated stiffness in rats with mild and severe right ventricular (RV) dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/8d/4c/hhf-9-e002636.PMC4956674.pdf
The Data Supplement is available at http://circheartfailure.ahajournals.org/lookup/suppl/doi:10.1161/CIRCHEARTFAILURE.115.002636/-/DC1.,OADS,/arxiv_data1/oa_pdf/8d/4c/hhf-9-e002636.PMC4956674.pdf
"This article was sent to Daniel W. Jones, Guest Editor, for review by expert referees, editorial decision, and final disposition.The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.",Non-OADS,/arxiv_data1/oa_pdf/50/24/hyp-68-511.PMC4956676.pdf
"Struijker-Boudier, Jan A. Staessen Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.116.07523 Blood Pressure Monitoring",Non-OADS,/arxiv_data1/oa_pdf/50/24/hyp-68-511.PMC4956676.pdf
Methods Study Population FLEMENGHO complies with the Helsinki declaration for research in  human subjects and the Belgian legislation for the protection of pri-vacy (http://www.privacycommission.be).,Non-OADS,/arxiv_data1/oa_pdf/50/24/hyp-68-511.PMC4956676.pdf
Detailed search strate-gies are shown in Supplemental Digital Content 1 (http://links.lww.com/AA/B409).,OADS,/arxiv_data1/oa_pdf/e5/24/ane-123-371.PMC4956677.pdf
Details of the consensus are shown in Supplemental Digital Content 2 (http://links.lww.com/AA/B410).,Non-OADS,/arxiv_data1/oa_pdf/e5/24/ane-123-371.PMC4956677.pdf
Detailed excluded articles are listed in Supplemental  Digital Content 2 (http://links.lww.com/AA/B410).,Non-OADS,/arxiv_data1/oa_pdf/e5/24/ane-123-371.PMC4956677.pdf
Study Characteristics The characteristics of the included studies are shown in  Supplemental Digital Content 3 (http://links.lww.com/ AA/B411).,Non-OADS,/arxiv_data1/oa_pdf/e5/24/ane-123-371.PMC4956677.pdf
"4 This model is characterized by the atrial  infiltration of neutrophils, significant fibrosis, and increased  levels of C-reactive protein and IL-6.5,6 Indeed, elevated IL-6  induces cardiac fibrosis, myocardial hypertrophy,7,8 and AF.9,10  Circ Arrhythm Electrophysiol is available at http://circep.ahajournals.org DOI: 10.1161/CIRCEP.115.003396Original Article Background—Postoperative atrial fibrillation is a frequent complication in cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/e4/7f/hae-9-e003396.PMC4956678.pdf
"*Drs Huang, Chen, and Qian contributed equally to this work.The Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/doi:10.1161/CIRCEP.115.003396/-/DC1.",OADS,/arxiv_data1/oa_pdf/e4/7f/hae-9-e003396.PMC4956678.pdf
"8,9 Contrast-enhanced cardiac magnetic resonance  (CE-CMR) imaging has become in the recent years part of  clinical work-up of athletes with V A.10 Besides evaluating  the presence of morphofunctional ventricular abnormalities,  CE-CMR allows myocardial tissue characterization by late  Circ Arrhythm Electrophysiol is available at http://circep.ahajournals.org DOI: 10.1161/CIRCEP.116.004229Original Article Background—The clinical profile and arrhythmic outcome of competitive athletes with isolated nonischemic left ventricular  (LV) scar as evidenced by contrast-enhanced cardiac magnetic resonance remain to be elucidated.",Non-OADS,/arxiv_data1/oa_pdf/48/99/hae-9-e004229.PMC4956679.pdf
"SASM Perioperative Guideline for Obstructive Sleep Apnea August 2016 • Volume 123 • Number 2  www.anesthesia-analgesia.org  455In group 2, the search used the controlled vocabulary  terms and key words: “mass screening,” “polysomnogra- phy,” “questionnaire,” “sleep apnea,” “sleep disordered  breathing,” obesity hypoventilation syndrome,” “Pickwick syndrome,” “Cheyne Stokes respiration,” “obesity  hypoventilation syndrome,” “central apnea,” “diagnostic test,” “probability,” “sensitivity and specificity,” “accuracy,”  and “diagnosis.” In group 3, the search used the controlled vocabulary  terms and key words: “preoperative care,” “preoperative  evaluation,” “preoperative assessment,” “patient selec-tion,” “identified high-risk patient,” “physician’s practice  patterns,” “referral,” “consult,” and “gatekeeping.” To  determine the efficacy of CPAP in the surgical patients,  the search used the MESH key words: “obstructive,”  “sleep apnea,” “continuous positive airway pressure,” “obstructive sleep apnea,” “obstructive sleep apnea syn- drome,” “obstructive sleep apnoea syndrome,” “sleep  disordered breathing,” “obesity hypoventilation syn- drome,” “apnoea or apnea,” “hypopnoea or hypopnea,”  “auto-titrating positive airway pressure,” “positive airway  pressure,” “bilevel positive airway pressure,” “postopera- tive” and one of “complications” or “outcome,” “periop-erative care,” “intraoperative care,” “postoperative care,”  “intraoperative monitoring,” “postoperative monitoring,”  “perioperative complications,” “intraoperative complica- tions,” “postoperative complications,” “outcome,” “risk,”  “morbidity” or “mortality,” and “death.” The full search strategies used in Medline for the different questions are  shown in the Supplemental Digital Content 1, Tables S1 to  S7 (http://links.lww.com/AA/B442).",Non-OADS,/arxiv_data1/oa_pdf/9c/3f/ane-123-452.PMC4956681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/4b/main.PMC4956682.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.07.003 .,OADS,/arxiv_data1/oa_pdf/12/4b/main.PMC4956682.pdf
E-mail address: amro.elshoury@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.07.003 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/12/4b/main.PMC4956682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 69 e71,Non-OADS,/arxiv_data1/oa_pdf/12/4b/main.PMC4956682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4956683.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.02.001 .,OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4956683.pdf
E-mail address: lbarnes@arspecialty.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.02.001 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4956683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 65 e68,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4956683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/61/main.PMC4956684.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.02.002 .,OADS,/arxiv_data1/oa_pdf/d5/61/main.PMC4956684.pdf
E-mail address: rivgio@libero.it Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.02.002 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/d5/61/main.PMC4956684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 81 e84,Non-OADS,/arxiv_data1/oa_pdf/d5/61/main.PMC4956684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC4956685.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.03.003 .,OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC4956685.pdf
E-mail address: patelvaibh@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.03.003 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC4956685.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 77 e80,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC4956685.pdf
J Arthritis 2013;3:116. http://dx.doi.org/10.4172/ 21677921.1000116 .,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC4956685.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4956686.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.06.001 .,OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4956686.pdf
E-mail address: di_papadopoulos@yahoo.gr Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.06.001 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4956686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 53 e57,Non-OADS,/arxiv_data1/oa_pdf/46/08/main.PMC4956686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/06/main.PMC4956687.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.04.003 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/90/06/main.PMC4956687.pdf
E-mail address: jtmoskal@carilionclinic.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.04.003 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/90/06/main.PMC4956687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 59 e63,Non-OADS,/arxiv_data1/oa_pdf/90/06/main.PMC4956687.pdf
Appendix A (http://links.lww.com/ JPP/A9) shows the speci ﬁc diagnostic codes asso- ciated with each diagnostic cluster.,Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
Appendix Bshows the list of states by region (http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
"Given these relationships between antipsychotic polypharmacy and gender, race, age, marital status, admission referral source, living situation at dis- charge, Medicare coverage, and length of stay,bivariate relationships among these covariateswere assessed (Appendix C) (http://links.lww.com/JPP/A9).",Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
Available at: http://www.jointcommission.org/assets/1/18/tjc_annual_report_2014_final.pdf.,OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
Availableat: https://cms.gov/Regulations-and-Guidance/guidance/ Manuals/Paper-Based-Manuals-Items/CMS021927.html.,Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
Avail-able at: http://www.createspace.com/4106422.,Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
Avail- able at: https://data.medicare.gov/Hospital-Compare/ Inpatient-Psychiatric-Facility-Quality-Measure-Dat/ s5xg-sys6.,Non-OADS,/arxiv_data1/oa_pdf/0f/24/pra-22-283.PMC4956725.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.04.004 .,OADS,/arxiv_data1/oa_pdf/3e/52/main.PMC4956740.pdf
E-mail address: stefano.bini@kp.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.04.004 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/3e/52/main.PMC4956740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 51 e52,Non-OADS,/arxiv_data1/oa_pdf/3e/52/main.PMC4956740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/a8/main.PMC4956741.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.05.004 .,OADS,/arxiv_data1/oa_pdf/c0/a8/main.PMC4956741.pdf
E-mail address: sjincavo@houstonmethodist.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.05.004 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/c0/a8/main.PMC4956741.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 73 e75,Non-OADS,/arxiv_data1/oa_pdf/c0/a8/main.PMC4956741.pdf
Medicine (2016) 95:28(e3890) Received: 2 January 2016 / Received in ﬁnal form: 9 May 2016 / Accepted: 11 May 2016 http://dx.doi.org/10.1097/MD.0000000000003890Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/46/63/medi-95-e3890.PMC4956776.pdf
"We listed all the markers used by the literatures (supplemental Table 1, http://links.lww.com/MD/B96).",OADS,/arxiv_data1/oa_pdf/46/63/medi-95-e3890.PMC4956776.pdf
Medicine (2016) 95:28(e3892)Received: 11 January 2016 / Received in ﬁnal form: 12 April 2016 / Accepted: 16 May 2016 http://dx.doi.org/10.1097/MD.0000000000003892Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b3/9d/medi-95-e3892.PMC4956777.pdf
Medicine (2016) 95:28(e3907)Received: 2 April 2016 / Received in ﬁnal form: 5 May 2016 / Accepted: 9 May 2016 http://dx.doi.org/10.1097/MD.0000000000003907 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/b9/medi-95-e3907.PMC4956778.pdf
Medicine (2016) 95:28(e3968)Received: 9 February 2016 / Received in ﬁnal form: 8 May 2016 / Accepted: 26 May 2016 http://dx.doi.org/10.1097/MD.0000000000003968Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/f7/medi-95-e3968.PMC4956780.pdf
Medicine (2016) 95:28(e3971)Received: 27 December 2015 / Received in ﬁnal form: 18 May 2016 / Accepted: 26 May 2016 http://dx.doi.org/10.1097/MD.0000000000003971Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/medi-95-e3971.PMC4956781.pdf
Medicine (2016) 95:28(e3985)Received: 14 March 2016 / Received in ﬁnal form: 18 May 2016 / Accepted: 30 May 2016 http://dx.doi.org/10.1097/MD.0000000000003985Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
"Figures 1 and 2 of the Supplemental Digital Content, http://links.lww.com/MD/B62 (SDG) of this article display the frequencies of major NRTI- andNNRTI-resistance mutations among the 74 adult and 34 pediatric patients with successful HIV genotyping, who had presented with ﬁrst- and second-VL above the plasma threshold of 80c/mL.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
"The SDG Table 1, http://links.lww.com/MD/B62 displays NRTI resistances strati ﬁed by the ﬁrst-line NRTI backbone.",OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
"Accessed May 5, 2016 at: http://www.who.int/hiv/pub/arv/policy-brief-arv-2015/en/.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
"; accessed Sep 4, 2015 at: http://www.croiconference.org/sessions/impact-nrti-cross-resistance-second-line-pi-nrti-therapy-outcomes-africa [17] Boyd MA, Moore CL, Molina J-M, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
"Accessed September 6, 2015 at: http://www.msfaccess.org/ content/untangling-web-antiretroviral-price-reductions-17th-edition- –- july-2014.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/medi-95-e3985.PMC4956783.pdf
Medicine (2016) 95:28(e4090)Received: 15 December 2015 / Received in ﬁnal form: 18 April 2016 / Accepted: 5 June 2016 http://dx.doi.org/10.1097/MD.0000000000004090Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a0/f2/medi-95-e4090.PMC4956787.pdf
Medicine (2016) 95:28(e4112)Received: 22 March 2016 / Received in ﬁnal form: 3 June 2016 / Accepted: 10 June 2016 http://dx.doi.org/10.1097/MD.0000000000004112Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Structures of glycans in each peak were determined by mass spectrometry and represented by alphanu- meric characters (see Table 1, Supplemental Content, http://links.lww.com/MD/B95, which illustrates the glycan structures in theIgG glycome).",OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Normality distributions of all variables were tested by Shapiro –- Wilk test ( “fBasics ”package) (see Tables 2 and 3, Supplemental Content, http://links.lww.com/MD/B95, which illustrate thenormality tests of IgG N-glycans before and after log transformation).",OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Formost of the variables that were not normally distributed, median together with interquartile range was used in descriptive statistics (see Table 4, Supplemental Content, http://links.lww.com/MD/B95, which illustrates the description of IgG N-glycans).",OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Compared with females, males had a higher proportion of nongalactosylated(FA1, A2, FA2, M5, FA2B), monogalactosylated (A2G1, FA2[6]BG1, FA2[3]BG1), and disialylated (FA2BG2S2) glycans ( P< 0.001) (Table 2; see Table 1, Supplemental Content, http://links.Table 1 Difference of clinical traits between males and females∗.",Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Supplemental Content, http://links.lww.com/MD/B95, which illustrates the relationshipbetween age and glycan structures).",Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"GlyAge indexes were also well known to be signi ﬁcantly related with unhealthy lifestyles or in ﬂammation process (Table 4; see Table 5, Supplemental Content, http://links.lww.com/MD/B95, which illustrates association of GlyAge index with clinical traitsafter adjustment of chronological age).",Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Many clinical traits were signi ﬁcantly associated with both the predicted age (predicted by GlyAge-Pooled, GlyAge-Male, andGlyAge-Female models) and the chronological age (see Table 6, Supplemental Content, http://links.lww.com/MD/B95, which illustrates association of chronological and GlyAge with clinicaltraits in pool, male, and female samples).",Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
"Supplemental Content, http://links.lww.com/MD/B95, which illustrates the relationship between age and glycan structures).",Non-OADS,/arxiv_data1/oa_pdf/38/5b/medi-95-e4112.PMC4956791.pdf
Medicine (2016) 95:28(e4119)Received: 10 March 2016 / Received in ﬁnal form: 6 May 2016 / Accepted: 26 May 2016 http://dx.doi.org/10.1097/MD.0000000000004119Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/33/22/medi-95-e4119.PMC4956792.pdf
"Taiwan, http://nhird.nhri.org.tw/en/index.html (cited in 2015).",Non-OADS,/arxiv_data1/oa_pdf/33/22/medi-95-e4119.PMC4956792.pdf
Medicine (2016) 95:28(e4123)Received: 3 April 2016 / Received in ﬁnal form: 7 June 2016 / Accepted: 10 June 2016 http://dx.doi.org/10.1097/MD.0000000000004123Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7a/28/medi-95-e4123.PMC4956793.pdf
YX12005 (URL: http://www.compe.cn).,Non-OADS,/arxiv_data1/oa_pdf/7e/e9/medi-95-e4135.PMC4956795.pdf
Medicine (2016) 95:28(e4135)Received: 2 March 2016 / Received in ﬁnal form: 26 May 2016 / Accepted: 30 May 2016 http://dx.doi.org/10.1097/MD.0000000000004135Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/e9/medi-95-e4135.PMC4956795.pdf
Medicine (2016) 95:28(e4144)Received: 5 February 2016 / Received in ﬁnal form: 7 June 2016 / Accepted: 14 June 2016 http://dx.doi.org/10.1097/MD.0000000000004144Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/61/e8/medi-95-e4144.PMC4956796.pdf
"In particular, in the CSF, there was asigniﬁcant correlation between sCD163 and sCD14 ( r=0.932, P<0.0001), sCD163 and CXCL10 ( r=0.531, P=0.016), sCD163 and CCL2 ( r=0.468, P=0.037), sCD163 and IL6 (r=0.517, P=0.019), sCD14 and CXCL10 ( r=0.558, P=0.01), and sCD14 and IL6 ( r=0.639, P=0.0024) (Supplementary material, http://links.lww.com/MD/B116).",OADS,/arxiv_data1/oa_pdf/61/e8/medi-95-e4144.PMC4956796.pdf
Linee Guida Italiane 2014 sull ’utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone coninfezione da HIV-1; 2014. http://www.salute.gov.it/imgs/C_17_pubbli cazioni_2261_allegato.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/e8/medi-95-e4144.PMC4956796.pdf
Medicine (2016) 95:28(e4149)Received: 9 March 2016 / Received in ﬁnal form: 9 June 2016 / Accepted: 11 June 2016 http://dx.doi.org/10.1097/MD.0000000000004149Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/ca/medi-95-e4149.PMC4956797.pdf
Medicine (2016) 95:28(e4151)Received: 28 March 2016 / Received in ﬁnal form: 16 May 2016 / Accepted: 6 June 2016 http://dx.doi.org/10.1097/MD.0000000000004151Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"Baseline PROs were generally lower in patients who would be nonadherent (Supplementary Table 1, http://links.lww.com/MD/ B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"During treatment, some adverse events, including anemia,fatigue, gastrointestinal symptoms, or nervous system disorders, were experienced more frequently by nonadherent subjects, but the overall adverse event rate was high in both groups receivingpeg-IFN+RBV (Supplementary Table 1, http://links.lww.com/ MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"1A, Supplementary Figure 1A, http://links.lww.com/MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"They were also less likely to have a historyof depression or be treatment-naive (Supplementary Table 1, http://links.lww.com/MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"From all the treatment-emer- gent adverse events, only anemia and fatigue were signi ﬁcantly different between adherent and nonadherent patients: 6.1%versus 23.7% and 36.1% versus 43.1%, respectively (both P< 0.01) (Supplementary Table 1, http://links.lww.com/MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"1B, Supplemen- tary Figure 1B, http://links.lww.com/MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"clinical parameters and PRO scores between the adherent and nonadherent groups (Supplementary Table 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
"1C, Supplementary Figure 1C, http://links.lww.com/MD/B124).",Non-OADS,/arxiv_data1/oa_pdf/03/9b/medi-95-e4151.PMC4956799.pdf
Medicine (2016) 95:28(e4174)Received: 3 March 2016 / Received in ﬁnal form: 22 May 2016 / Accepted: 16 June 2016 http://dx.doi.org/10.1097/MD.0000000000004174Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/22/89/medi-95-e4174.PMC4956805.pdf
Medicine (2016) 95:28(e4181)Received: 16 November 2015 / Received in ﬁnal form: 16 June 2016 / Accepted: 16 June 2016 http://dx.doi.org/10.1097/MD.0000000000004181Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/28/70/medi-95-e4181.PMC4956807.pdf
"The baseline characteristics of the CDAF and NDAF groups in the PPM subgroup and ICD or CRT subgroups are shown in Tables S1 and S2 in the Supplementary Appendix,http://links.lww.com/MD/B118.3.2.",OADS,/arxiv_data1/oa_pdf/28/70/medi-95-e4181.PMC4956807.pdf
"In the subgroup analysis of the present study, the risk factors for new development of AF were different between the PPM subgroup and the ICD and CRT subgroups, which mayhave been due to different baseline characteristics of the patientpopulation between the 2 groups (See Table S3 in the Supplementary Appendix, http://links.lww.com/MD/B118).",Non-OADS,/arxiv_data1/oa_pdf/28/70/medi-95-e4181.PMC4956807.pdf
Medicine (2016) 95:28(e4186)Received: 21 December 2015 / Received in ﬁnal form: 31 May 2016 / Accepted: 16 June 2016 http://dx.doi.org/10.1097/MD.0000000000004186Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/0e/medi-95-e4186.PMC4956810.pdf
"Available at: http://secure.healthlinks.net.au/content/msd/pi.cfm?product=mkpnovas (accessed October 9, 2015).",Non-OADS,/arxiv_data1/oa_pdf/87/0e/medi-95-e4186.PMC4956810.pdf
"Available at: http://www.merck.com/product/usa/pi_circulars/e/ elocon_lotion/elocon_lotion_pi.pdf (accessed October 9, 2015).",Non-OADS,/arxiv_data1/oa_pdf/87/0e/medi-95-e4186.PMC4956810.pdf
"Greenwood Village (CO): Truven Health Analytics; Available from:http://www.thomsonhc.com (accessed October 9, 2015).",Non-OADS,/arxiv_data1/oa_pdf/87/0e/medi-95-e4186.PMC4956810.pdf
"Jan/Feb 2007; Available at: http://www.med.navy.mil/sites/nhbeaufort/Patients/Documents/Safe%20Medicine.pdf (accessed October 9, 2015).Naunton et al.",OADS,/arxiv_data1/oa_pdf/87/0e/medi-95-e4186.PMC4956810.pdf
Medicine (2016) 95:28(e4189)Received: 5 April 2016 / Received in ﬁnal form: 13 June 2016 / Accepted: 16 June 2016 http://dx.doi.org/10.1097/MD.0000000000004189Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
More information on HCUP-NIScan be obtained: https://www.hcup-us.ahrq.gov/nisoverview.jsp.,Non-OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
"OR and estimates from multivariable adjusted analysis of in-hospital mortality and hospital LOS in relation to BMI are presented in Supplementary Tables 1 and 2, http://links.lww.com/MD/B117.",OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi_dis.htm.,Non-OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
http://www.ncbi.nlm.nih.gov/books/NBK52651/.,Non-OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
"Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) Global Initiative for Asthma [Internet];2014. http://www.ginasthma.org/documents/14.",Non-OADS,/arxiv_data1/oa_pdf/ae/46/medi-95-e4189.PMC4956812.pdf
Medicine (2016) 95:28(e4194)Received: 19 April 2016 / Received in ﬁnal form: 15 June 2016 / Accepted: 17 June 2016 http://dx.doi.org/10.1097/MD.0000000000004194Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/11/40/medi-95-e4194.PMC4956814.pdf
Medicine (2016) 95:28(e4207)Received: 30 March 2016 / Received in ﬁnal form: 9 June 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004207Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f2/6c/medi-95-e4207.PMC4956816.pdf
Medicine (2016) 95:28(e4210)Received: 8 October 2015 / Received in ﬁnal form: 16 May 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004210Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/60/59/medi-95-e4210.PMC4956817.pdf
Medicine (2016) 95:28(e4217)Received: 1 November 2015 / Received in ﬁnal form: 24 May 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004217Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/db/48/medi-95-e4217.PMC4956820.pdf
Medicine (2016) 95:28(e4228)Received: 31 March 2016 / Received in ﬁnal form: 29 April 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004228Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/36/f1/medi-95-e4228.PMC4956823.pdf
Available at: http://esa.un.org/unpp.,Non-OADS,/arxiv_data1/oa_pdf/36/f1/medi-95-e4228.PMC4956823.pdf
Medicine (2016) 95:28(e4233) Received: 13 March 2016 / Received in ﬁnal form: 2 June 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004233Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a0/ea/medi-95-e4233.PMC4956824.pdf
Medicine (2016) 95:28(e4241)Received: 7 March 2016 / Received in ﬁnal form: 17 June 2016 / Accepted: 21 June 2016 http://dx.doi.org/10.1097/MD.0000000000004241Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/33/47/medi-95-e4241.PMC4956826.pdf
Medicine (2016) 95:28(e4244)Received: 3 March 2016 / Received in ﬁnal form: 14 June 2016 / Accepted: 17 June 2016 http://dx.doi.org/10.1097/MD.0000000000004244Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ed/42/medi-95-e4244.PMC4956827.pdf
Medicine (2016) 95:28(e4245)Received: 8 January 2016 / Received in ﬁnal form: 17 June 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004245Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/00/b2/medi-95-e4245.PMC4956828.pdf
"2012; http://www.sport.gov.cn/n16/n33193/n33208/n33448/n33793/ 3425606.html Accessed Mar, 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/b2/medi-95-e4245.PMC4956828.pdf
"Global Strategy on Diet, physical Activity and Health 2004; http://www.who.int/dietphysicalactivity/strategy/eb11344/strategy_english_web.pdf Accessed Mar, 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/b2/medi-95-e4245.PMC4956828.pdf
Medicine (2016) 95:28(e4256)Received: 24 May 2016 / Received in ﬁnal form: 16 June 2016 / Accepted: 21 June 2016 http://dx.doi.org/10.1097/MD.0000000000004256Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"All participating patientswere included between January 2015 and May 2015 (Supple-mental Digital Content Figure S1, http://links.lww.com/MD/ B126).",Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"[17,18]All QUIPS data were made anonymous and transferred via internet (http://www.quips-projekt.de/) to the external database for the benchmark project of QUIPS allowingan anonymous comparison to the results of other participating hospitals (not shown).",Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"Clinical and outcome parameters of all patients weresummarized descriptively (Tables 1 and 2, Supplemental Digital Content Table 1, http://links.lww.com/MD/B126).",OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"[20]Associations among patients ’characteristics and maximal pain were examined via Pearson correlation (Supplemental Digital Content Table 2, http://links.lww.com/MD/B126).",Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"QUIPS: Process parameter Supplemental Digital Content Table 1, http://links.lww.com/ MD/B126 gives an overview about the perioperative andTable 1 Patients ’characteristics and preoperative psychological assess- ments (n =82).",Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
"Factors associated with more maximal postoperative pain By univariate analysis, several factors were signi ﬁcantly ( P< 0.05) associated with maximal postoperative pain (Supplemental Digital Content Table 2, http://links.lww.com/MD/B126).",Non-OADS,/arxiv_data1/oa_pdf/af/09/medi-95-e4256.PMC4956830.pdf
Medicine (2016) 95:28(e4261)Received: 29 January 2016 / Received in ﬁnal form: 16 June 2016 / Accepted: 18 June 2016 http://dx.doi.org/10.1097/MD.0000000000004261Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/64/82/medi-95-e4261.PMC4956832.pdf
"ISBN 3-900051-07-0, Available at: URL http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/64/82/medi-95-e4261.PMC4956832.pdf
Medicine (2016) 95:28(e4273)Received: 31 May 2016 / Received in ﬁnal form: 19 June 2016 / Accepted: 22 June 2016 http://dx.doi.org/10.1097/MD.0000000000004273Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8d/21/medi-95-e4273.PMC4956836.pdf
"Three PTW and 1 FTW were left to heal by secondary intention  alone (sham) as a negative control (Supplemental 	 Digital	 Content	 1, http://links.lww.com/PRSGO/ A199), each animal received at least 1 STSG, to allow characterization and comparison of the wound bed  vascularity/quality grafting technique.",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"• Self-assembled Skin as an Alternative to Skin Graft 5(Supplemental	 Digital	 Content	 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"4–6) (Supplemental	 Digital	 Content	 1, http:// links.lww.com/PRSGO/A199 and Supplemental	 Digi- tal	Content	 2, http://links.lww.com/PRSGO/A200).",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"4) (Supplemental	 Digital	 Content 	 1, http://links.lww.com/PRSGO/A199).",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"Complete engraftment of ASCs and STSGs  was observed for up to 1 year (Supplemental	 Digital 	 Content	1, http://links.lww.com/PRSGO/A199).",OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"4) (Supplemental	 Digital	 Content	 1,	http://links.lww.com/PRSGO/A199).",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"4) (Supplemental	 Digital	 Content	 1,   http://links.lww.com/PRSGO/A199).",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
"H, Histology of 1 representative sham wound (untreated with St Sg or aSc ) at late time-point (POD 99), entirely re-epithelialized by secondary intention  with collagen disorganization and scar (gross image in Supplemental Digital Content 3, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/dd/31/gox-4-e731.PMC4956843.pdf
Available at: http://www.plasticsurgery.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/gox-4-e732.PMC4956844.pdf
Available at:  http://www.plasticsurgery.org/Documents/medical-pro- fessionals/health-policy/key-issues/6–13%20PSN%20VTE.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
Available at: http://www.venousdisease.com/ Publications/Caprini-bergan%20final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
Available at: http://www.venousdisease.com/ Publications/APOLLOJAMARevision5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
Available  at: http://cmetracker.net/THRI/Files/Brochures/6246.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
Available at: http://www.journals.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
Available at: http://www.aaaasf.org/Surveyor/asf_web/ PDF%20FILES/Standards%20and%20Checklist%20Manual%20V14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/fe/gox-4-e733.PMC4956845.pdf
"See video, Supplemental Digital Content  1, which demonstrates infiltrations of wetting solution per - formed in the “superwet” fashion (a 1:1 ratio of infiltrate to esti-mated aspirate), http://links.lww.com/PRSGO/A220.",Non-OADS,/arxiv_data1/oa_pdf/59/63/gox-4-e734.PMC4956846.pdf
"See video, Supplemental Digital Content 2, which demonstrates a U al performed with an ultrasound  generator, a 5-mm blunt-tip cannula or a 4-mm golf-tee can-nula, and a surgical aspirator for evacuation, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/59/63/gox-4-e734.PMC4956846.pdf
"See video, Supplemental Digital Content 3, which demonstrates an Sal performed using a 3.7-mm can- nula for evacuation and final contouring, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/59/63/gox-4-e734.PMC4956846.pdf
Available at: http://www.physicians- foundation.org/uploads/default /2014_Physicians_Foundation_Biennial_Physician_Survey_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available at: http://www.hscic.gov.uk/catalogue/PUB02722/clin-audi-supp-prog-mast-brea-reco-2009-rep1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available at:  http://www.rcseng.ac.uk/surgeons/research/surgical-re-search/docs/national-mastectomy-and-breast-reconstruc- tion-audit-third-report-2010.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available at: http://www.nice.org.uk/nicemedia/pdf/Improving_outcomes_breastcancer_ manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available  at: http://www.rcseng.ac.uk/surgeons/research/surgical- research/docs/national-mastectomy-and-breast-recon-struction-audit-first-report.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available at: http://www.ahrq.gov/consumer/guidetoq/guidetoq4.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
Available at: http://bma.org.uk/-/media/files/ pdf/practical%20advice%20at%20work/private%20prac-tice/setting%20up.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/5f/gox-4-e738.PMC4956850.pdf
This video is available in the “Related Videos” section of the Full-Text article on PRSGloba-lOpen.com or at http://links.lww.com/PRSGO/A203.),Non-OADS,/arxiv_data1/oa_pdf/c6/31/gox-4-e747.PMC4956859.pdf
this video is available  in the “r elated Videos” section of the Full- text article on Prs - globalopen.com or at http://links.lww.com/PRSGO/A202.,Non-OADS,/arxiv_data1/oa_pdf/c6/31/gox-4-e747.PMC4956859.pdf
this video is available in the “r elated  Videos” section of the Full- text article on Prsglobalopen.com  or at http://links.lww.com/PRSGO/A203.,Non-OADS,/arxiv_data1/oa_pdf/c6/31/gox-4-e747.PMC4956859.pdf
"3Robotic-Assisted Rejuvenation Digital	 Content	 3,	http://links.lww.com/PRSGO/ A211).",Non-OADS,/arxiv_data1/oa_pdf/c6/31/gox-4-e747.PMC4956859.pdf
"http://www.plasticsurgery.org/ Documents/news-resources/statistics/2013-statistics/plastic-surgery-statistics-full-report-2013.pdf (last updated August 13, 2015, Accessed August 2015).",Non-OADS,/arxiv_data1/oa_pdf/f4/00/gox-4-e754.PMC4956866.pdf
 Uemura et al • Transconjunctival Approach for Zygomatic Fracture 3of the Full-Text article on PRSGlobalOpen.com or  available at http://links.lww.com/PRSGO/A206.),Non-OADS,/arxiv_data1/oa_pdf/78/70/gox-4-e757.PMC4956869.pdf
"RESULTS Mean age of the 46 patients at the time of sur - gery was 27.2 years (range, 8–67 years) (See	 Table,	 Supplemental	 Digital	 Content	 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/78/70/gox-4-e757.PMC4956869.pdf
this video is available in the “r elated Videos” sec - tion of the Full- text article on PrSglobalOpen.com or avail- able at http://links.lww.com/PRSGO/A206.,Non-OADS,/arxiv_data1/oa_pdf/78/70/gox-4-e757.PMC4956869.pdf
The Top-rated Web Sites (>95th Percentile According to the Modified EQIP Instrument) Ranking Website Country	of	Origin Source	of	Information Score 1 http://cosmeticsurgery.ucla.edu/body.cfm?id=35 United States Academic center 29 2 http://westcountyplasticsurgeons.wustl.edu/Procedures/Body-  Procedures/Tumescent-LiposuctionUnited States Academic center 26 2 http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/  liposuctionAustralia Health department 26 2 http://www.cosmosclinic.com.au/tummy/liposuction Australia Practitioner 26 5 http://www.answers.com/topic/liposuction United States Portal 25 5 http://www.deramonpsi.com/liposuction-harrisburg.html United States Practitioner 25 7 http://www.buzzle.com/articles/liposuction United States Portal 24 7 http://www.plasticsurgery.org/cosmetic-procedures/liposuction.html United States Professional society 24 9 http://www.austinplasticsurgerycenter.com/liposuction.php United States Practitioner 23 9 http://www.emedicinehealth.com/liposuction/article_em.htm United States Portal 23 9 http://www.surgery.com/procedure/liposuction United States Portal 23 9 http://www.thevictoriancosmeticinstitute.com.au/liposuction Australia Practitioner 23 Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://www.ebizmba.com/articles/search-engines.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://uk.askmen.com/ sports/health/13_mens_health.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://www.liposuc- tionlosangeles.biz.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://www.plasticsurgery.org/cosmetic-procedures/liposuction/liposuc- tion-overview.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://en.wikipedia.org/wiki/English_language#Geographical_distribution.,Non-OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
Available at: http://idpdas.ohri.ca/IPDAS_Background.pdf.,OADS,/arxiv_data1/oa_pdf/e2/1b/gox-4-e759.PMC4956871.pdf
"METHODS Device	Specifications The Ecous SC MiCron (Air Water Safety Service  Inc., Kobe, Japan, http://www.awb.co.jp/medical_ en/index.html) is a commercially available camera  for medical use.",Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
This content is available at http://links.lww.com/PRSGO/A208.),Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
This content is available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
This content is available at http://links.lww.com/ PRSGO/A210.),Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
"Supplemental digital Content 1 demon-strates a dIeP flap-harvesting procedure, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
"Supplemental digital Content 2 demon-strates a T aP flap-harvesting procedure, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
"Supplemental digital Content 3 demon- strates a SIea flap-harvesting procedure, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/f7/f4/gox-4-e765.PMC4956877.pdf
Available at:  http://psychiatry.org/psychiatrists/practice/dsm/dsm-5.,Non-OADS,/arxiv_data1/oa_pdf/9f/e5/gox-4-e767.PMC4956879.pdf
Available at: http://apps.who.int/classifications/icd10/ browse/2016/en.,OADS,/arxiv_data1/oa_pdf/9f/e5/gox-4-e767.PMC4956879.pdf
2015. https://www.aamc.org/download/321468/data/fact- stablea6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/gox-4-e768.PMC4956880.pdf
2015. https://www.aamc.org/data/448482/b3table.html.,OADS,/arxiv_data1/oa_pdf/44/f4/gox-4-e768.PMC4956880.pdf
A  readily accessible source of data for creation of anatomical  models is the Visible Human Project (https://www.nlm.,Non-OADS,/arxiv_data1/oa_pdf/82/d8/gox-4-e773.PMC4956885.pdf
"With the advent of immersion technology, such as Oculus  Rift (https://www.oculus.com/en-us/rift/) and Microsoft  Hololens (https://www.microsoft.com/microsoft-hololens/ en-us), the simulation world is experiencing a rapid shift to- ward virtual and augmented reality.",Non-OADS,/arxiv_data1/oa_pdf/82/d8/gox-4-e773.PMC4956885.pdf
this video is available in the   “Related Videos” section of the full-text article on PRSglobalOpen.com or available at http://links.lww.com/PRSGO/A225.,Non-OADS,/arxiv_data1/oa_pdf/71/ab/gox-4-e789.PMC4956901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/d5/main.PMC4956902.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.001 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/d5/main.PMC4956902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 40 e42,Non-OADS,/arxiv_data1/oa_pdf/5e/d5/main.PMC4956902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/35/main.PMC4956904.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.005 2049-0801/Crown Copyright ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/6c/35/main.PMC4956904.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Sebastià C, Quiroga S, Espin E, et al .",Non-OADS,/arxiv_data1/oa_pdf/d0/64/bcr-2016-215977.PMC4956968.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 661–670 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.007 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/4e/55/main.PMC4957008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/55/main.PMC4957008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/55/main.PMC4957008.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jare.2016.",OADS,/arxiv_data1/oa_pdf/4e/55/main.PMC4957008.pdf
"687 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/54/hyw047.PMC4957009.pdf
http://www.nice.org.uk/guidance/cg69/ evidence/full-guideline-196853293  (accessed on 5 February 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/bf/cmw022.PMC4957011.pdf
"http://www.rcgp.org.uk/clinical-and-research/toolkits/target-antibiotics- toolkit.aspx  (accessed on 4 February 2016).400 Family Practice , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9e/bf/cmw022.PMC4957011.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/5d/main.PMC4957073.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.05.003 .,OADS,/arxiv_data1/oa_pdf/a6/5d/main.PMC4957073.pdf
E-mail address: daniel_delgaizo@med.unc.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.05.003 2352-3441/Copyright ©2016 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/a6/5d/main.PMC4957073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 19 e22,Non-OADS,/arxiv_data1/oa_pdf/a6/5d/main.PMC4957073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/21/nihms800059.PMC4957139.pdf
"Available at: http://www.montevideo.gub.uy/sites/default/files/ monitoreo_metales_suelos_2010-2011.pdf  [Accessed August 3, 2015] 9.",Non-OADS,/arxiv_data1/oa_pdf/1c/21/nihms800059.PMC4957139.pdf
Available at: http://www2.epa.gov/lead/hazard- standards-lead-paint-dust-and-soil-tsca-section-403 10.,Non-OADS,/arxiv_data1/oa_pdf/1c/21/nihms800059.PMC4957139.pdf
Available at: http://www.msp.gub.uy/sites/default/files/22748.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/1c/21/nihms800059.PMC4957139.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.01.005 .,OADS,/arxiv_data1/oa_pdf/10/f1/main.PMC4957153.pdf
E-mail address: nathan.grimm@duke.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.01.005 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/f1/main.PMC4957153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 45 e47,Non-OADS,/arxiv_data1/oa_pdf/10/f1/main.PMC4957153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/f3/main.PMC4957154.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.05.005 .,OADS,/arxiv_data1/oa_pdf/33/f3/main.PMC4957154.pdf
E-mail address: chris_scheuerman@trihealth.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.05.005 2352-3441/Copyright ©2016 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/33/f3/main.PMC4957154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 37 e42,Non-OADS,/arxiv_data1/oa_pdf/33/f3/main.PMC4957154.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.08.002 .,OADS,/arxiv_data1/oa_pdf/c8/75/main.PMC4957155.pdf
E-mail address: ortho ﬂeming@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.08.002 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/75/main.PMC4957155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 53 e56,Non-OADS,/arxiv_data1/oa_pdf/c8/75/main.PMC4957155.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.11.003 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/9d/42/main.PMC4957156.pdf
E-mail address: Thomas.Fehring@orthocarolina.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.11.003 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/42/main.PMC4957156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 15 e18,Non-OADS,/arxiv_data1/oa_pdf/9d/42/main.PMC4957156.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.11.002 .,OADS,/arxiv_data1/oa_pdf/ef/60/main.PMC4957157.pdf
E-mail address: Research_Coordinator@oriql.com.au Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthroplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.11.002 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/60/main.PMC4957157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 26 e36,Non-OADS,/arxiv_data1/oa_pdf/ef/60/main.PMC4957157.pdf
J Bone Joint Surg Am 2000;82(3):342. http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/ef/60/main.PMC4957157.pdf
Case Reports Orthop Hindawi Publ Corp. 2014;2014(Article ID 645927):4. http://dx.doi.org/10.1155/2014/645927 .,Non-OADS,/arxiv_data1/oa_pdf/ef/60/main.PMC4957157.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.03.001 .,OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
E-mail address: dibraff@ortho.u ﬂ.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.03.001 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 63 e67,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
"Rockville, MD: Agency for Healthcare Research and Quality; 2013. http://hcupnet.ahrq.gov/HCUPnet.jsp [accessed 13.12.15].",Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
http://www.aahks.org/care-for-hips-and-knees/do-i-need-a-joint-replacement/ total-hip-replacement/ [accessed 03.03.2016].,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
2012. https://www.britishhipsociety.com/uploaded/Blue%20Book% 202012%20fsh%20nov%202012.pdf [accessed 03.03.2016].,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4957158.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.01.003 .,OADS,/arxiv_data1/oa_pdf/a7/76/main.PMC4957166.pdf
E-mail address: mcgrob1@mmc.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.01.003 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/76/main.PMC4957166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 1,Non-OADS,/arxiv_data1/oa_pdf/a7/76/main.PMC4957166.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.01.004 .,OADS,/arxiv_data1/oa_pdf/6b/4f/main.PMC4957167.pdf
E-mail address: ddalury@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.01.004 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/4f/main.PMC4957167.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 23 e25,Non-OADS,/arxiv_data1/oa_pdf/6b/4f/main.PMC4957167.pdf
J Arthroplasty 2015. http://dx.doi.org/10.1016/j.arth.2015.10.030 .,OADS,/arxiv_data1/oa_pdf/6b/4f/main.PMC4957167.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.11.004 .,OADS,/arxiv_data1/oa_pdf/00/85/main.PMC4957168.pdf
: þ16 0 1 815 3161 E-mail address: bstronach@umc.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.11.004 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/85/main.PMC4957168.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 11 e14,Non-OADS,/arxiv_data1/oa_pdf/00/85/main.PMC4957168.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.12.007 .,OADS,/arxiv_data1/oa_pdf/a2/f0/main.PMC4957169.pdf
E-mail address: aseviciu@emhs.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.12.007 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/main.PMC4957169.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 77 e82,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/main.PMC4957169.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.artd.2015.12.007 .,OADS,/arxiv_data1/oa_pdf/a2/f0/main.PMC4957169.pdf
2014. http://www.pbm.va.gov/PBM/clinicalguidance/clinicalrecommendations/Tranexamic_Acid_in_TKA_ or_THA_Clinical_Recommendations.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/main.PMC4957169.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.12.006 .,OADS,/arxiv_data1/oa_pdf/72/e0/main.PMC4957170.pdf
E-mail address: yeemi@med.umich.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthroplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.12.006 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/e0/main.PMC4957170.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 6 e10,Non-OADS,/arxiv_data1/oa_pdf/72/e0/main.PMC4957170.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.01.001 .,OADS,/arxiv_data1/oa_pdf/6f/14/main.PMC4957171.pdf
E-mail address: jdl2161@columbia.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.01.001 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/14/main.PMC4957171.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 49 e52,Non-OADS,/arxiv_data1/oa_pdf/6f/14/main.PMC4957171.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.12.005 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/8d/1e/main.PMC4957172.pdf
E-mail address: TylerWatters@Centura.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthroplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.12.005 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/1e/main.PMC4957172.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 2 e5,Non-OADS,/arxiv_data1/oa_pdf/8d/1e/main.PMC4957172.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/18/main.PMC4957173.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.07.001 .,OADS,/arxiv_data1/oa_pdf/4a/18/main.PMC4957173.pdf
E-mail address: truntzer@stanford.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.07.001 2352-3441/Copyright ©2016 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/4a/18/main.PMC4957173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 69 e76,Non-OADS,/arxiv_data1/oa_pdf/4a/18/main.PMC4957173.pdf
Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016037 66.,Non-OADS,/arxiv_data1/oa_pdf/74/cc/ANIE-55-8661.PMC4957245.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.03.004 .,OADS,/arxiv_data1/oa_pdf/30/89/main.PMC4957263.pdf
E-mail address: bryan.springer@orthocarolina.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.03.004 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/89/main.PMC4957263.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 43,Non-OADS,/arxiv_data1/oa_pdf/30/89/main.PMC4957263.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/b4/main.PMC4957264.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 91–95 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.12.002 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/00/b4/main.PMC4957264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/b4/main.PMC4957264.pdf
"Instrument and data collection The questionnaire was developed from the e-cigarette part of theWorld Health Organization’s Global Adult Tobacco Sur- vey ( http://www.cdc.gov/tobacco/global/gats/questionnaire/ index.htm [updated 25 May 2009, accessed June 2009]) and was peer-reviewed, piloted, and determined to be comprehen- sive.",OADS,/arxiv_data1/oa_pdf/00/b4/main.PMC4957264.pdf
Avalible at: http://www.who.int/tobacco/surveillance/survey/gats/en/ .,Non-OADS,/arxiv_data1/oa_pdf/00/b4/main.PMC4957264.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.04.003 .,OADS,/arxiv_data1/oa_pdf/b3/30/main.PMC4957265.pdf
E-mail address: mcgrob1@mmc.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.04.003 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/30/main.PMC4957265.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 83 e86,Non-OADS,/arxiv_data1/oa_pdf/b3/30/main.PMC4957265.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 80–85 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.11.001 1013-9052 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2e/54/main.PMC4957266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/54/main.PMC4957266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/54/main.PMC4957266.pdf
J. http://dx.doi.org/10.1016/j.jsps.2014.04.004 (E-pub ahead of print).,OADS,/arxiv_data1/oa_pdf/2e/54/main.PMC4957266.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.03.002 .,OADS,/arxiv_data1/oa_pdf/13/ae/main.PMC4957267.pdf
E-mail address: josephrlangston@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.03.002 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/ae/main.PMC4957267.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 57 e61,Non-OADS,/arxiv_data1/oa_pdf/13/ae/main.PMC4957267.pdf
"Key words: dust-bathing behavior, laying hen, sham dust bathing 2016 Poultry Science 95:1482–1491 http://dx.doi.org/10.3382/ps/pew109 INTRODUCTION The enriched colony housing systems for laying hens (also known as enriched cages) were introduced in Ger- many as an alternative to conventional cages after these were forbidden by German law.",Non-OADS,/arxiv_data1/oa_pdf/77/77/pew109.PMC4957303.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/77/pew109.PMC4957303.pdf
"Pressemitteilung 93, Bundesministerium f¨ ur Ern¨ahrung, Landwirtschaft und Verbraucherschutz, 29.3.2012. http://www.bmelv.de/SharedDocs/Pressemitteilungen/2012/93-Legehennen.html (last accessed 3/25/2013).",Non-OADS,/arxiv_data1/oa_pdf/77/77/pew109.PMC4957303.pdf
http://www.efsa.europa.eu/ de/efsajournal/doc/197.pdf (last accessed 1/18/2013).,Non-OADS,/arxiv_data1/oa_pdf/77/77/pew109.PMC4957303.pdf
"Key words: Salmonella enterica , poultry, heat shock, Clp, Lon 2016 Poultry Science 95:1617–1623 http://dx.doi.org/10.3382/ps/pew103 INTRODUCTION Infections caused by Salmonella enterica (S. enter- ica) account for the majority of bacterial food-borne illnesses [Center for Disease Control (CDC), 2015].",Non-OADS,/arxiv_data1/oa_pdf/32/bb/pew103.PMC4957304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/bb/pew103.PMC4957304.pdf
"1Corresponding author: bryan troxell@ncsu.eduIn 2013, an outbreak occurred across 39 states that was associated with backyard flocks of chickens within the United States ( http://www.cdc.gov/salmonella/ typhimurium-live-poultry-04-13/ ).",Non-OADS,/arxiv_data1/oa_pdf/32/bb/pew103.PMC4957304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/4f/rjw039.PMC4957406.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/1a/jiw036.PMC4957434.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/a3/jiw209.PMC4957446.pdf
"Key words: Carcass trait, chicken, GWAS, SLAF-seq 2016 Poultry Science 95:500–506 http://dx.doi.org/10.1093/ps/pev266 INTRODUCTION The increasing worldwide human population has re- sulted in a growing demand for meat products.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/pev266.PMC4957485.pdf
"This is an Open Access article distributed under the terms of the Cre- ative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/pev266.PMC4957485.pdf
Quantile-quantile plots for each trait and Manhattan plots of genome-wide asso- ciation analyses were produced using TASSEL 3.0 soft- ware ( http://www.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/b5/61/pev266.PMC4957485.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/ef/cvw097.PMC4957491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/4c/main.PMC4957503.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 86–90 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2016.01.002 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/05/4c/main.PMC4957503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/4c/main.PMC4957503.pdf
"Key words: chicken, genome integration, Marek’s disease, fluorescence in situ hybridization, telomere 2016 Poultry Science 95:412–429 http://dx.doi.org/10.3382/ps/pev369 INTRODUCTION Marek’s Disease – Characteristics and History Marek’s disease ( MD) is a complex, immunosuppres- sive disease characterized by paralysis, chronic wast- ing, lymphoma development in the viscera and mus- culature, and blindness in chickens (Davison and Nair, 2004; Jarosinski et al., 2006) infected by Marek’s dis- ease virus ( MDV ) (Churchill and Biggs, 1967).",Non-OADS,/arxiv_data1/oa_pdf/0a/7f/pev369.PMC4957504.pdf
"This is an Open Access article distributed under the terms of the Cre- ative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/7f/pev369.PMC4957504.pdf
"Key words: blood gas, blood chemistry, layer pullet, laying hen, W-36 2016 Poultry Science 95:466–471 http://dx.doi.org/10.3382/ps/pev350 INTRODUCTION Advancements in clinical veterinary medicine have resulted in portable diagnostic tools that provide rapid, cost-effective means to investigate metabolic distur- bances using blood samples.",Non-OADS,/arxiv_data1/oa_pdf/d4/b5/pev350.PMC4957505.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/b5/pev350.PMC4957505.pdf
University of Manchester (http://dx.doi.org/10.5257/wb/wdi/2012-09).,Non-OADS,/arxiv_data1/oa_pdf/c5/ae/bjporcpsych002170.PMC4957519.pdf
2007 (http://www.ncdc.noaa.gov/sotc/hazards/2007/8).,OADS,/arxiv_data1/oa_pdf/c5/ae/bjporcpsych002170.PMC4957519.pdf
EM-DAT: The OFDA/CRED International Disaster Database (http://www.em-dat.net).,OADS,/arxiv_data1/oa_pdf/c5/ae/bjporcpsych002170.PMC4957519.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/dvw006.PMC4957520.pdf
We calculated DNAm-age through Horvath’s publically avail- able online calculator (http://labs.genetics.ucla.edu/horvath/dnamage/) [ 20].,OADS,/arxiv_data1/oa_pdf/a4/f9/dvw006.PMC4957520.pdf
"http://genomebiology.com/ 2013/14/10/R115 (19 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/dvw006.PMC4957520.pdf
"Key words: Pectoralis major , myosin heavy chain, isoform, myogenesis, transcriptome 2016 Poultry Science 95:1151–1155 http://dx.doi.org/10.3382/ps/pew011 INTRODUCTION The Pectoralis major ( PM ) is the predominant breast muscle in poultry and continued selection for proportional increases in breast muscle size in broil- ers and turkeys has increased the potential for corre- lated negative effects in both fresh and cooked mus- cle products.",Non-OADS,/arxiv_data1/oa_pdf/c6/d9/pew011.PMC4957532.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/d9/pew011.PMC4957532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/4e/main.PMC4957535.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 63–69 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.08.002 1013-9052 /C2112015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/84/4e/main.PMC4957535.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/4e/main.PMC4957535.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/f1/main.PMC4957536.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 96–101 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2016.01.001 1013-9052 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/f1/main.PMC4957536.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/f1/main.PMC4957536.pdf
< http://esa.un.org/wpp/ >.,Non-OADS,/arxiv_data1/oa_pdf/97/f1/main.PMC4957536.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/39/main.PMC4957537.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 70–75 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.09.002 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/0c/39/main.PMC4957537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/39/main.PMC4957537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/9b/main.PMC4957538.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 76–79 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.12.001 1013-9052 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f8/9b/main.PMC4957538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/9b/main.PMC4957538.pdf
The connectivity domain can be  constructed from any technique that identifies sets of features that are similar across subjects and  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/40/nihms798618.PMC4957565.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.neuroimage.2016.04.006 HHS Public Access Author manuscript Neuroimage .,OADS,/arxiv_data1/oa_pdf/71/40/nihms798618.PMC4957565.pdf
"The FSL software  package ( http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ ) was used for rsfMRI data preprocessing,  including discarding the first five volumes for magnetization equilibrium purposes, brain  extraction, motion correction, slice-time correction, spatial smoothing with a 5 mm full  width at half-maximum (FWHM= 5 mm), prewhitening, and grand mean removal.",OADS,/arxiv_data1/oa_pdf/71/40/nihms798618.PMC4957565.pdf
ICA analysis was performed using the GIFT software package from MIALAB  (http://mialab.mrn.org/software/gift/ ).,OADS,/arxiv_data1/oa_pdf/71/40/nihms798618.PMC4957565.pdf
2011-11-5] http://www.nitrc.org/docman/view.php/55/295/v1.3d_GIFTManual pdf .,Non-OADS,/arxiv_data1/oa_pdf/71/40/nihms798618.PMC4957565.pdf
"13, 1706 –1714 http://dx.doi.org/10.1080/15384101.2016.1175796",Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Nature 1997; 386:623-7; PMID:9121588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"EMBO Reports 2012; 13:515-27;PMID:22614003; http://dx.doi.org/10.1038/embor.2012.65 [4] Holland AJ, Cleveland DW.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"EMBO Reports 2012; 13:501-14; PMID:22565320; http://dx.doi.org/10.1038/embor.2012.55 [5] McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic chal- lenges.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"EMBO Reports 2012; 13:528-38; PMID:22595889; http://dx.doi.org/10.1038/embor.2012.61 [6] Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Can- cer Cell 2007; 11:25-36; PMID:17189716; http://dx.doi.org/10.1016/j.ccr.2006.12.003 [7] Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, et al.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Nature 2010;468:321-5; PMID:20962780; http://dx.doi.org/10.1038/nature09529 [9] Pariente N. A balancing act: focu s on aneuploidy.,Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"EMBO Reports 2012; 13:472; PMID:22653484; http://dx.doi.org/10.1038/embor.2012.66 [10] Heim S, Mitelman F. Cancer cytogenetics New York: Wiley-Liss, 1995.",Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Hormones Cancer 2011; 2:113-6; PMID:21475725; http://dx.doi.org/10.1007/s12672-010-0059-x [13] Thompson SL, Bakhoum SF, Compton DA.",Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Curr Biol 2010; 20:R285-95; PMID:20334839; http://dx.doi.org/10.1016/j.cub.2010.01.034 [14] Gordon DJ, Resio B, Pellman D. Causes and consequences of aneu- ploidy in cancer.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"J Cell Biol 2008; 180:665-72; PMID:18283116; http://dx.doi.org/10.1083/jcb.200712029 [16] Bakker B, van den Bos H, Lansdorp PM, Foijer F. How to count chromosomes in a cell: An overview of current and novel technolo- gies.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Chromosome Res 2012; 20:505-19; PMID:22825423; http://dx.doi.org/10.1007/s10577-012-9293-0 [19] Kouprina N, Earnshaw WC, Masumoto H, Larionov V. A new gener- ation of human arti ﬁcial chromosomes for functional genomics and gene therapy.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Cell Mol Life Sci 2013; 70:1135-48; PMID:22907415;http://dx.doi.org/10.1007/s00018-012-1113-3 [20] Nakano M, Cardinale S, Noskov VN, Gassmann R, Vagnarelli P, Kandels-Lewis S, Larionov V, Earnshaw WC, Masumoto H. Inactiva- tion of a human kinetochore by speci ﬁc targeting of chromatin modi ﬁers.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Dev Cell 2008; 14:507-22; PMID:18410728; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"BMC Cancer 2013; 13:252; PMID:23694679; http://dx.doi.org/10.1186/1471-2407-13-252 [22] Lee HS, Lee NC, Kouprina N, Kim JH, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V. Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies.",Non-OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Cancer Res 2016; 76:902-11;PMID:26837770; http://dx.doi.org/10.1158/0008-5472.CAN-15-1617[23] Kim JH, Lee HS, Lee NC, Goncharov NV, Kumeiko V, Masumoto H, Earnshaw WC, Kouprina N, Larionov V. Development of a novel HAC-based “gain of signal ”quantitative assay for measuring chromosome instability (CIN) in cancer cells.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Quarterly Rev Biophys 2011; 44:153-90;http://dx.doi.org/10.1017/S0033583510000259 [25] Zou H, McGarry TJ, Bernal T, Kirschner MW.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Science 1999; 285:418-22; PMID:10411507;http://dx.doi.org/10.1126/science.285.5426.418 [26] Musacchio A, Salmon ED.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Nat Rev Mol Cell Biol 2007; 8:379-93; PMID:17426725;http://dx.doi.org/10.1038/nrm2163 [27] Janssen A, Medema RH.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Oncogene 2011; 30:2799-809; PMID:21339734; http://dx.doi.org/10.1038/ onc.2011.30 [28] Weaver BA.,OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Mol Biol Cell 2014; 25:2677-81; PMID:25213191; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Cell Motility Cyto- skeleton 2009; 66:437-47; http://dx.doi.org/10.1002/cm.20316 [30] Ikui AE, Yang CP, Matsumoto T, Horwitz SB.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Cell Cycle 2005; 4:1385-8;PMID:16138009; http://dx.doi.org/10.4161/cc.4.10.2061 [31] Zasadil LM, Andersen KA, Yeum D, Rocque GB, Wilke LG, Tevaar- werk AJ, Raines RT, Burkard ME, Weaver BA.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"J Cell Biol 2010; 190:73-87; PMID:20624901; http://dx.doi.org/10.1083/jcb.201001036 [33] Lampson MA, Kapoor TM.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Nat Chem Biol 2006; 2:19-27;PMID:16408087; http://dx.doi.org/10.1038/nchembio757 [34] Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, et al.Replication stress links structural and numerical cancer chromo- somal instability.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"DNA Res 2010; 17:293-301; PMID:20798231;http://dx.doi.org/10.1093/dnares/dsq020 [37] Kim JH, Ebersole T, Kouprina N, Noskov VN, Ohzeki J, Masumoto H, Mravinac B, Sullivan BA, Pavlicek A, Dovat S, et al.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
"Genome Res 2009; 19:533-44; PMID:19141594; http://dx.doi.org/10.1101/gr.086496.108 [38] KimJH, KononenkoA, ErliandriI,KimTA, NakanoM,IidaY,Barrett JC, OshimuraM,MasumotoH,EarnshawWC,etal.Humanarti ﬁcialchromo- some(HAC)vectorwithaconditionalce ntromereforcorrectionofgenetic deﬁciencies in human cells.",OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
Nat Genetics 1997; 16:133-43; PMID:9171824;http://dx.doi.org/10.1038/ng0697-1331714 S. MARKOSSIAN ET AL.,OADS,/arxiv_data1/oa_pdf/8e/8b/kccy-15-13-1175796.PMC4957569.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Eucommia ulmoidesTranscriptomeIllumina sequencingFlower bud 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/07/main.PMC4957572.pdf
1Equal contributor http://dx.doi.org/10.1016/j.gdata.2016.07.0012213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/07/main.PMC4957572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/07/main.PMC4957572.pdf
"[20] T. Thiel, MISA-microsatellite Identi ﬁcation Tool, 2003, URL: http://pgrc.ipk- gatersleben.de/misa/misa.html .",OADS,/arxiv_data1/oa_pdf/0d/07/main.PMC4957572.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cancer metabolism Protein kinase A (PKA) Glucose starvationCancer cell resistance Speciﬁcations Where applicable, please follow the Ontology for Biomedical Investi- gations: http://obi-ontology.org/page/Main_Page Organism/cell line/tissueNIH3T3 mouse ﬁbroblasts and transformed NIH3T3-K-ras Sex NA Sequencer or array typeMouse Genechip MoGene-1_0 -st-v1 Arrays (Affymetrix) Data format Raw data: CEL ﬁles, normalized data: SOFT, MINIML, TXT Experimental factorsImmortalized NIH3T3 mouse ﬁbroblasts vs. transformed NIH3T3-K-ras mouse ﬁbroblasts cultured at 1 mM glucose and daily treated with 10 μM Forskolin Experimental featuresTranscriptome pro ﬁling of genes modulated by PKA in immortalized and transformed mouse ﬁbroblasts.",Non-OADS,/arxiv_data1/oa_pdf/91/a9/main.PMC4957573.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68266 2.,OADS,/arxiv_data1/oa_pdf/91/a9/main.PMC4957573.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.004 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/a9/main.PMC4957573.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/a9/main.PMC4957573.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Nonparametric multilevel latent class analysisHealthy schoolsHigh school students 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.016 2211-3355/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
"OSDUHS 2011 received approval from the Research Ethics Boards of CAMH, York University, and school boards re- quiring review (for details including questionnaires: http://www.camh.",Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
"Latent class indicators and covariates We used 10 health-related indicators to extract student latent class membership, grounded in the Ontario Ministry of Education's (EDU)Foundations for a Healthy School Framework ( http://www.edu.gov.on.",Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
We obtained two school-level covariates for the 2011/2012 school year from the EDU website http://www.edu.gov.on.ca/eng/sift/ glossary.asp : the percentage of students living in low income house- holds and school enrolment.,Non-OADS,/arxiv_data1/oa_pdf/9a/98/main.PMC4957574.pdf
"13, 1667 –1673 http://dx.doi.org/10.1080/15384101.2016.1152435",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Analysis of ﬁbrosis-associated pathways with IPA Ingenuity and MetaCore We next performed parallel analyses using QIAGEN ’s Ingenuity Pathway Analysis (IPA®,QIAGEN Redwood City,www.qiagen.com/ingenuity) and MetaCore from ThomsonReuters (http://thomsonreuters.com/en/products-services/pharma-life-sciences/pharmaceutical-research/metacore.html)software with the same input data sets utilized to elucidateﬁbrosis-associated pathways with Regeneration Intelligence toolset and compared data generated by these alternative methods with our results.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Onlytwo datasets met our inclusion criteria (clinical material obtainedvia biopsy or surgical resection ): GSE2052 (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"pulmonary transplant, and 11 histologically normal lung tissue samples resected from lung cancer patients.53The second set, GSE49541 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accDGSE49541) contains data for 72 samples obtained via diagnostic biopsy in nonalcoholic fatty liver disease (NAFLD)patients.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Annu Rev Pathol 2011; 6:425-56; PMID:21073339; http://dx.doi.org/ 10.1146/annurev-pathol-011110-130246 [2] Mehal WZ, Iredale J, Friedman SL.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Am J Respir Crit Care Med 2006; 174:810-6; PMID:16809633; http://dx.doi.org/10.1164/rccm.200602-163OC [4] Sass DA, Chang P, Chopra KB.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Dig Dis Sci 2005; 50:171-80; PMID:15712657; http://dx.doi.org/10.1007/s10620-005-1267-z [5] Zeisberg M, Kalluri R. Cellular mechanisms of tissue ﬁbrosis.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Am J Physiol Cell Physiol 2013; 304:C216-25; PMID: 23255577; http://dx.doi.org/10.1152/ajpcell.00328.2012 [6] Eddy AA.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Nat Med 2011; 17:553-5; PMID:21546974; http://dx.doi.org/10.1038/nm0511-553 [7] Yu Z, Xie M, Fan X, Jia J. Interferon alpha2b Increases MMP-13 and IL-10 expression in Kupffer cells through MAPK signaling pathways.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Nat Rev Drug Discov 2015; 14:693-720; PMID:26338155; http://dx.doi.org/10.1038/nrd4592 [9] Rockey DC, Bell PD, Hill JA.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"N Engl J Med 2015; 372:1138-49; PMID:25785971; http://dx.doi.org/10.1056/NEJMra1300575 [10] Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Front Genet 2014; 5:55; PMID:24723936; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Front Mol Biosci 2014; 1:8;PMID:25988149; http://dx.doi.org/10.3389/fmolb.2014.00008 [12] Zhu Q, Izumchenko E, Aliper AM, Makarev E, Paz K, Buzdin AA, Zhavoronkov AA, Sidransky D. Pathway activation strength is anovel independent prognostic biomarker for cetuximab sensitivity incolorectal cancer patients.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Am J Respir Cell Mol Biol 2012; 46:380-8; PMID:22021337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"FEBS Lett 2008; 582:291-8; PMID:18154735;http://dx.doi.org/10.1016/j.febslet.2007.12.021 [15] Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS, Santini AM, HutchinsonCELL CYCLE 1671",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Br J Pharmacol 2010; 160:1699-713; PMID:20649573; http://dx.doi.org/10.1111/j.1476-5381.2010.00828.x [16] Pyne NJ, Dubois G, Pyne S. Role of sphingosine 1-phosphate and lysophosphatidic acid in ﬁbrosis.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Biochim Biophys Acta 2013; 1831:228-38; PMID:22801038; http://dx.doi.org/10.1016/j.bbalip.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Nature 2003; 425:577-84;PMID:14534577; http://dx.doi.org/10.1038/nature02006 [18] Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF- beta in hepatic ﬁbrosis.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Front Biosci 2002; 7:d793-807; PMID: 11897555; http://dx.doi.org/10.2741/gressner [19] Nishida M, Okumura Y, Sato H, Hamaoka K. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal ﬁbrosis in obstructive nephropathy.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Nephrol Dial Transplant 2008; 23:2520-4;PMID:18515792; http://dx.doi.org/10.1093/ndt/gfn309 [20] Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y. Involvem ent of integrin-linked kinase in carbon tetrachloride-induced hepatic ﬁbrosis in rats.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Hepatol- ogy 2006; 44:612-22; PMID:16941698; http://dx.doi.org/10.1002/ hep.21315 [21] Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, Williams AS, Lambie M, Foster TL, Liao CT, et al.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Immunity 2014; 40:40-50; PMID:24412616; http://dx.doi.org/10.1016/j.immuni.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Front Physiol 2012; 3:69; PMID:22493582; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Hepatology 2014; 59:1577-90;PMID:24677197; http://dx.doi.org/10.1002/hep.26898 [25] Johnson A, DiPietro LA.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"FASEB J 2013; 27:3893-901; PMID:23783074; http://dx.doi.org/10.1096/fj.12-214189 [26] Koike K, Ueda S, Yamagishi S, Yasukawa H, Kaida Y, Yokoro M, Fukami K, Yoshimura A, Okuda S. Protective role of JAK/STAT sig- naling against renal ﬁbrosis in mice with unilateral ureteral obstruc- tion.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Clin Immunol 2014; 150:78-87; PMID:24333535; http://dx.doi.org/10.1016/j.clim.2013.11.003 [27] Serrano I, McDonald PC, Lock FE, Dedhar S. Role of the integrin- linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithe-lial-mesenchymal transition (EMT).",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Oncogene 2013; 32:50-60;PMID:22310280; http://dx.doi.org/10.1038/onc.2012.30 [28] Deng YL, Xiong XZ, Cheng NS.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Hepatobiliary Pancreat DisInt 2012; 11:467-78; PMID:23060391; http://dx.doi.org/10.1016/ S1499-3872(12)60210-0 [29] Zhang YE.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Cell Res 2009; 19:128-39; PMID:19114990; http://dx.doi.org/10.1038/cr.2008.328 [30] Leask A, Abraham DJ.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"FASEB J 2004; 18:816-27; PMID:15117886; http://dx.doi.org/10.1096/fj.03-1273rev [31] Hanna C, Hubchak SC, Liang X, Rozen-Zvi B, Schumacker PT, Hay- ashida T, Schnaper HW.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Am J Physiol Renal Physiol 2013; 305:F1323-31; PMID:23946285;http://dx.doi.org/10.1152/ajprenal.00155.2013 [32] Pohlers D, Brenmoehl J, Lof ﬂer I, Muller CK, Leipner C, Schultze- Mosgau S, Stallmach A, Kinne RW, Wolf G. TGF-beta and ﬁbrosis in different organs - molecular pathway imprints.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Biochim BiophysActa 2009; 1792:746-56; PMID:19539753; http://dx.doi.org/10.1016/ j.bbadis.2009.06.004 [33] Mallat A, Lotersztajn S. The liver X receptor in hepatic stellate cells: a novel anti ﬁbrogenic target?",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"J Hepatol 2011; 55:1452-4; PMID:21782759; http://dx.doi.org/10.1016/j.jhep.2011.05.018 [34] Wang Z, Xu J, Zheng Y, Chen W, Sun Y, Wu Z, Luo M. Effect of the regulation of retinoid X receptor-alpha gene expression on rat hepatic ﬁ brosis.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Hepatol Res 2011; 41:475-83; PMID:21518404; http://dx.doi.org/10.1111/j.1872-034X.2011.00794.x [35] Pan LH, Ohtani H, Yamauchi K, Nagura H. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary ﬁbrotic diseases: an immunohistochemical analysis.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Pathol Int 1996; 46:91-9; PMID: 10846556; http://dx.doi.org/10.1111/j.1440-1827.1996.tb03584.x [36] Gieling RG, Wallace K, Han YP.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Am J Physiol Gastrointest Liver Physiol 2009; 296:G1324-31; PMID:19342509; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Mediators In ﬂamm 2015; 2015:764641; PMID:26199463; http://dx.doi.org/10.1155/2015/764641 [38] Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, Shanley TP.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Am J PhysiolLung Cell Mol Physiol 2011; 300:L341-53; PMID:21131395; http://dx.doi.org/10.1152/ajplung.00122.2010 [39] Fernandez IE, Eickelberg O.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Proc Am Thorac Soc 2012; 9:111-6; PMID:22802283; http://dx.doi.org/10.1513/pats.201203-023AW [40] Morrisey EE.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Am J Pathol 2003; 162:1393-7; PMID:12707021; http://dx.doi.org/10.1016/S0002- 9440(10)64271-X [41] Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J. Wnt signaling in liver ﬁbrosis: progress, challenges and potential directions.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Biochimie 2013; 95:2326-35; PMID:24036368;http://dx.doi.org/10.1016/j.biochi.2013.09.003 [42] Wells RG.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Oncotarget 2014; 5:10198-205;PMID:25415353; http://dx.doi.org/10.18632/oncotarget.2548 [45] Le TT, Karmouty-Quintana H, Melicoff E, Le TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, et al.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"J Immunol 2014; 193:3755-68; PMID:25172494; http://dx.doi.org/10.4049/jimmunol.1302470 [46] O ’Reilly S, Ciechomska M, Cant R, van Laar JM.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"J Biol Chem 2014; 289:9952-60; PMID:24550394; http://dx.doi.org/ 10.1074/jbc.M113.545822 [47] Kavvadas P, Kypreou KP, Protopapadakis E, Prodromidi E, Sideras P, Charonis AS.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Virchows Arch 2010; 457:563-75; PMID:20857141; http://dx.doi.org/10.1007/s00428-010-0976-7 [48] Khatri P, Sirota M, Butte AJ.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"PLoS Comput Biol 2012; 8: e1002375; PMID:22383865; http://dx.doi.org/10.1371/journal.pcbi.1002375 [49] Jin L, Zuo XY, Su WY, Zhao XL, Yuan MQ, Han LZ, Zhao X, Chen YD, Rao SQ.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Genomics Proteomics Bioinformatics 2014; 12:210-20;PMID:25462153; http://dx.doi.org/10.1016/j.gpb.2014.10.0021672 E. MAKAREV ET AL.,OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Oncotarget 2015; 6:27227-38; PMID:26317900; http://dx.doi.org/10.18632/oncotarget.4507 [51] Artemov A, Aliper A, Korzinkin M, Lezhnina K, Jellen L, Zhukov N, Roumiantsev S, Gaifullin N, Zhavoronkov A, Borisov N, et al.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"Oncotarget 2014;5:9022-32; PMID:25296972; http://dx.doi.org/10.18632/oncotarget.2493 [53] Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, Ifedigbo E, Xu X, Oury TD, Kaminski N, et al.",OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
J Exp Med 2006; 203:2895-906; PMID:17178917; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
Hepatology 2014; 59:471-82; PMID:23913408; http://dx.doi.org/10.1002/hep.26661CELL CYCLE 1673,Non-OADS,/arxiv_data1/oa_pdf/f5/df/kccy-15-13-1152435.PMC4957589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"13, 1779 –1786 http://dx.doi.org/10.1080/15384101.2016.1187342",Non-OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
J Cell Sci 2012; 125:2805-14; PMID:22736044; http://dx.doi.org/10.1242/jcs.092429 [2] Rieder CL.,OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
Chromosoma 1981; 84:145-58; PMID:7297248;http://dx.doi.org/10.1007/BF00293368 [3] Rieder CL.,Non-OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Chromosoma 2005; 114:310-8;PMID:16270218; http://dx.doi.org/10.1007/s00412-005-0028-2 [4] Meunier S, Vernos I. Acentrosomal Microtubule Assembly in Mito- sis: The Where, When, and How.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Int Rev Cell Mol Biol 2013; 306:83-125; PMID:24016524; http://dx.doi.org/10.1016/B978-0-12-407694-5.00003-1 [6] Kalab P, Pralle A, Isacoff EY, Heald R, Weis K. Analysis of a RanGTP- regulated gradient in mitotic somatic cells.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nature 2006; 440:697-701; PMID:16572176; http://dx.doi.org/10.1038/nature04589 [7] Kalab P, Weis K, Heald R. Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Science 2002; 295:2452-6; PMID:11923538; http://dx.doi.org/10.1126/science.1068798 [8] Kalab P, Heald R. The RanGTP gradient - a GPS for the mitotic spin- dle.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"J Cell Sci 2008; 121:1577-86; PMID:18469014; http://dx.doi.org/10.1242/jcs.005959 [9] Karsenti E, Vernos I.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Sci- ence 2001; 294:543-7; PMID:11641489; http://dx.doi.org/10.1126/ science.1063488 [10] Meunier S, Vernos I. K- ﬁbre minus-ends are stabilized by a RanGTP-dependent mechanism essential for functional spindle assembly.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nat Cell Biol 2011; 13:1406-14; PMID:22081094; http://dx.doi.org/10.1038/ncb2372 [11] Meunier S, Shvedunova M, Van Nguyen N, Avila L, Vernos I, Akhtar A.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nat Commun 2015; 6:7889;PMID:26243146; http://dx.doi.org/10.1038/ncomms8889 [12] Bayliss R, Sardon T, Vernos I, Conti E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Mol Cell2003; 12:851-62; PMID:14580337; http://dx.doi.org/10.1016/ S1097-2765(03)00392-7 [13] Eyers PA, Erikson E, Chen LG, Maller JL.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"A novel mechanism for activation of the protein kinase Aurora A. Curr Biol 2003; 13:691-7; PMID:12699628; http://dx.doi.org/10.1016/S0960-9822 (03)00166-0 [14] Sardon T, Peset I, Petrova B, Vernos I. Dissecting the role of Aurora A during spindle assembly.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"EMBO J 2008; 27:2567-79; PMID:18756265; http://dx.doi.org/10.1038/emboj.2008.173 [15] Scrofani J, Sardon T, Meunier S, Vernos I. Microtubule nucle- ation in mitosis by a RanGTP-dependent protein complex.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Curr Biol 2015; 25:131-40; PMID:25532896; http://dx.doi.org/10.1016/ j.cub.2014.11.025 [16] Tsai MY, Wiese C, Cao K, Martin O, Donovan P, Ruderman J, Prigent C, Zheng Y.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nat Cell Biol 2003; 5:242-8; PMID:12577065; http://dx.doi.org/10.1038/ncb936 [17] Malik R, Lenobel R, Santamaria A, Ries A, Nigg EA, Korner R. Quan- titative analysis of the human spindle phosphoproteome at distinct mitotic stages.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"J Proteome Res 2009; 8:4553-63; PMID:19691289; http://dx.doi.org/10.1021/pr9003773 [18] Nousiainen M, Sillje HH, Sauer G, Nigg EA, Korner R. Phosphopro- teome analysis of the human mitotic spindle.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Curr Biol2004; 14:1801-11; PMID:15498487; http://dx.doi.org/10.1016/j.cub.2004.10.002 [20] Luders J, Patel UK, Stearns T. GCP-WD is a gamma-tubulin target- ing factor required for centrosomal and chromatin-mediated micro-tubule nucleation.",Non-OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nat Cell Biol 2006; 8:137-47; PMID:16378099; http://dx.doi.org/10.1038/ncb1349 [21] Ganem NJ, Compton DA.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Cell Cycle 2006; 5:481-5; PMID:16552178; http://dx.doi.org/10.4161/cc.5.5.2519 [22] Waters JC, Mitchison TJ, Rieder CL, Salmon ED.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Mol Biol Cell 1996; 7:1547-58;PMID:8898361; http://dx.doi.org/10.1091/mbc.7.10.1547 [23] Mitchison T, Evans L, Schulze E, Kirschner M. Sites of microtu- bule assembly and disassembly in the mitotic spindle.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Cell 1986;45:515-27; PMID:3708686; http://dx.doi.org/10.1016/0092-8674 (86)90283-7 [24] Rogers GC, Rogers SL, Schwimmer TA, Ems-McClung SC, Walczak CE, Vale RD, Scholey JM, Sharp DJ.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Nature 2004; 427:364-70; PMID:14681690; http://dx.doi.org/10.1038/nature02256 [25] Chen W, Zhang D. Kinetochore ﬁbre dynamics outside the context of the spindle during anaphase.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Curr Biol 2006; 16:1217-23;PMID:16782013; http://dx.doi.org/10.1016/j.cub.2006.04.046 [27] Barr AR, Gergely F. Aurora-A: the maker and breaker of spindle poles.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"J Cell Sci 2007; 120:2987-96; PMID:17715155; http://dx.doi.org/10.1242/jcs.013136 [28] Peset I, Seiler J, Sardon T, Bejarano LA, Rybina S, Vernos I.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"J Cell Biol 2005; 170:1057-66;PMID:16172207; http://dx.doi.org/10.1083/jcb.200504037 [29] Pinyol R, Scrofani J, Vernos I.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"Curr Biol 2013; 23:143-9; PMID:23273898; http://dx.doi.org/10.1016/j.cub.2012.11.046 [30] Lioutas A, Vernos I. Aurora A kinase and its substrate TACC3 are required for central spindle assembly.",OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
EMBO Rep 2013; 14:829-36;PMID:23887685; http://dx.doi.org/10.1038/embor.2013.1091786 S. MEUNIER ET AL.,OADS,/arxiv_data1/oa_pdf/43/97/kccy-15-13-1187342.PMC4957591.pdf
"13, 1724 –1732 http://dx.doi.org/10.1080/15384101.2016.1182267",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nature 2004; 432:298- 306; PMID:15549091; http://dx.doi.org/10.1038/nature03094 [2] Bertoli C, Skotheim JM, de Bruin RA.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
Nat Rev Mol Cell Biol 2013; 14:518-28; PMID:23877564; http://dx.doi.org/10.1038/nrm3629[3] Weinberg RA.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Cell 1995; 81:323-30; PMID:7736585; http://dx.doi.org/10.1016/0092-8674(95)90385-2 [4] Burkhart DL, Sage J.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
Nat Rev Cancer 2008; 8:671-82; PMID: 18650841; http://dx.doi.org/10.1038/nrc2399 [5] Dyson N. The regulation of E2F by pRB-family proteins.,Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
Gen Dev 1998; 12:2245-62; PMID:9694791; http://dx.doi.org/10.1101/gad.12.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Mol Cellular Biol 2001; 21:4773-84; PMID:11416152; http://dx.doi.org/10.1128/MCB.21.14.4773-4784.2001 [7] Giacinti C, Giordano A. RB and cel l cycle progression.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Oncogene 2006; 25:5220-7; PMID:16936740; http://dx.do i.org/10.1038/sj.onc.1209615 [8] Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
Proc Natl Acad Sci U S A 1997; 94:10699-704; PMID:9380698; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Biol Chem 1997; 272:12738-46; PMID:9139732; http://dx.doi.org/10.1074/jbc.272.19.12738 [10] Stevens C, La Thangue NB.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Archives of biochemistry and biophysics 2003; 412:157-69; PMID:12667479; http://dx.doi.org/10.1016/S0003-9861(03)00054-7 [11] Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6 [12] Harbour JW, Dean DC.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Gen Dev 2000; 14:2393-409; PMID:11018009;http://dx.doi.org/10.1101/gad.813200 [13] Gareau JR, Lima CD.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Rev Mol Cell Biol 2010; 11:861-71; PMID:21102611; http://dx.doi.org/10.1038/nrm3011 [14] Yao Q, Li H, Liu BQ, Huang XY, Guo L. SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteo- mics analyses.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Biol Chem 2011; 286:27342-9; PMID:21685386; http://dx.doi.org/10.1074/jbc.M111.220848 [15] Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Mol Cell 2005; 18:1-12; PMID:15808504; http://dx.doi.org/10.1016/j.molcel.2005.03.012 [17] Hickey CM, Wilson NR, Hochstrasser M. Function and regulation of SUMO proteases.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Rev Mol Cell Biol 2012; 13:755-66;PMID:23175280; http://dx.doi.org/10.1038/nrm3478 [18] Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cel- lular LxCxE proteins repress SUMO modi ﬁcation of the retinoblas- toma tumor suppressor.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Oncogene 2005; 24:3810-8; PMID:15806172; http://dx.doi.org/10.1038/sj.onc.1208539 [19] Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC, Chock PB.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Biol Chem 2006; 281:36221-7; PMID:17012228; http://dx.doi.org/10.1074/jbc.M608236200 [20] Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modi ﬁcation.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Biol Chem 2000; 275:13321-9; PMID:10788439; http://dx.doi.org/10.1074/jbc.275.18.13321 [21] Tan JA, Song J, Chen Y, Durrin LK.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Mol Cellular Biol 2010; 30:2823-36; PMID:20351170; http://dx.doi.org/10.1128/MCB.01603-09 [22] Gresko E, Ritterhoff S, Sevilla-Perez J, Roscic A, Frobius K, Kotevic I, Vichalkovski A, Hess D, Hemmings BA, Schmitz ML.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Oncogene 2009; 28:698-708; PMID: 19015637; http://dx.doi.org/10.1038/onc.2008.420 [23] Gupta P, Ho PC, Huq MM, Ha SG, Park SW, Khan AA, Tsai NP, Wei LN.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Curr Opin Genet Dev 1998; 8:21-7; PMID:9529601; http://dx.doi.org/10.1016/S0959-437X(98)80057-9 [25] Jakobs A, Koehnke J, Himstedt F, Funk M, Korn B, Gaestel M, Nie- denthal R. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Methods 2007; 4:245-50; PMID:17277783; http://dx.doi.org/10.1038/nmeth1006 [26] Hamdane M, Bretteville A, Sambo AV, Schindowski K, Begard S, Dela- courte A, Bertrand P, Buee L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Cell Sci2005; 118:1291-8; PMID:15741232; http://dx.doi.org/10.1242/jcs.01724 [27] Simone C, Bagella L, Bellan C, Giordano A.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
Oncogene 2002; 21:4158- 65; PMID:12037672; http://dx.doi.org/10.1038/sj.onc.1205511 [28] Kerscher O. SUMO junction-what ’s your function?,Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"EMBO reports 2007; 8:550-5; PMID:17545995; http://dx.doi.org/10.1038/sj.embor.7400980 [29] Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. Identi ﬁca- tion of a SUMO-binding motif that recognizes SUMO-modi ﬁed pro- teins.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nucleic Acids Res 2014; 42:W325-30; PMID:24880689; http://dx.doi.org/10.1093/nar/gku383 [31] Cobrinik D, Francis RO, Abramson DH, Lee TC.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Mol Cancer 2006; 5:72; PMID:17163992; http://dx.doi.org/10.1186/1476-4598-5-72 [32] Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Science 2008; 319:620-4;PMID:18239126; http://dx.doi.org/10.1126/science.1149200 [33] Chen LZ, Li XY, Huang H, Xing W, Guo W, He J, Sun ZY, Luo AX, Liang HP, Hu J, et al.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
PloS one 2014; 9:e100457; PMID:24971752; http://dx.doi.org/10.1371/journal.pone.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"PloS one 2015; 10:e0123882; PMID:25860128; http://dx.doi.org/ 10.1371/journal.pone.0123882 [35] Bellail AC, Olson JJ, Hao C. SUMO1 modi ﬁcation stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Commun 2014; 5:4234; PMID:24953629; http://dx.doi.org/10.1038/ ncomms5234 [36] Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Gros- schedl R, Dejean A.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Mol cell 2006; 22:783-94; PMID:16793547; http://dx.doi.org/10.1016/j.molcel.2006.05.016 [37] Ni HJ, Chang YN, Kao PH, Chai SP, Hsieh YH, Wang DH, Fong JC.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Biochimica et biophysica acta 2012;1820:1893-900; PMID:22906975; http://dx.doi.org/10.1016/j.bbagen.2012.08.002 [38] Nie M, Xie Y, Loo JA, Courey AJ.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"PloS one 2009; 4:e5905; PMID: 19529778; http://dx.doi.org/10.1371/journal.pone.0005905 [39] Macdonald JI, Dick FA.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Genes & cancer 2012; 3:619-33; PMID:23634251; http://dx.doi.org/ 10.1177/1947601912473305 [40] De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Clau- dio PP, Baldi A, Khalili K, Giordano A.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"J Biol Chem 1997;272:20971-4; PMID:9261093; http://dx.doi.org/10.1074/jbc.272.34.20971 [41] Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Cell 2000; 101:79-89; PMID:10778858; http://dx.doi.org/ 10.1016/S0092-8674(00)80625-X [42] Dick FA, Rubin SM.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Rev Mol Cell Biol 2013; 14:297-306; PMID:23594950;http://dx.doi.org/10.1038/nrm3567 [43] Uchida C, Miwa S, Kitagawa K, Hattori T, Isobe T, Otani S, Oda T, Sugimura H, Kamijo T, Ookawa K, et al.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
EMBO J 2005; 24:160-9; PMID:15577944; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Cell Biol 2001; 3:667-74; PMID:11433299; http://dx.doi.org/10.1038/35083062 [45] Markham D, Munro S, Soloway J, O ’Connor DP, La Thangue NB.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
EMBO reports 2006; 7:192-8; PMID:16374512; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"EMBO J 2004; 23:1609-18; PMID:15044952;http://dx.doi.org/10.1038/sj.emboj.7600176 [47] Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"EMBO J 2011; 30:317-27; PMID:21119616; http://dx.doi.org/10.1038/emboj.2010.311 [48] Dong M, Pang X, Xu Y, Wen F, Zhang Y. Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Int J Mol Sci 2013; 14:11061-71; PMID:23708104; http://dx.doi.org/10.3390/ijms140611061 [49] Li F, Li X, Kou L, Li Y, Meng F, Ma F. SUMO-conjugating enzyme UBC9 promotes proliferation and migration of ﬁbroblast-like syno- viocytes in rheumatoid arthritis.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"In ﬂammation 2014; 37:1134-41; PMID:24531852; http://dx.doi.org/10.1007/s10753-014-9837-x [50] Zhao Z, Tan X, Zhao A, Zhu L, Yin B, Yuan J, Qiang B, Peng X. microRNA-214-mediated UBC9 expression in glioma.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"BMB reports2012; 45:641-6; PMID:23187003; http://dx.doi.org/10.5483/BMBRep.2012.45.11.097 [51] Zhang GJ, Safran M, Wei W, Sorensen E, Lassota P, Zhelev N, Neu- berg DS, Shapiro G, Kaelin WG, Jr. Bioluminescent imaging of Cdk2inhibition in vivo.",OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"Nat Med 2004; 10:643-8; PMID:15122251; http://dx.doi.org/10.1038/nm1047 [52] Pabla N, Bhatt K, Dong Z. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cellcycle and DNA damage checkpoints.",Non-OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
PloS one 2011; 6:e20397; PMID:21633703; http://dx.doi.org/10.1371/journal.pone.00203971732 F. MENG ET AL.,OADS,/arxiv_data1/oa_pdf/e3/f2/kccy-15-13-1182267.PMC4957593.pdf
"13, 1693 –1705 http://dx.doi.org/10.1080/15384101.2016.1146836",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
68 His-MYC fusion proteins were bacterially expressed from pET- 15b-MYC 250 –439 and pET-15b-MYC 353 –434 vectors and puriﬁed as described elsewhere.69 Protein-protein interaction analysis Physical protein-protein interactions were identi ﬁed using Interologous Interaction Database (I2D) version 2.2 (http://ophid.utoronto.ca/i2d).,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Network analysis and visualizationwas performed in NAViGaTOR version 2.3 (http://ophid.utoronto.ca/navigator).,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cell 2013; 153:38-55; PMID:23540689; http://dx.doi.org/10.1016/j.cell.2013.03.008 [2] You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin?",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cancer Cell 2012; 22:9-20; PMID:22789535; http://dx.doi.org/10.1016/j.ccr.2012.06.008 [3] Meyer N, Penn LZ.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Rev Can- cer 2008; 8:976-90; PMID:19029958; http://dx.doi.org/10.1038/nrc2231 [4] Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nature 1992; 359:423-6;PMID:1406955; http://dx.doi.org/10.1038/359423a0 [5] Blackwood EM, Eisenman RN.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Science 1991; 251:1211-7; PMID:2006410; http://dx.doi.org/10.1126/science.2006410 [6] Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H. Oncogenic activity of the c-Myc protein requires dimerization withMax.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cell 1993; 72:233-45; PMID:8425220; http://dx.doi.org/10.1016/0092-8674(93)90663-B [7] Amati B, Littlewood TD, Evan GI, Land H. The c-Myc protein indu- ces cell cycle progression and apoptosis through dimerization withMax.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cold Spring Harb Perspect Med 2014; 4: a014399; PMID:24939054; http://dx.doi.org/10.1101/cshperspect.a014399 [9] Tu WB, Helander S, Pilstal R, Hickman KA, Lourenco C, Jurisica I, Raught B, Wallner B, Sunnerhagen M, Penn LZ.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Genet 1999; 22:102-5;PMID:10319872; http://dx.doi.org/10.1038/8811[11] Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Proc Natl Acad Sci U S A2000; 97:13796-800; PMID:11095756; http://dx.doi.org/10.1073/ pnas.250492697 [12] Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nature 1998; 394:203-6; PMID:9671307; http://dx.doi.org/10.1038/28212 [13] Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Genet 2013; 45:592-601; PMID:23644491; http://dx.doi.org/10.1038/ng.2628 [15] Biegel JA, Busse TM, Weissman BE.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Am J Med Genet C Semin Med Genet 2014; 166C:350-66; PMID:25169151; http://dx.doi.org/10.1002/ajmg.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell Biol 1987; 7:1697- 709; PMID:3299053; http://dx.doi.org/10.1128/MCB.7.5.1697 [17] Evan GI, Lewis GK, Ramsay G, Bishop JM.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell Biol 1985; 5:3610-6; PMID:3915782; http://dx.doi.org/10.1128/ MCB.5.12.3610 [18] Reincke BS, Rosson GB, Oswald BW, Wright CF.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"J Cell Physiol 2003; 194:303-13;PMID:12548550; http://dx.doi.org/10.1002/jcp.10201 [19] Facchini LM, Chen S, Marhin WW, Lear JN, Penn LZ.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell Biol 1997;17:100-14; PMID:8972190; http://dx.doi.org/10.1128/MCB.17.1.100 [20] Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Science 1994; 266:2002-6; PMID:7801128;http://dx.doi.org/10.1126/science.7801128 [21] Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. SWI/SNF com- plex interacts with tumor suppressor p53 and is necessary for theactivation of p53-mediated transcription.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
J Biol Chem 2002;277:22330-7; PMID:11950834; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Proc Natl Acad Sci U S A 1998; 95:1120-5; PMID:9448295; http://dx.doi.org/ 10.1073/pnas.95.3.1120 [23] Wu DY, Tkachuck DC, Roberson RS, Schubach WH.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
J Biol Chem 2002;277:27706-15; PMID:12016208; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
PLoS Genet 2011; 7:e1002008;PMID:21408204; http://dx.doi.org/10.1371/journal.pgen.1002008CELL CYCLE 1703,Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nature 2012; 489:57-74; PMID:22955616;http://dx.doi.org/10.1038/nature11247 [27] Quinlan AR, Hall IM.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Bioinformatics 2010; 26:841-2;PMID:20110278; http://dx.doi.org/10.1093/bioinformatics/btq033 [28] Bickel PJ, Boley N, Brown JB, Huang H, Zhang NR.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Ann Appl Stat 2010; 4:1660-97;http://dx.doi.org/10.1214/10-AOAS363 [29] Wang S, Sun H, Ma J, Zang C, Wang C, Wang J, Tang Q, Meyer CA, Zhang Y, Liu XS.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Protoc 2013; 8:2502-15;PMID:24263090; http://dx.doi.org/10.1038/nprot.2013.150 [30] DeCristofaro MF, Betz BL, Wang W, Weissman BE.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Oncogene 1999; 18:7559-65; PMID:10602515; http://dx.doi.org/10.1038/sj.onc.1203168 [31] Kerl K, Ries D, Unland R, Borchert C, Moreno N, Hasselblatt M, Jur- gens H, Kool M, Gorlich D, Eveslage M, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"BMC Cancer 2013; 13:286; PMID:23764045; http://dx.doi.org/10.1186/1471-2407-13-286 [32] Helming KC, Wang X, Wilson BG, Vazquez F, Haswell JR, Manches- ter HE, Kim Y, Kryukov GV, Ghandi M, Aguirre AJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Med 2014; 20:251-4; PMID:24562383; http://dx.doi.org/10.1038/nm.3480 [33] Wilson BG, Helming KC, Wang X, Kim Y, Vazquez F, Jagani Z, Hahn WC, Roberts CW.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.Mol Cell Biol 2014; 34:1136-44; PMID:24421395; http://dx.doi.org/ 10.1128/MCB.01372-13 [34] Romero OA, Setien F, John S, Gimenez-Xavier P, Gomez-Lopez G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-CespedesM.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"EMBO Mol Med 2012; 4:603-16; PMID:22407764; http://dx.doi.org/10.1002/emmm.201200236 [35] Stojanova A, Penn LZ.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Biochem Cell Biol 2009; 87:163-77; PMID:19234532; http://dx.doi.org/10.1139/O08-113 [36] Andresen C, Helander S, Lemak A, Fares C, Csizmok V, Carlsson J, Penn LZ, Forman-Kay JD, Arrowsmith CH, Lundstrom P, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nucleic Acids Res 2012; 40:6353-66; PMID:22457068; http://dx.doi.org/10.1093/nar/gks263 [37] McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cell 1998; 94:363-74;PMID:9708738; http://dx.doi.org/10.1016/S0092-8674(00)81479-8 [38] von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell 2003; 11:1189-200; PMID:12769844; http://dx.doi.org/10.1016/S1097-2765 (03)00193-X [39] Ae K, Kobayashi N, Sakuma R, Ogata T, Kuroda H, Kawaguchi N, Shinomiya K, Kitamura Y. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-de ﬁcient cells.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Oncogene 2002; 21:3112-20; PMID:12082626; http://dx.doi.org/10.1038/sj.onc.1205414 [40] Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, Verrijzer CP.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Genes Dev 2005; 19:665-70; PMID:15769941; http://dx.doi.org/10.1101/gad.335805 [41] Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. Genomic targets of the human c-Myc protein.Genes Dev 2003; 17:1115-29; PMID:12695333; http://dx.doi.org/ 10.1101/gad.1067003 [42] Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT, Ooi HS, Orlov YL, Shahab A, Yong HC, et al.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nucleic Acids Res 2009; 37:6019-27;PMID:19696073; http://dx.doi.org/10.1093/nar/gkp677 [44] Kim SI, Bultman SJ, Kiefer CM, Dean A, Bresnick EH.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Immunol 2008; 9:785-93;PMID:18500344; http://dx.doi.org/10.1038/ni.1619 [46] Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, Minder JL, Mercan F, Wang E, Eckersley-Maslin MA, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Genes Dev 2013; 27:2648-62; PMID:24285714; http://dx.doi.org/10.1101/gad.232710.113 [47] Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypi- cal teratoid and rhabdoid tumors.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"J Clin Invest 2012; 122:2983-8; PMID:22797305; http://dx.doi.org/10.1172/JCI64400 [49] Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell Biol 2002; 22:5975-88; PMID:12138206;http://dx.doi.org/10.1128/MCB.22.16.5975-5988.2002 [50] Chai J, Charboneau AL, Betz BL, Weissman BE.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Cancer Res 2005; 65:10192-8; PMID:16288006; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"J Biol Chem2004; 279:3807-16; PMID:14604992; http://dx.doi.org/10.1074/jbc.M309333200 [52] Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fill- more CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Proc Natl Acad Sci U S A 2005; 102:17745-50; PMID:16301525; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Cancer Res 2010; 70:1854-65; PMID:20179200; http://dx.doi.org/10.1158/0008-5472.CAN-09-1922 [54] Birks DK, Donson AM, Patel PR, Su ﬁ t A, Algar EM, Dunham C, Kleinschmidt-DeMasters BK, Handler MH, Vibhakar R, ForemanNK.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Pediatr Blood Cancer 2013; 60:1095-102; PMID:23382118; http://dx.doi.org/10.1002/pbc.24481 [55] Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, et al.",Non-OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Nature 2011; 478:524-8; PMID:21814200; http://dx.doi.org/10.1038/nature103341704 A. STOJANOVA ET AL.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Cell 2011;146:904-17; PMID:21889194; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nature 2008; 455:679-83; PMID:18716624; http://dx.doi.org/10.1038/nature07260 [58] Soucek L, Whit ﬁeld JR, Sodir NM, Masso-Valles D, Serrano E, Karnezis AN, Swigart LB, Evan GI.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Genes Dev 2013; 27:504-13; PMID:23475959; http://dx.doi.org/10.1101/gad.205542.112 [59] Fletcher S, Prochownik EV.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Biochim Biophys Acta 2015; 1849:525-43; PMID:24657798; http://dx.doi.org/10.1016/j.bbagrm.2014.03.005 [60] Hsu TY, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, Eche- verria GV, Sun T, Kurley SJ, Tyagi S, et al.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nature 2015; 525:384-8; PMID:26331541; http://dx.doi.org/10.1038/nature14985 [61] Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang CV.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Semin Cell Dev Biol 2015; 43:11- 21; PMID:26277543; http://dx.doi.org/10.1016/j.semcdb.2015.08.003 [62] Penn LJ, Brooks MW, Laufer EM, Littlewood TD, Morgenstern JP, Evan GI, Lee WM, Land H. Domains of human c-myc proteinrequired for autosuppression and cooperation with ras oncogenes are overlapping.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Mol Cell Biol 1990; 10:4961-6; PMID:2201910; http://dx.doi.org/10.1128/MCB.10.9.4961 [63] Nolan GP, Shatzman AR.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Curr Opin Biotechnol 1998; 9:447-50; PMID:9821270; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Curr Biol 2003; 13:882-6; PMID:12747840;http://dx.doi.org/10.1016/S0960-9822(03)00297-5 [65] Sif S, Stukenberg PT, Kirschner MW, Kingston RE.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Genes Dev 1998; 12:2842-51; PMID:9744861; http://dx.doi.org/10.1101/gad.12.18.2842 [66] Nikolaev AY, Li M, Puskas N, Qin J, Gu W. Parc: a cytoplasmic anchor for p53.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Cell 2003; 112:29-40; PMID:12526791; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Nat Struct Mol Biol 2008; 15:1334-42; PMID:19043414; http://dx.doi.org/10.1038/nsmb.1521 [69] Kaustov L, Lukin J, Lemak A, Duan S, Ho M, Doherty R, Penn LZ, Arrowsmith CH.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"J Biol Chem 2007; 282:11300-7; PMID:17298945;http://dx.doi.org/10.1074/jbc.M611297200 [70] Brown KR, Jurisica I.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Genome Biol 2007; 8:R95; PMID:17535438; http://dx.doi.org/10.1186/gb-2007-8-5-r95 [71] Brown KR, Jurisica I. Online predicted human interaction database.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Bioinformatics 2005; 21:2076-82; PMID:15657099; http://dx.doi.org/10.1093/bioinformatics/bti273 [72] Brown KR, Otasek D, Ali M, McGuf ﬁn MJ, Xie W, Devani B, Toch IL, Jurisica I. NAViGaTOR: network analysis, visualization andgraphing Toronto.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Bioinformatics 2009; 25:3327-9; PMID:19837718;http://dx.doi.org/10.1093/bioinformatics/btp595 [73] Huang da W, Sherman BT, Lempicki RA.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211 [74] Huang da W, Sherman BT, Lempicki RA.",OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
Oncogene 2003; 22:1998-2010; PMID:12673205; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/17/d7/kccy-15-13-1146836.PMC4957596.pdf
"13, 1674 –1684 http://dx.doi.org/10.1080/15384101.2016.1152433",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Lancet (London, England) 2012; 380:2163-96; PMID: 23245607; http://dx.doi.org/10.1016/S0140-6736(12)61729-2 [2] Hong J, Reed C, Novick D, Happich M. Costs associated with treat- ment of chronic low back pain: an analysis of the UK General Prac- tice Research Database.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2013; 38:75-82; PMID:23038621; http://dx.doi.org/10.1097/BRS.0b013e318276450f [3] Cheung KM, Karppinen J, Chan D, Ho DW, Song YQ, Sham P, Cheah KS, Leong JC, Luk KD.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2009; 34:934-40;PMID:19532001; http://dx.doi.org/10.1097/BRS.0b013e3181a01b3f [4] Takatalo J, Karppinen J, Niinimaki J, Taimela S, Nayha S, Mutanen P, Sequeiros RB, Kyllonen E, Tervonen O.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2011; 36:2180-9; PMID:21358475; http://dx.doi.org/10.1097/BRS.0b013e3182077122 [5] Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Ander- son DG.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Spine J 2013; 13:318-30; PMID:23537454; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nature reviews Rheumatol- ogy 2014; 10:44-56; PMID:24166242; http://dx.doi.org/10.1038/ nrrheum.2013.160 [7] Muller M. Cellular senescence: molecular mechanisms, in vivo signiﬁcance, and redox considerat ions.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Antioxidants & redoxsignaling 2009; 11:59-98; PMID:18976161; http://dx.doi.org/ 10.1089/ars.2008.2104 [8] van Deursen JM.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nature 2014; 509:439-46; PMID:24848057; http://dx.doi.org/10.1038/ nature13193 [9] Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathology.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nat Rev Mol Cell Biol 2014; 15:482-96; PMID:24954210; http://dx.doi.org/10.1038/nrm3823 [10] Sharpless NE, Sherr CJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nat Rev Cancer 2015; 15:397-408; PMID:26105537; http://dx.doi.org/10.1038/nrc3960 [11] Acosta JC, O ’L o g h l e nA ,B a n i t oA ,G u i j a r r oM V ,A u g e r tA , R a g u zS ,F u m a g a l l iM ,D aC o s t aM ,B r o w nC ,P o p o vN ,e ta l .Chemokine signaling via the CXCR2 receptor reinforces senes-cence.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Cell 2008; 133:1006-18; PMID:18555777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nat Cell Biol 2013; 15:978-90; PMID:23770676; http://dx.doi.org/10.1038/ncb2784 [13] Wang F, Cai F, Shi R, Wang XH, Wu XT.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"The international journal of biochemistry & cell biology 2005; 37:961-76; PMID:15743671; http://dx.doi.org/10.1016/j.biocel.2004.10.013 [15] Roberts S, Evans EH, Kletsas D, Jaffray DC, Eisenstein SM.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2006; 15 Suppl 3:S312-6; PMID:16773379; http://dx.doi.org/10.1007/s00586-006-0126-8 [16] Gruber HE, Ingram JA, Norton HJ, Hanley EN, Jr. Senescence in cells of the aging and degenerating intervertebral disc: immunoloc- alization of senescence-associated beta-galactosidase in human and sand rat discs.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2007; 32:321-7; PMID:17268263; http://dx.doi.org/10.1097/01.brs.0000253960.57051.de [17] Gruber HE, Ingram JA, Davis DE, Hanley EN, Jr.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine J 2009; 9:210-5;PMID:18440281; http://dx.doi.org/10.1016/j.spinee.2008.01.012 [18] Kim KW, Chung HN, Ha KY, Lee JS, Kim YY.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine J 2009; 9:658-66; PMID:19540815; http://dx.doi.org/10.1016/j.spinee.2009.04.018 [19] Le Maitre CL, Freemont AJ, Hoyland JA.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2007;9:R45; PMID:17498290; http://dx.doi.org/10.1186/ar2198 [20] Gruber HE, Watts JA, Hoelscher GL, Bethea SF, Ingram JA, Zin- chenko NS, Hanley EN, Jr. Mitochondrial gene expression in thehuman annulus: in vivo data from annulus cells and selectively har-vested senescent annulus cells.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine J 2011; 11:782-91; PMID:21784712; http://dx.doi.org/10.1016/j.spinee.2011.06.012 [21] Jeong SW, Lee JS, Kim KW.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine J 2014; 14:499-504; PMID:24345469; http://dx.doi.org/10.1016/j.spinee.2013.06.099 [22] Gruber HE, Mougeot JL, Hoelscher G, Ingram JA, Hanley EN, Jr. Microarray analysis of laser capture microdissected-anulus cells from the human intervertebral disc.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2007; 32:1181-7;PMID:17495774; http://dx.doi.org/10.1097/BRS.0b013e318053ec89 [23] Markova DZ, Kepler CK, Addya S, Murray HB, Vaccaro AR, Sha- piro IM, Anderson DG, Albert TJ, Risbud MV.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2013; 15:R121; PMID:24171898; http://dx.doi.org/10.1186/ar4301 [24] Hiyama A, Sakai D, Risbud MV, Tanaka M, Arai F, Abe K, Mochida J. Enhancement of intervertebral disc cell senescence byWNT/beta-catenin signaling-induced matrix metalloproteinaseCELL CYCLE 1681",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Rheum 2010; 62:3036-47; PMID:20533544; http://dx.doi.org/10.1002/art.27599 [25] Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, et al.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Cell 2013; 155:1119-30;PMID:24238961; http://dx.doi.org/10.1016/j.cell.2013.10.041 [26] Olovnikov AM.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Theoretical Biol 1973; 41:181-90; PMID:4754905; http://dx.doi.org/10.1016/0022-5193 (73)90198-7 [27] Stein GH, Beeson M, Gordon L. Failure to phosphorylate the reti- noblastoma gene product in senescent human ﬁbroblasts.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Science 1990; 249:666-9; http://dx.doi.org/10.1126/science.2166342 [28] d ’Adda di Fagagna F, Teo SH, Jackson SP.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Gen Dev2004; 18:1781-99; PMID:15289453; http://dx.doi.org/10.1101/gad.1214504 [29] von Zglinicki T, Saretzki G, Ladhoff J, d ’Adda di Fagagna F, Jackson SP.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Mech Age-ing Dev 2005; 126:111-7; PMID:15610769; http://dx.doi.org/ 10.1016/j.mad.2004.09.034 [30] Vo N, Seo HY, Robinson A, Sowa G, Bentley D, Taylor L, Studer R, Usas A, Huard J, Alber S, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Res 2010; 28:1600-7; PMID:20973062; http://dx.doi.org/10.1002/jor.21153 [31] Nasto LA, Wang D, Robinson AR, Clauson CL, Ngo K, Dong Q, Roughley P, Epperly M, Huq SM, Pola E, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nat Cell Biol 2001; 3:E277-86; PMID:11781586; http://dx.doi.org/10.1038/ncb1201-e277 [34] Frank KM, Sharpless NE, Gao Y, Sekiguchi JM, Ferguson DO, Zhu C, Manis JP, Horner J, DePinho RA, Alt FW.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Molecular cell 2000; 5:993-1002; PMID:10911993; http://dx.doi.org/10.1016/S1097-2765(00)80264-6 [35] Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nature 2000; 404:897-900; PMID:10786799; http://dx.doi.org/10.1038/35009138 [36] Ongusaha PP, Ouchi T, Kim KT, Nytko E, Kwak JC, Duda RB, Deng CX, Lee SW. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Oncogene 2003; 22:3749-58; PMID:12802282; http://dx.doi.org/10.1038/sj.onc.1206439 [37] Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, Wyn- ford-Thomas D. Posttranslational modi ﬁcations of p53 in replica- tive senescence overlapping but distinct from those induced by DNA damage.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Mol Cell Biol 2000; 20:2803-8; PMID:10733583;http://dx.doi.org/10.1128/MCB.20.8.2803-2808.2000 [38] Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16INK4a contrib-utes to the outcome of cancer therapy.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Cell 2002; 109:335-46;PMID:12015983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2008; 17:1317-23; PMID:18682991; http://dx.doi.org/10.1007/s00586-008-0738-2 [40] Ogawa T, Matsuzaki H, Uei H, Nakajima S, Tokuhashi Y, Esumi M. Alteration of gene expression in intervertebral disc degeneration ofpassive cigarette- smoking rats: separate quantitation in separatednucleus pulposus and annulus ﬁbrosus.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Pathobiology 2005; 72:146- 51; PMID:15860932; http://dx.doi.org/10.1159/000084118 [41] Holm S, Nachemson A.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Ups J Med Sci 1988; 93:91-9; PMID:3376356; http://dx.doi.org/10.1517/ 03009734000000042 [42] Uematsu Y, Matuzaki H, Iwahashi M. Effects of nicotine on the intervertebral disc: an experimental study in rabbits.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Sci 2001; 6:177-82; PMID:11484105; http://dx.doi.org/10.1007/s007760100067 [43] Wang D, Nasto LA, Roughley P, Leme AS, Houghton AM, Usas A, Sowa G, Lee J, Niedernhofer L, Shapiro S, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Osteoarthri-tis Cartilage 2012; 20:896-905; PMID:22531458; http://dx.doi.org/10.1016/j.joca.2012.04.010 [44] Wang E. Senescent human ﬁbroblasts resist programmed cell death, and failure to suppress bcl2 is involved.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Bio- chem Biophys Res Commun 2002; 296:93-101; PMID:12147232; http://dx.doi.org/10.1016/S0006-291X(02)00818-5 [47] Hubackova S, Krejcikova K, Bartek J, Hodny Z. IL1- and TGFbeta- Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine ‘ bystander senescence ’.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Aging 2012; 4:932-51; PMID: 23385065; http://dx.doi.org/10.18632/aging.100520 [48] An HS, Anderson PA, Haughton VM, Iatridis JC, Kang JD, Lotz JC, Natarajan RN, Oegema TR, Jr., Roughley P, Setton LA, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2004; 29:2677-8;PMID: 15564916; http://dx.doi.org/10.1097/01.brs.0000147573.88916.c6 [49] Kerttula LI, Serlo WS, Tervonen OA, Paakko EL, Vanharanta HV.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2000; 25:1104-8; PMID:10788855; http://dx.doi.org/10.1097/00007632-200005010- 00011 [50] Haschtmann D, Stoyanov JV, Gedet P, Ferguson SJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2008; 17:289-99; PMID:17929064;http://dx.doi.org/10.1007/s00586-007-0509-5 [51] Urban JP, Smith S, Fairbank JC.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2004; 29:2700-9; PMID:15564919; http://dx.doi.org/10.1097/ 01.brs.0000146499.97948.52 [52] Grunhagen T, Wilde G, Soukane DM, Shirazi-Adl SA, Urban JP.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Bone Joint Surg Am 2006; 88 Suppl 2:30-5; PMID:16595440; http://dx.doi.org/ 10.2106/JBJS.E.01290 [53] Le Maitre CL, Hoyland JA, Freemont AJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2007; 9: R77; PMID:17688691; http://dx.doi.org/10.1186/ar2275 [54] Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, Bullock R, Isaacs RE, Brown C, Richardson WJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Ann N Y Acad Sci2007; 1096:239-48; PMID:17405935; http://dx.doi.org/10.1196/ annals.1397.090 [56] Hou G, Lu H, Chen M, Yao H, Zhao H. Oxidative stress participates in age-related changes in rat lumbar intervertebral discs.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Gerontol Geriatr 2014; 59:665-9; PMID:25081833; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2005; 7:R380-91; PMID: 15743486; http://dx.doi.org/10.1186/ar1499 [58] Brandl A, Hartmann A, Bechmann V, Graf B, Nerlich M, Angele P. Oxidative stress induces senescence in chondrocytes.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Res2011; 29:1114-20; PMID:21284033; http://dx.doi.org/10.1002/ jor.21348 [59] Gruber HE, Hoelscher GL, Ingram JA, Bethea S, Hanley EN.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Growth factors (Chur, Switzerland) 2008; 26:220-5; PMID:19021034; http://dx.doi.org/ 10.1080/08977190802273814 [60] Jiang L, Jin Y, Wang H, Jiang Y, Dong J. Glucosamine protects nucleus pulposus cells and induces autophagy via the mTOR- dependent pathway.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Res 2014; 32:1532-42; PMID:25087910; http://dx.doi.org/10.1002/jor.22699 [61] Park JS, Park JB, Park IJ, Park EY.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Int Orthop 2014; 38:1311-20;PMID:24535573; http://dx.doi.org/10.1007/s00264-014-2296-z [62] Johnson WE, Stephan S, Roberts S. The in ﬂuence of serum, glucose and oxygen on intervertebral disc cell growth in vitro: implications for degenerative disc disease.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2008; 10:R46;PMID:18433481; http://dx.doi.org/10.1186/ar2405 [63] Stephan S, Johnson WE, Roberts S. The in ﬂuence of nutrient supply and cell density on the growth and survival of intervertebral disc cells in 3D culture.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Asian Spine J 2015; 9:155-61; PMID:25901224; http://dx.doi.org/10.4184/asj.2015.9.2.155 [65] Gruber HE, Norton HJ, Hanley EN, Jr. Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2000; 25:2153-7; PMID:10973395; http://dx.doi.org/10.1097/00007632-200009010-00002 [66] Pratsinis H, Kletsas D. PDGF, bFGF and IGF-I stimulate the prolif- eration of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2007; 16:1858-66;PMID:17763874; http://dx.doi.org/10.1007/s00586-007-0408-9 [67] Bibby SR, Urban JP.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2004; 13:695-701; PMID:15048560; http://dx.doi.org/10.1007/s00586-003-0616-x [68] Jiang L, Zhang X, Zheng X, Ru A, Ni X, Wu Y, Tian N, Huang Y, Xue E, Wang X, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Res 2013; 31:692-702; PMID:23238821;http://dx.doi.org/10.1002/jor.22289 [69] Le Maitre CL, Freemont AJ, Hoyland JA.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.Arthritis Res Ther 2005; 7:R732-45; PMID:15987475; http://dx.doi.org/10.1186/ar1732 [70] Seguin CA, Pilliar RM, Roughley PJ, Kandel RA.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2005; 30:1940-8; PMID:16135983; http://dx.doi.org/10.1097/01.brs.0000176188.40263.f9 [71] Purmessur D, Walter BA, Roughley PJ, Laudier DM, Hecht AC, Iatridis J.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Biochem Biophys Res Commun 2013; 433:151-6; PMID:23438440; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2006; 31:2151-61; PMID:16915105; http://dx.doi.org/10.1097/01.brs.0000231761.73859.2c [73] Liang QQ, Zhou Q, Zhang M, Hou W, Cui XJ, Li CG, Li TF, Shi Q, Wang YJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2008; 33:2052-8; PMID:18758360; http://dx.doi.org/10.1097/BRS.0b013e318183f949 [74] Xing QJ, Liang QQ, Bian Q, Ding DF, Cui XJ, Shi Q, Wang YJ.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2010; 35:E1253-61; PMID:20938386; http://dx.doi.org/ 10.1097/BRS.0b013e3181e7d087 [75] Martin JA, Brown TD, Heiner AD, Buckwalter JA.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Spine 2004; 29:2757-69; PMID:15564925; http://dx.doi.org/10.1097/01.brs.0000146048.14946.af [77] Masuda K, An HS.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Eur Spine J 2006; 15 Suppl 3:S422-32; PMID:16865380; http://dx.doi.org/10.1007/s00586-006-0149-1 [78] Gire V, Roux P, Wynford-Thomas D, Brondello JM, Dulic V. DNA damage checkpoint kinase Chk2 triggers replicative senescence.EMBO J 2004; 23:2554-63; PMID:15192702; http://dx.doi.org/10.1038/sj.emboj.7600259 [79] Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Mol Cell 2004; 14:501-13; PMID:15149599; http://dx.doi.org/10.1016/S1097- 2765(04)00256-4 [80] Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ, Van Lohuizen M, Band V, Campisi J, Dimri GP.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Mol Cell Biol 2003; 23:389-401; PMID:12482990;http://dx.doi.org/10.1128/MCB.23.1.389-401.2003 [81] Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter- Kochanek K, Jansen-Durr P, Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"AgingCell 2006; 5:379-89; PMID:16911562; http://dx.doi.org/10.1111/ j.1474-9726.2006.00231.x [82] Heath ﬁeld SK, Le Maitre CL, Hoyland JA.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2008; 10:R87; PMID: 18681962; http://dx.doi.org/10.1186/ar2468 [83] Park JB, Byun CH, Park EY.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Asian Spine J2015; 9:495-502; PMID:26240705; http://dx.doi.org/10.4184/asj.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Front Pharmacol 2012; 3:4; PMID:22319497; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Science 2000; 289:2126-8; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Nature 2001; 410:227-30; PMID:11242085; http://dx.doi.org/10.1038/35065638 [87] Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T. Human SIR2 deacetylates p53 and antag-onizes PML/p53-induced cellular senescence.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"EMBO J 2002;21:2383-96; PMID:12006491; http://dx.doi.org/10.1093/emboj/ 21.10.2383 [88] Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 mod- ulates premature senescence-like phenotype in human endothelial cells.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2011; 13:R200; PMID:22152608; http://dx.doi.org/10.1186/ar3533 [90] Xia X, Guo J, Lu F, Jiang J. SIRT1 Plays a Protective Role in Inter- vertebral Disc Degeneration in a Puncture-induced Rodent Model.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Spine 2015; 40:E515-24; PMID:25646749; http://dx.doi.org/10.1097/BRS.0000000000000817CELL CYCLE 1683,Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Biol Chem 2000; 275:20847-52; PMID:10781609; http://dx.doi.org/10.1074/jbc.M908162199 [93] Cho KA, Ryu SJ, Oh YS, Park JH, Lee JW, Kim HP, Kim KT, Jang IS, Park SC.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Biol Chem 2004; 279:42270-8; PMID:15263006; http://dx.doi.org/10.1074/jbc.M402352200 [94] Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Biochemistry 2000; 39:13916-24; PMID:11076533; http://dx.doi.org/10.1021/bi001489b [95] Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase path- ways mediates oncogenic ras-induced premature senescence.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"MolCell Biol 2002; 22:3389-403; PMID:11971971; http://dx.doi.org/ 10.1128/MCB.22.10.3389-3403.2002 [96] Iwasa H, Han J, Ishikawa F. Mitogen-activated protein kinase p38 deﬁnes the common senescence-signalling pathway.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Gen Cells 2003; 8:131-44; http://dx.doi.org/10.1046/j.1365-2443.2003.00620.x [97] Martin JA, Buckwalter JA.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Pharmacy Pharmacol 2008; 60:969-76;PMID:18644190; http://dx.doi.org/10.1211/jpp.60.8.0004 [100] Nasto LA, Robinson AR, Ngo K, Clauson CL, Dong Q, St Croix C, Sowa G, Pola E, Robbins PD, Kang J, et al.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Orthop Res 2013; 31:1150-7;PMID:23389888; http://dx.doi.org/10.1002/jor.22320 [101] Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, Wappler I, Birket MJ, Harold G, Schaeuble K, et al.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"PLoS biology 2007; 5:e110; PMID:17472436; http://dx.doi.org/10.1371/journal.pbio.0050110 [102] Zhu M, Chen M, Zuscik M, Wu Q, Wang YJ, Rosier RN, O ’Keefe RJ, Chen D. Inhibition of beta-catenin signaling in articular chon- drocytes results in articular cartilage destruction.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Rheum 2008; 58:2053-64; PMID:18576323; http://dx.doi.org/10.1002/art.23614 [103] Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"ArthritisRheum 2010; 62:1393-402; PMID:20131282; http://dx.doi.org/ 10.1002/art.27357 [104] Hartmann C, Tabin CJ.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Cell 2006; 127:469-80; PMID:17081971; http://dx.doi.org/10.1016/j.cell.2006.10.018 [106] Hiyama A, Sakai D, Arai F, Nakajima D, Yokoyama K, Mochida J.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J CellBiochem 2011; 112:2974-86; PMID:21678465; http://dx.doi.org/ 10.1002/jcb.23217 [107] Hiyama A, Sakai D, Tanaka M, Arai F, Nakajima D, Abe K, Mochida J.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"J Cell Physiol 2011; 226:1139-48; PMID:20945354; http://dx.doi.org/10.1002/jcp.22438 [108] Hiyama A, Yokoyama K, Nukaga T, Sakai D, Mochida J.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Arthritis Res Ther 2013; 15:R189; PMID:24286133; http://dx.doi.org/10.1186/ar4379 [109] Demidenko ZN, Blagosklonny MV.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
"Cell cycle (Geor- getown, Tex) 2008; 7:3355-61; PMID:18948731; http://dx.doi.org/ 10.4161/cc.7.21.6919 [110] Chung SA, Wei AQ, Connor DE, Webb GC, Molloy T, Pajic M, Diwan AD.",OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
Spine 2007; 32:1188-96; PMID:17495775; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
J Orthop Res 2014; 32:159-66; PMID:23983186; http://dx.doi.org/10.1002/jor.224741684 C. FENG ET AL.,OADS,/arxiv_data1/oa_pdf/49/b7/kccy-15-13-1152433.PMC4957599.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/58/main.PMC4957606.pdf
"On  examination, http://dx.doi.org/10.1016/j.ijscr.2016.07.012 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b2/58/main.PMC4957606.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/02/main.PMC4957607.pdf
"Further questioning  revealed  that  two  years  earlier  the  boy  allegedly  met with  a  Road  trafﬁc  accident  (RTA)  −  the  victim  fell  ﬂat  on  his  face, chin  ﬁrst,  after  being  hit  on  the  head,  while  traveling  home  in  an http://dx.doi.org/10.1016/j.ijscr.2016.07.011 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/0c/02/main.PMC4957607.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/50/02/12325_2016_Article_331.PMC4957626.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 389–398Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 389 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S100660Developing a competency-based medical education  curriculum for the core basic medical sciences in  an African Medical School Funmilayo Eniola Olopade1  Oluwatosin Adekunle  Adaramoye2  Yinusa Raji3  Abiodun Olubayo Fasola4  Emiola Oluwabunmi Olapade-Olaopa 5 1Department of Anatomy,   2Department of Biochemistry,   3Department of Physiology,   4Department of Oral Pathology,   5Department of Surgery, College  of Medicine, University of Ibadan,   Ibadan,  NigeriaAbstract:  The College of Medicine of the University of Ibadan recently revised its MBBS  and BDS curricula to a competency-based medical education method of instruction.",Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
"Competency-based Correspondence: Emiola Oluwabunmi  Olapade-Olaopa Department of Surgery, College of Medicine, University of Ibadan, PO Box 7193 Secretariat, Ibadan, Nigeria   Tel +234 81 8677 4485Email okeoffa@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Olopade et alRunning head recto: CBME curriculum for the core basic medical sciencesDOI: http://dx.doi.org/10.2147/AMEP .S100660",Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 398 Olopade et al  8.,Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
Avail-able from: http://www.wfme.org.,Non-OADS,/arxiv_data1/oa_pdf/d4/71/amep-7-389.PMC4957633.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 399–400Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 399 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S110386 Benefits of simulation training in medical  education Tamkin Abas Fatema Zehra Juma Manchester Medical School, University  of Manchester, Manchester, UKDear editor We read about the satisfaction of simulation experiences of paramedic students1 with  great interest.",Non-OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
"The practice provided by simulation training builds up confidence and hence satisfaction, Correspondence: Tamkin Abas 2 Dennis Avenue, Wembley, Middlesex HA9 8AZ, UKTel +44 754 284 2451Email tamkin.abas@student.manchester.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Abas and JumaRunning head recto: Benefits of simulation training in medical educationDOI: http://dx.doi.org/10.2147/AMEP .S110386",Non-OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 400 Abas and Juma as students would feel more competent to handle real-life  situations in the future.3 Many students in this study felt that the simulation train- ing developed their clinical decision-making abilities.,Non-OADS,/arxiv_data1/oa_pdf/2e/d4/amep-7-399.PMC4957634.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 213–216Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 213 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S89839 Smartphone applications to aid weight loss and  management: current perspectives Elizabeth F Sutton Leanne M Redman Pennington Biomedical Research  Center, Louisiana State University,  Baton Rouge, LA, USAAbstract:  The development and dissemination of smart devices has cultivated a global environment  of hyperconnectivity and increased our access to information.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
"Remote tools, including pedometers,  accelerometers, bathroom scales,  pill bottles, and blood pressure cuffs, are paired with these devices through apps to allow the user to interpret their own data and self-monitor health behaviors such as tracking  Correspondence: Leanne M Redman Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA   Tel +1 225 763 0947 Fax +1 225 763 3009   Email Leanne.Redman@pbrc.eduJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: COMMENTAR YY ear: 2016V olume: 9Running head verso: Sutton and RedmanRunning head recto: Smartphone applications to aid weight loss and managementDOI: http://dx.doi.org/10.2147/DMSO.S89839",Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 216 Sutton and Redman versus the in-person model may be a more advantageous path  to determine the efficacy of these products.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
Available from: https://www.cdrnet.org/registry-statistics.,OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
Available from: http://www.appbrain.com/stats/android-market-app-categories.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
Available from: http://www.healthypeople.gov/2020/topics-objectives/topic/nutrition-and-weight-status/objectives.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/dmso-9-213.PMC4957635.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/55/cia-11-961.PMC4957636.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 961–966Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  961OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9823 2 Predicting gleason score using the initial serum  total prostate-specific antigen in Black men with  symptomatic prostate adenocarcinoma in nigeria Ikenna I Nnabugwu Emeka I Udeh Fredrick O Ugwumba Francis O Ozoemena Urology Unit, Department of Surgery,   College of Medicine, Enugu Campus,   University of Nigeria, Enugu, NigeriaBackground:  Men of Black African descent are known to have the highest incidence of  prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/b5/55/cia-11-961.PMC4957636.pdf
"The incidence is lowest in Asians (4.5–28.0 per  100,000  person-years), higher in native Africans (10.6–27.0 per 100,000  person-years),  and highest in North Americans (97.2–100,000  person-years) and Australia/New Zealand  (111.6 per 100,000 person-years).2 The incidence is particularly high among men of  African descent in Northern America at 220 per 100,000 population.3 The disease has  also been noted to be more aggressive in Blacks possibly due to late presentation of  patients or development of a biologically more aggressive tumor.4,5 Adenocarcinoma of the prostate is by far the commonest histological variant.6,7 With  the discovery of serum prostate-specific antigen (sPSA) and its derivatives came a new  era in the management of prostate cancer: more cases are diagnosed especially in the Correspondence: Ikenna I Nnabugwu Urology Unit, Department of Surgery,  College of Medicine, Enugu Campus,  University of Nigeria, PMB 01129,  Enugu, Nigeria email ikenna.nnabugwu@unn.edu.n g Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Nnabugwu et al Running head recto: Predicting the Gleason Score using the serum total PSA at presentation DOI: http://dx.doi.org/10.2147/CIA.S98232",Non-OADS,/arxiv_data1/oa_pdf/b5/55/cia-11-961.PMC4957636.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b5/55/cia-11-961.PMC4957636.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b5/55/cia-11-961.PMC4957636.pdf
"[*]D.E.Williams ,E.A.Dolgopolov a,D.C.Godfrey ,E.D.Ermolae va, Dr.P.J.Pellechia, Prof. Dr.A.B.Greytak, Dr.M.D.Smith, Prof. Dr.N.B.Shustova Department ofChemist ryandBiochem istry TheUniversity ofSouth Carolina 631Sumter Street, Columbia, SC29208 (USA) E-mail :shustova@s c.edu Dr.S.M.Avdoshenk o,Dr.A.A.Popov Leibniz Institute forSolid State and Materials Research, 01069 Dresden (Germany) E-mail :A.Popov@ifw-d resden.d e Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016035 84.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/ANIE-55-9070.PMC4957671.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/fe/kew192.PMC4957673.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/25/kew208.PMC4957676.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 297–303Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  297 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S75537Biomarkers and the prediction of atrial fibrillation:  state of the art Wesley T O’Neal1 Sanjay Venkatesh2 Stephen T Broughton2 William F Griffin3 Elsayed Z Soliman4,5 1Department of Medicine, Division  of Cardiology, Emory University  School of Medicine, Atlanta, GA,  USA;  2Department of Internal  Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA;   3Department of Internal Medicine,   Medical University of South Carolina,  Charleston, SC, USA;  4Department  of Internal Medicine, Division of Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, USA;   5Epidemiological Cardiology Research  Center, Wake Forest School of Medicine, Winston-Salem, NC, USAAbstract:  Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in  clinical practice, and it places a substantial burden on the health care system.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
"Correspondence: Wesley T O’Neal Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USAEmail wesley.oneal@emory.eduJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: O’Neal et alRunning head recto: Biomarkers and atrial fibrillationDOI: http://dx.doi.org/10.2147/VHRM.S75537",Non-OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 303 Biomarkers and atrial fibrillation  61.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/vhrm-12-297.PMC4957677.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/b1/opth-10-1297.PMC4957678.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1297–1303Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1297CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11208 0 Transzonular vitreous injection vs a single drop  compounded topical pharmaceutical regimen after  cataract surgery Bret l Fisher1 rick potvin2 1eye Center of north Florida, panama  City, Fl, USa; 2Science in Vision,   akron, nY, USaPurpose:  To compare the relative effectiveness of a Tri-Moxi-Vanc intraocular solution injected  transzonularly into the vitreous with the topical formulation of Pred-Moxi-Ketor (given for the  first week postoperatively) followed by Pred-Ketor (given for weeks 2–4 after surgery).",Non-OADS,/arxiv_data1/oa_pdf/c9/b1/opth-10-1297.PMC4957678.pdf
Or use: http://youtu.be/SLOIYpHvyF oVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/c9/b1/opth-10-1297.PMC4957678.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c9/b1/opth-10-1297.PMC4957678.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/b1/opth-10-1297.PMC4957678.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/3a/ppa-10-1251.PMC4957679.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1251–1258Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1251OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10058 8 simultaneous surgery in patients with both cardiac  and noncardiac diseases Yang Yang1 Feng Xiao1 Jin Wang1 Bo song1 Xi-hui li1 Jian li2 Zhi-song he3 huan Zhang4 ling Yin5 1Department of cardiac surgery,   2Department of Thoracic surgery,   3Department of Urology surgery,   4Department of general surgery,   5Department of Obstetrics and  gynecology, Peking University  First hospital, Beijing, People’s  republic of chinaBackground:  To investigate the possibility and feasibility of simultaneous cardiac and  noncardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/8b/3a/ppa-10-1251.PMC4957679.pdf
"This is the largest domestic single-center report in the People’s  Republic of China nowadays.correspondence: Yang Yang Department of cardiac surgery,  Peking University First hospital,  no 8 Xishiku street, Beijing 100034,  People’s republic of china Tel +86 10 8357 2744 email yangyang_12456@126.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y ang et al Running head recto: Simultaneous cardiac and noncardiac surgery DOI: http://dx.doi.org/10.2147/PPA.S100588",Non-OADS,/arxiv_data1/oa_pdf/8b/3a/ppa-10-1251.PMC4957679.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8b/3a/ppa-10-1251.PMC4957679.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 139–144Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  139 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S108479Clinical applications of therapeutic phlebotomy Kyung Hee Kim1  Ki Y oung Oh2 1Department of Laboratory Medicine,   Gachon University Gil Medical  Center, Incheon, 2Department of  Physical Medicine and Rehabilitation,  Soonchunhyang University, Cheonan Hospital, Cheonan, South KoreaAbstract:  Phlebotomy is the removal of blood from the body, and therapeutic phlebotomy is  the preferred treatment for blood disorders in which the removal of red blood cells or serum  iron is the most efficient method for managing the symptoms and complications.",Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
"7 Therapeutic phlebotomy has several physiological mechanisms.8 For example,  bone marrow stem cells are stimulated by bloodletting to generate new red blood cells Correspondence: Ki Young Oh   Department of Physical Medicine  and Rehabilitation, Soonchunhyang University Cheonan Hospital, Bongmyeong-dong, Dongnam-gu, Cheonan-si, Chungcheongnam-do 330-721, South Korea   Tel +82 41 570 3884   Fax +82 41 570 2776   Email okokykkh@schmc.ac.krJournal name: Journal of Blood Medicine Article Designation: COMMENTAR YY ear: 2016V olume: 7Running head verso: Kim and OhRunning head recto: Clinical applications of therapeutic phlebotomyDOI: http://dx.doi.org/10.2147/JBM.S108479",Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 144 Kim and Oh  16.,Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
Available from: http://www.ahfsdruginformation.com/.,Non-OADS,/arxiv_data1/oa_pdf/c3/89/jbm-7-139.PMC4957680.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3191–3203International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3191RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S11054 2 Remote magnetic targeting of iron oxide  nanoparticles for cardiovascular diagnosis and  therapeutic drug delivery: where are we now?",Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
"Thus, along with their particular magnetic Correspondence: Ali Yilmaz Department of Cardiology and  Angiology, University Hospital  Münster, Albert-Schweitzer-Campus 1,  Building A1, 48149 Münster, Germany Tel +49 251 834 5185 Fax +49 251 834 8143 email ali.yilmaz@ukmuenster.d e Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Bietenbeck et al Running head recto: Magnetic targeting of iron oxide nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S110542",Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0003433 3.,Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/43/ijn-11-3191.PMC4957681.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/ijn-11-3255.PMC4957682.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3255–3263International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3255OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10460 4 Controlled release hydrogen sulfide delivery system  based on mesoporous silica nanoparticles protects  graft endothelium from ischemia–reperfusion injury Wenshuo Wang1,* Xiaotian sun1,2,* huili Zhang3 cheng Yang1 Ye liu4,5 Wuli Yang4,5 changfa guo1 chunsheng Wang1 1Department of cardiac surgery,   shanghai Institute of cardiovascular  Diseases, Zhongshan hospital,   2Department of cardiothoracic  surgery, huashan hospital, Fudan  University, 3Department of cardiology,   shanghai Ninth People’s hospital,   shanghai Jiao T ong University,   4state Key laboratory of Molecular  engineering of Polymers, 5Department  of Macromolecular science, Fudan  University, shanghai, People’s republic  of china *These authors contributed equally  to this workAbstract:  Hydrogen sulfide (H2S) functions as a protective gas transmitter in various  physiological and pathological processes, but the lack of ideal donors severely hampers the  clinical application of H2S.",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/ijn-11-3255.PMC4957682.pdf
"Recently, hydrogen sulfide (H2S) has emerged as a new organ-preserving agent in  the field of transplantation.2,3 H2S has been reported to significantly improve short- and  long-term graft function and survival when used as an additive in conjunction with  common organ preservation solutions, such as histidine–tryptophan–ketoglutarate solu - tion and the University of Wisconsin (UW) solution.4 Despite these benefits, clinical  utility of H2S is severely limited by the cytotoxic effects that it demonstrates at high  dosages, particularly on mitochondrial membrane transport.5 Furthermore, the rate of correspondence: changfa guo;  chunsheng Wang Department of cardiac surgery, shanghai  Institute of cardiovascular Diseases,  Zhongshan hospital, Fudan University,  180 Fenglin road, shanghai 200032,  People’s republic of china Tel +86 6404 1990 email guo.changfa@zs-hospital.sh.c n;  wang.chunsheng@zs-hospital.sh.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: A novel controlled release hydrogen sulfide donor DOI: http://dx.doi.org/10.2147/IJN.S104604",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/ijn-11-3255.PMC4957682.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/ijn-11-3255.PMC4957682.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/0a/ijn-11-3255.PMC4957682.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 231–239Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 231 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S106338 Computed tomography and magnetic resonance  imaging contrast media injectors: technical feature  review – what is really needed?",Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"1 There are cost and handling issues with the consumables that are required for the  injection (syringes, bags, bottle, tubing), problems with the actual injection pathway, and patient access (and the consumables for this).Correspondence: Michael Friebe Institute of Medical Engineering, Otto-von-Guericke-University, Universitätsplatz 2, D-39106 Magdeburg, GermanyEmail michael.friebe@ovgu.deJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: FriebeRunning head recto: CT and MRI contrast media injectors - what is really needed?DOI: http://dx.doi.org/10.2147/MDER.S106338",Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Reproduced  from wikimedia.org (http://creativecommons.org/licenses/by-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.medtron.com/verbrauchsmaterial/sets.html.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"Available from: https://www.radiologie.bayer.de/ct/verbrauchsmaterial-ct. Accessed February 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.debio-tech.com/newsite/page/index.php?page= product_01&id= 1&id_   prod=59#type=Brief.,OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://dx.doi.org/10.1016/j.jacr.2012.04.007.,OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.acr.org/~ /media/37 D84428BF1D4E1B9A3A2918DA9E27A3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: https://commons.wikimedia.org/wiki/File:Bluthirnschranke_nach_Infarkt_nativ_und_KM.png.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.medicines.org.uk/EMC/medicine/1825/SPC/Magnevist/.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.guerbet-us.com/prod-ucts/dotarem.html.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://braccoimaging.com/sites/braccoimaging.com/files/technica_sheet_pdf/MultiHance%20Prescribing%20Information.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www3.gehealthcare.com/en/products/categories/contrast_media/omniscan#tabs/tab488621DA-BE7848C7837C18A88CFE9FFF .,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.apollo-rt.com/index.php/ct-injectors.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.ulrichmedi-cal.de/de/3t-tennessee.html.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.medtron.de/en/magnetic-resonance-imaging/accutron-mr3.html.,OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.nemoto-do.co.jp/ nemoto_en/pr_mr/moreinfo/ss_7.html.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.radiologie.bayer.de/medizintechnik/mrt/medrad-solaris.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://brac-coimaging.com/us-en/products-and-solutions/injectors/empowermr.,OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.scannexus.nl/news/bericht-quot_empower_your_mri_research__even_at_9_4t_quot.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.hospitalpharmacyeurope.com/featured-articles/safety-and-hygiene-aspectscontrast-media-administration-germany.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://www.itnonline.com/article/trends-contrast-media-injection-systems.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
Available from: http://mripatientsafety.com/blog/?p=285.,Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/5d/23/mder-9-231.PMC4957683.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/34/ijn-11-3239.PMC4957684.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3239–3253International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3239OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10814 3 annonaceous acetogenins nanosuspensions  stabilized by PCL-PEG block polymer: significantly  improved antitumor efficacy Jingyi hong1,* Yanhong li1,2,* Yijing li1 Yao Xiao1,2 haixue Kuang2 Xiangtao Wang1 1Key laboratory of Bioactive  substances and resources Utilization  of chinese herbal Medicine, Institute  of Medicinal Plant Development,   chinese academy of Medical sciences,   Peking Union Medical college, Beijing,   2school of Pharmacy, heilongjiang  University of chinese Medicine,   harbin, People’s republic of china *These authors contributed equally  to this workAbstract:  Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a  variety of cancer cell lines, but their clinical application has been limited by their poor solubility.",Non-OADS,/arxiv_data1/oa_pdf/c0/34/ijn-11-3239.PMC4957684.pdf
"Keywords:  annonaceous acetogenins, mPEG2000–PCL2000, near–infrared fluorescence,  biodistribution, antitumor efficacy Introduction Annonaceous acetogenins (ACGs), which are an effective fraction separated from  the seeds of Annonaceae species,1–3 have attracted much attention over the past 3  decades due to their strong antitumor activity and broad antineoplastic spectrum.4–6 For  example, bullatacin, the major component from ACGs, displayed 104–105 times the  antitumor activity of doxorubin against both the A549 (human lung carcinoma cells)  and the MCF-7 (human breast cancer cells)7 cell lines and 300 times the activity of  taxol in L1210 (murine leukemia cells)-bearing mice.8 The three bis-tetrahydrofuran  compounds from Annona squamosa seeds showed 50% inhibitory concentration (IC50)  values that were one to two orders of magnitude less than fluorouracil against SMMC  7721 (human hepatocellular carcinoma), HeLa (human cervix carcinoma), MKN-45  (human gastric cancer), and HepG2 (human hepatocellular carcinoma) cell lines.9 It  was demonstrated that ACGs exerted antitumor effects via inhibition of mitochondrial  complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain,10,11  which might favor reversing multiple drug resistance in many tumor cell lines because  multiple drug resistance is an energy-consuming process.12 In vivo tests in mice showed the antitumor effects and even some possible  adverse effects of ACGs.5 It was reported that bullatacin led to liver and kidney correspondence: Xiangtao Wang Key laboratory of Bioactive substances  and resources Utilization of chinese  herbal Medicine, Institute of Medicinal  Plant Development, chinese academy  of Medical sciences, Peking Union  Medical college, room 109, chemistry  Building, 151 Malianwa North road,  Beijing, haidian District 100193,  People’s republic of china Tel/fax +86 10 5783 3266 email xtaowang@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hong et al Running head recto: Preparation of ACGs-NSps and their improved antitumor efficacy DOI: http://dx.doi.org/10.2147/IJN.S108143",Non-OADS,/arxiv_data1/oa_pdf/c0/34/ijn-11-3239.PMC4957684.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c0/34/ijn-11-3239.PMC4957684.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/34/ijn-11-3239.PMC4957684.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 193–195International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 193 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S106323Administration of palmitoylethanolamide in  combination with topiramate in the preventive  treatment of nummular headache Domenico Chirchiglia1  Attilio Della T orre2  Francesco Signorelli2  Giorgio Volpentesta2  Giusy Guzzi2  Carmelino Angelo Stroscio2  Federica Deodato2  Donatella Gabriele2  Angelo Lavano2 1Department of Neurosurgery,   Neurophysiopathology Unit,   2Department of Neurosurgery,   University of Catanzaro “Magna  Graecia”, Catanzaro, ItalyAbstract:  Nummular headache has been recently described as a primary disorder character - ized by head pain exclusively felt in a small rounded area typically 2–6 cm in diameter, not  attributed to another disorder.",Non-OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
"The patient had no personal or family history of typical forms of primary headache, but she was a habitual consumer of Correspondence: Domenico Chirchiglia   Department of Neurosurgery,  Neurophysiopathology Unit, University of Catanzaro “Magna Graecia”, Viale Europa, Germaneto 88100, Catanzaro, Italy Tel +39 961 364 7389   Fax +39 961 364 7092   Email chirchiglia@unicz.itJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Chirchiglia et alRunning head recto: Administration of PEA with topiramate in the treatment of NHDOI: http://dx.doi.org/10.2147/IMCRJ.S106323",Non-OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 195 Administration of PEA with topiramate in the treatment of NH  7.,Non-OADS,/arxiv_data1/oa_pdf/bb/10/imcrj-9-193.PMC4957685.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/94/opth-10-1305.PMC4957686.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1305–1313Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1305Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11079 3 Optical coherence tomography parameters  predictive of visual outcome after anti-VegF  therapy for retinal vein occlusion akiko Fujihara-Mino Y oshinori Mitamura naoki inomoto hiroki sano Kei akaiwa Kentaro semba Department of Ophthalmology,   institute of Biomedical sciences,   Tokushima University graduate  school, T okushima, JapanPurpose:  To determine the optical coherence tomography (OCT) parameters that are predictive  of visual outcome after anti-VEGF therapy for a retinal vein occlusion (RVO).",Non-OADS,/arxiv_data1/oa_pdf/6d/94/opth-10-1305.PMC4957686.pdf
"Thus, it would be helpful to know if there  is an ocular parameter that can be used to predict the visual outcome after the ME is  resolved by therapy.Correspondence: Yoshinori Mitamura Department of Ophthalmology, institute  of Biomedical sciences, Tokushima  University graduate school, 3-18-15  Kuramoto, Tokushima 770-8503, Japan Tel +81 88 633 7163 Fax +81 88 631 4848 email ymitaymitaymita@yahoo.co.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Fujihara-Mino et al Running head recto: OCT parameters and visual outcome in anti-VEGF therapy for RVO DOI: http://dx.doi.org/10.2147/OPTH.S110793",Non-OADS,/arxiv_data1/oa_pdf/6d/94/opth-10-1305.PMC4957686.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6d/94/opth-10-1305.PMC4957686.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/94/opth-10-1305.PMC4957686.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1769–1778Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1769OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10679 1 Parenting, identity development, internalizing  symptoms, and alcohol use: a cross-sectional  study in a group of italian adolescents Monica Pellerone giacomo T olini caterina Polopoli Faculty of human and social sciences,   “Kore” University of enna, enna, italyBackground:  Literature has demonstrated the adaptive function of identity development and  parenting toward manifestation of problem behaviors in adolescence.",Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
"Recent literature emphasizes the importance of examining the risk and protection  factors for the internalizing and externalizing symptoms in adolescence, which appear in  different contexts: social and interpersonal, such as family, school, and peer group; and  individual factors, such as identity development, and cognitive and behavioral patterns.correspondence: Monica Pellerone Faculty of human and social sciences,  “Kore” University of enna, Via  cittadella Universitaria, snc, enna (en),  94100, italy Tel +39 329 432 4311 email monica.pellerone@unikore.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Pellerone et al Running head recto: A cross-sectional study in Italian adolescents DOI: http://dx.doi.org/10.2147/NDT.S106791",Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
Available from: https://www.diva-portal.,Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/2b/ndt-12-1769.PMC4957687.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/d2/sfv154.PMC4957711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/af/sfw022.PMC4957712.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/f4/sfw025.PMC4957713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/ef/sfw030.PMC4957714.pdf
http://www.hsa.gov.sg/content/ hsa/en/Health_Products_Regulation/Safety_Information_and_Product_Recalls/Product_Safety_Alerts/2013/increase_in_ antibody-mediated.html .,Non-OADS,/arxiv_data1/oa_pdf/a9/ef/sfw030.PMC4957714.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/04/sfw031.PMC4957715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/df/sfw034.PMC4957716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/e9/sfw036.PMC4957718.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/96/sfw039.PMC4957719.pdf
http://www.nps.org.au/publications/health-professional/ health-news-evidence/2014/tamper-proof-oxycodone2.,Non-OADS,/arxiv_data1/oa_pdf/09/96/sfw039.PMC4957719.pdf
http://secure.healthlinks.net.au/content/mf/ pi.cfm?product=mfpoxycr 3.,Non-OADS,/arxiv_data1/oa_pdf/09/96/sfw039.PMC4957719.pdf
"FDA NewsRelease 2013. http://fda.gov/NewsEvents/Newsroom/Press Announcements/ucm348252.htm (15 February 2015, date last accessed) 10.",Non-OADS,/arxiv_data1/oa_pdf/09/96/sfw039.PMC4957719.pdf
"Drugsafety and availability 2012. http://www.fda.gov/drugs/ drugsafety/ucm322432.htm (15 February 2015, date last accessed) 11.",Non-OADS,/arxiv_data1/oa_pdf/09/96/sfw039.PMC4957719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/5a/sfw040.PMC4957720.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/f4/95/sfw041.PMC4957721.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/cc/sfw042.PMC4957722.pdf
"http://www.who.int/mediacentre/factsheets/fs094/en (26 December 2015, date last accessed) 2.",Non-OADS,/arxiv_data1/oa_pdf/07/cc/sfw042.PMC4957722.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/fa/sfw046.PMC4957723.pdf
Supplementary data Supplementary data are available online at http://ndt.oxfordjour- nals.org.,OADS,/arxiv_data1/oa_pdf/a8/fa/sfw046.PMC4957723.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/fd/sfw047.PMC4957724.pdf
"2005. http://www.anzdata.org (February 2016, date last accessed) 17.",Non-OADS,/arxiv_data1/oa_pdf/1f/fd/sfw047.PMC4957724.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/d8/sfw049.PMC4957725.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/a1/sfw050.PMC4957726.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/c5/sfw051.PMC4957727.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/67/sfw052.PMC4957728.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/35/sfw054.PMC4957729.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/6f/sfw055.PMC4957730.pdf
Supplementary data Supplementary data are available online at http://ndt.oxford journals.org.,OADS,/arxiv_data1/oa_pdf/87/6f/sfw055.PMC4957730.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/d0/sfw056.PMC4957731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/6b/sfw059.PMC4957733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/11/13/sfw061.PMC4957734.pdf
Supplementary data Supplementary data are available online at http://ndt.oxfordjour- nals.org.,OADS,/arxiv_data1/oa_pdf/11/13/sfw061.PMC4957734.pdf
"The selective preservation of the retinal ganglion cells  suggests that while TPP1 protein delivered via the CSF may protect these cells, preservation of the  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/02/67/nihms803039.PMC4957944.pdf
"Indeed,  this treatment recently completed combined phase 1/2 clinical trials with promising  preliminary results ( https://clinicaltrials.gov/ct2/results?term=CLN2&Search=Search ).",Non-OADS,/arxiv_data1/oa_pdf/02/67/nihms803039.PMC4957944.pdf
"Axon  numbers were determined using Adobe Photoshop Touch (Adobe Systems, Inc., San Jose,  CA) and Image J ( http://rsb.info.nih.gov/ij/ ) (Whiting et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/02/67/nihms803039.PMC4957944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/33/main.PMC4957954.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.03.007,OADS,/arxiv_data1/oa_pdf/75/33/main.PMC4957954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/be/main.PMC4957955.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.01.006,OADS,/arxiv_data1/oa_pdf/36/be/main.PMC4957955.pdf
"The interviewer used a semistructured inter-view guide that was developed based on relevant litera-ture suggesting important aspects of treatment (Kvale & Brinkmann, 2009) (see Supplemental Digital Content 1, available at:  http://links.lww.com/ONJ/A8 ).",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Retrieved from  http://doi.org/10.1186/1471-2474-15-62.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"The original article is an open access article distributed under the terms of the Creat ive Com- mons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,  and repro duction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Supplemental Digital Content 2  (available at:  http://links.lww.com/ONJ/A9 ) provides  examples of the analysis process for each constituent of the lived experience.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Using comparative content analysis, we applied the cognitive-behavioral model as a theoretical perspective on the data ( Elo & Kyngäs, 2008 ),  creating a matrix (see Supplemental Digital Content 3, available at:  http://links.lww.com/ONJ/A10 ).",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1097/ BRS.0b013e3181d1049f         Abbott  ,   A. D.  ,     Tyni-Lenné  ,   R.  ,      &   Hedlund  ,   R.    ( 2010b ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from   http://doi.org/10.1016/j.pain.2006.01.027         Burns  ,   J. W.  ,     &   Moric  ,   M.    ( 2011 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Retrieved from  http://doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Retrieved from  http://doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Retrieved from  http://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1111/ecc.12131         Harris  ,   I.",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"The Cochrane Database of Systematic Reviews  ,  ( 7 ),   http://doi.org/10.1002/14651858.CD002014.pub3 .",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1586/ern.09.20         Koch  ,   M. B.  ,     Davidsen  ,   M.  ,     &   Juel  ,   K.    ( 2011 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from   http://doi.org/10.1016/j.spinee.2013.06.101         McCracken  ,   L. M.  ,     &   Samuel  ,   V. M.    ( 2007 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from   http://doi.org/10.1016/j.pain.2006.11.016         Monticone  ,   M.  ,     Ambrosini  ,   E.  ,     Rocca  ,   B.  ,     Magni  ,   S.  ,     Brivio  ,     F.  ,     &   Ferrante  ,   S.    ( 2014 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved  from  http://doi.org/10.1007/s00586-014-3478-5         Moore  ,   J. E.    ( 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from   http://doi.org/10.1016/j.pmr.2010.06.005         Neukamp  ,   M.  ,     Perler  ,   G.  ,     Pigott  ,   T.  ,     Munting  ,   E.  ,     Aebi  ,   M.  ,     &    Röder  ,   C.    ( 2013 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved  from  http://doi.org/10.1007/s00586-013-2943-x         Nielson  ,   W. R.  ,     Jensen  ,   M. P.  ,     Karsdorp  ,   P. A  ,     &   Vlaeyen  ,   J.  W. S.    ( 2013 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1093/ptr/kph019         Polomano  ,   R. C.  ,     Marcotte  ,   P. J.  ,     &   Farrar  ,    J. T.    ( 2006 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from   http://doi.org/10.1002/ejsp.837         Rolving  ,   N.  ,     Nielsen  ,   C. V.  ,     Christensen  ,   F. B.  ,     Holm  ,   R.  ,      Bünger  ,   C. E.  ,     &   Oestergaard  ,   L. G.    ( 2015 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1097/ BRS.0000000000000843         Rolving  ,   N.  ,      Oestergaard  ,   L. G.  ,     Willert  ,   M. V.  ,     Christensen  ,    F. B.  ,     Blumensaat  ,   F.  ,     Bünger  ,   C.  ,     &   Nielsen  ,   C. V.     ( 2014 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved  from  http://doi.org/10.1186/1471-2474-15-62         Saltychev  ,   M.  ,     Eskola  ,   M.  ,     &   Laimi  ,   K.    ( 2014 ).",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1097/ MRR.0b013e328363ba4b         Strunin   ,   L.  ,     &   Boden  ,   L. I.",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"Retrieved from  http://doi.org/10.1016/ S0277-9536 (03)00333-2        Strömqvist  ,   B.  ,     Fritzell  ,   P.  ,     Hägg  ,   O.  ,     Jönsson  ,   B.  ,        Sandén  ,    B.    ,   &   Swedish Society of Spinal Surgeons .",OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
Retrieved from  http://doi.org/10.1007/s00586-013- 2758-9       The Danish Parliament .,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/ornur-35-238.PMC4957958.pdf
"A total of 30 preoperative factors, including details of the patients’ characteristics and tumor findings, were identified (Supplementary Table 1, http://links.lww.com/SLA/A974).",OADS,/arxiv_data1/oa_pdf/84/db/ansu-264-214.PMC4957962.pdf
http://orwh.od.nih.gov/about/mission.asp.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2014. http://orwh.od.nih.gov/career/bircwh/index.asp.,OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2015. http://grants.nih.gov/grants/guide/pa-files/PA-15–321.html.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2012. http://womeninscience.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2012. http://orwh.od.nih.gov/career/pdf/Causal-Factor-Summary.pdf.,OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2011. http://grants.nih.gov/grants/ family_friendly.htm.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2009. http://grants.nih.gov/grants/ guide/notice-files/NOT-OD-09-034.html.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2011. http://grants.nih.gov/grants/guide/ notice-files/NOT-OD-11–045.html.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2015. https://oir.nih.gov/sourcebook/personnel/ recruitment-processes-policies-checklists/keep- thread-policy.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
http://irp.nih.gov/research- training/nih-work-life-resources.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
http://www.wocrn.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2008. http://grants.nih.gov/grants/guide/rfa-files/RFA- GM-09-012.html.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
1999. http://web.mit.edu/ fnl/women/women.html.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
2011. http://web.mit.edu/faculty/ reports/pdf/women_faculty.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/0e/acm-91-1057.PMC4957965.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/83/main.PMC4958110.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.09.001 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/fa/83/main.PMC4958110.pdf
E-mail address: art.malkani@louisville.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.09.001 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/fa/83/main.PMC4958110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 117 e120,Non-OADS,/arxiv_data1/oa_pdf/fa/83/main.PMC4958110.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.03.001 .,OADS,/arxiv_data1/oa_pdf/34/df/main.PMC4958111.pdf
E-mail address: schwarzk@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.03.001 2352-3441/Copyright ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/df/main.PMC4958111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 111 e115,Non-OADS,/arxiv_data1/oa_pdf/34/df/main.PMC4958111.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.09.002 .,OADS,/arxiv_data1/oa_pdf/12/e9/main.PMC4958112.pdf
E-mail address: aharri26@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.09.002 2352-3441/Copyright ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/e9/main.PMC4958112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 89 e91,Non-OADS,/arxiv_data1/oa_pdf/12/e9/main.PMC4958112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/32/main.PMC4958113.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.03.005 .,OADS,/arxiv_data1/oa_pdf/71/32/main.PMC4958113.pdf
E-mail address: jtmoskal@carilionclinic.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.03.005 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/71/32/main.PMC4958113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 103 e106,Non-OADS,/arxiv_data1/oa_pdf/71/32/main.PMC4958113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/5d/main.PMC4958114.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.07.002 .,OADS,/arxiv_data1/oa_pdf/5e/5d/main.PMC4958114.pdf
E-mail address: benjaminrpulley@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.07.002 2352-3441/Copyright ©2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/5e/5d/main.PMC4958114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 93 e98,Non-OADS,/arxiv_data1/oa_pdf/5e/5d/main.PMC4958114.pdf
J Arthroplasty 2015. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5e/5d/main.PMC4958114.pdf
Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ Arthroplasty Today 1 (2015) 85 http://dx.doi.org/10.1016/j.artd.2015.10.003 2352-3441/Copyright ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/97/68/main.PMC4958116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/68/main.PMC4958116.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.10.001 .,OADS,/arxiv_data1/oa_pdf/d9/09/main.PMC4958117.pdf
E-mail address: Mcgrob1@mmc.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.10.001 2352-3441/Copyright ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/09/main.PMC4958117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 107 e110,Non-OADS,/arxiv_data1/oa_pdf/d9/09/main.PMC4958117.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.11.001 .,OADS,/arxiv_data1/oa_pdf/15/be/main.PMC4958118.pdf
E-mail address: dvancitters@dartmouth.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.11.001 2352-3441/Copyright ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/15/be/main.PMC4958118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 87 e88,Non-OADS,/arxiv_data1/oa_pdf/15/be/main.PMC4958118.pdf
Epub ahead of print; http://dx.doi.org/10.1016/j.arth.2015.07.039 .,Non-OADS,/arxiv_data1/oa_pdf/15/be/main.PMC4958118.pdf
J Orthop Surg Res 2013;8:20. http://dx.doi.org/ 10.1186/1749-799X-8-20 .,Non-OADS,/arxiv_data1/oa_pdf/15/be/main.PMC4958118.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.10.002 .,OADS,/arxiv_data1/oa_pdf/56/ef/main.PMC4958119.pdf
E-mail address: sierra.rafeael@mayo.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.10.002 2352-3441/Copyright ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/ef/main.PMC4958119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 1 (2015) 99 e102,Non-OADS,/arxiv_data1/oa_pdf/56/ef/main.PMC4958119.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 32756 - http://dx.doi.org/10.3402/ljm.v11.32756 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/80/95/LJM-11-32756.PMC4958135.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32756 - http://dx.doi.org/10.3402/ljm.v11.32756",Non-OADS,/arxiv_data1/oa_pdf/80/95/LJM-11-32756.PMC4958135.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ott-9-4337.PMC4958350.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4337–4342OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4337Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9580 7 association between cD14 snP -159 c/T and  gastric cancer: an independent case–control  study and an updated meta-analysis ai-Min gong1,2,* Xin-Yuan li2,* Yi-Qiang Xie1 Zhan-Dong Jia3 Yuan-Xin li4 Y ong-Yan Zou5 chang-Qing Xu2,* Zhen-Yu Wang2,* 1Department of internal Medicine  of Traditional chinese Medicine,   hainan Medical University, hainan,   2Department of Pathophysiology,   harbin Medical University, harbin,   3Department of nephrology, ningbo  Tradition chinese Medicine hospital  affiliated to Zhejiang chinese  Medical University, ningbo, 4The  Fifth Department of acupuncture,   5Department of nephrology, Jining  Tradition chinese Medicine hospital,   Jining, People’s republic of china *These authors contributed equally  to this workPurpose:  The association between CD14 -159C/T polymorphism and the susceptibility to  gastric cancer (GC) has been reported.",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ott-9-4337.PMC4958350.pdf
"Antigenic molecules on the surface of both Gram-positive (peptidoglycans and lipote - ichoic acid) and Gram-negative (lipopolysaccharide, LPS) bacteria can be detected by correspondence: chang-Qing Xu;  Zhen-Yu Wang Department of Pathophysiology,  harbin Medical University, 157 Baojian  road, nangang District, harbin,  People’s republic of china Tel/fax +86 152 4467 5386 email haofabiao@126.co m;  hrbwzy2015@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gong et al Running head recto: CD14 SNP -159 C/T is associated with gastric cancer risk DOI: http://dx.doi.org/10.2147/OTT.S95807",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ott-9-4337.PMC4958350.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ott-9-4337.PMC4958350.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ott-9-4337.PMC4958350.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/e1/dddt-10-2333.PMC4958351.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2333–2339Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2333Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S10881 9 Voiding dysfunction in patients with nasal congestion  treated with pseudoephedrine: a prospective   study i-hung shao1,* chia-chen Wu2,* hsiao-Jung Tseng3 Ta-Jen lee2 Yu-hsiang lin4 Yuan-Yun Tam5 1Division of Urology, Department  of surgery, lotung Poh-ai hospital,   Yilan county, 2Department of  Otorhinolaryngology – head and  neck surgery, linkou chang gung  Memorial hospital, chang gung  University, 3Biostatistical center  for clinical research, chang-gung  Memorial hospital, Taoyuan city,   4Division of Urology, Department  of surgery, linkou chang gung  Memorial hospital, chang gung  University, Taoyuan city, 5Department  of Otorhinolaryngology – head and  neck surgery, lotung Poh-ai hospital,   Yilan county, Taiwan *These authors contributed equally   to this workBackground:  Pseudoephedrine is a sympathomimetic drug widely used as a nasal deconges - tant.",Non-OADS,/arxiv_data1/oa_pdf/9e/e1/dddt-10-2333.PMC4958351.pdf
"correspondence: Yuan-Yun Tam Department of Otorhinolaryngology –  head and neck surgery, lotung Poh-ai  hospital, no 83, nanchang st, luodong  Township, Yilan county 265, Taiwan email darcietam@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shao et al Running head recto: Pseudoephedrine causes voiding dysfunction in older males DOI: http://dx.doi.org/ 10.2147/DDDT.S10881 9",Non-OADS,/arxiv_data1/oa_pdf/9e/e1/dddt-10-2333.PMC4958351.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9e/e1/dddt-10-2333.PMC4958351.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/e1/dddt-10-2333.PMC4958351.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ndt-12-1779.PMC4958352.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1779–1785Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1779OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10881 4 association of brain-derived neurotrophic factor  and nerve growth factor gene polymorphisms  with susceptibility to migraine salih coskun1 sefer Varol2 hasan h Ozdemir2 elif agacayak3 Birsen Aydın4 Oktay Kapan5 Mehmet akif camkurt6 saban T unc7 Mehmet Ugur cevik2 1Department of Medical genetics,   2Department of Neurology,   3Department of Obstetrics and  gynecology, Medical Faculty, Dicle  University, Diyarbakır, T urkey;   4Department of Neurology, Diyarbakır  education and research hospital,   Diyarbakır, T urkey; 5Department of  Neurology, Elazıg ˘ Education and  Research Hospital, Elazıg ˘, T urkey;   6Department of Psychiatry, afsin state  Hospital, Kahramanmaras, T urkey;   7laboratory of Molecular genetics,   Medical Faculty, Dicle University,   Diyarbakır, T urkeyAbstract:  Migraine is one of the most common neurological diseases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ndt-12-1779.PMC4958352.pdf
"Advances in technology have informed us about the significance to  migraine of events such as cortical spreading depression (CSD) and activation of the correspondence: salih coskun Department of Medical genetics, Dicle  Üniversitesi, Tıp Fakültesi, Tıbbi Genetik  AD, 21280, Sur/Diyarbakır, Turkey Tel +90 412 248 8001 Fax +90 412 248 8440 email scoskun9@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Coskun et al Running head recto: BDNF and NGF polymorphisms association with migraine susceptibility DOI: http://dx.doi.org/10.2147/NDT.S108814",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ndt-12-1779.PMC4958352.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ndt-12-1779.PMC4958352.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/ndt-12-1779.PMC4958352.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2299–2310Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2299Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10403 7rational design and synthesis of novel diphenyl  ether derivatives as antitubercular agents sidhartha s Kar1 Varadaraj Bhat g1 Praveen P n rao2 Vishnu P shenoy3 indira Bairy4 g gautham shenoy1 1Department of Pharmaceutical  chemistry, Manipal college of  Pharmaceutical sciences, Manipal  University, Manipal, india; 2school of  Pharmacy, health sciences campus,   University of Waterloo, Waterloo, On ,   canada; 3Department of Microbiology,   Kasturba Medical college, Manipal,   4Melaka-Manipal Medical college,   Manipal University, Manipal, indiaAbstract:  A series of triclosan mimic diphenyl ether derivatives have been synthesized  and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis  H37Rv.",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
"In the pres - ent study, we report the design of triclosan mimic diphenyl ether derivatives as anti-TB correspondence: g gautham shenoy Department of Pharmaceutical  chemistry, Manipal college of  Pharmaceutical sciences, Manipal  University, Manipal 576 104, india Tel +91 820 292 2482 Fax +91 820 257 1998 email gautham.gs@manipal.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kar et al Running head recto: Diphenyl ether derivatives as anti-TB agents DOI: http://dx.doi.org/10.2147/DDDT.S104037",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
"Available from: http://www.industrycortex.com/ datasheets/profile/759758262/manual-tf000017-rev-1.0-mammalian- liver-microsomes-guidelines-fo r. Accessed April 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/dddt-10-2299.PMC4958353.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/8d/copd-11-1615.PMC4958354.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1615–1622International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1615OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10905 6 effects of biomass smoke on pulmonary functions:  a case control study Baran Balcan1 selcuk akan2 aylin Ozsancak Ugurlu1 Bahar Ozcelik handemir3 Berrin Bagcı Ceyhan4 sevket Ozkaya5 1Department of Pulmonary Medicine,   Baskent University Faculty of  Medicine, Istanbul, 2Department of  Internal Medicine, ankara education  and T eaching hospital, ankara,   3Department of Pulmonary Medicine,   Irmet hospital, 4Department of  Pulmonary Medicine, Marmara  University Faculty of Medicine,   5Department of Pulmonary Medicine,   Faculty of Medicine, Bahcesehir  University, Istanbul, T urkeyBackground:  Biomass smoke is the leading cause of COPD in developing countries such  as Turkey.",Non-OADS,/arxiv_data1/oa_pdf/ac/8d/copd-11-1615.PMC4958354.pdf
"Carbon monoxide, nitrous oxide, sulfur oxide, formaldehyde, and polycyclic organic  matter, including carcinogens such as benzopyrene, are all products of biomass smoke.5  These microparticulate products reach the peripheral airways and produce adverse effects  on pulmonary functions.6 The primary aim of this study was to determine the difference  of pulmonary functions between females who were exposed to biomass smoke and those  who were not and the secondary aim was to determine the time course relationship with Correspondence: Baran Balcan Department of Pulmonary Medicine,  Baskent University Faculty of Medicine,  7 Oymaci street, Istanbul 34662, Turkey Tel +90 530 414 2308 Fax +90 216 554 1500 email drbaranbalcan@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Balcan et al Running head recto: Effects of biomass smoke on pulmonary functions DOI: http://dx.doi.org/10.2147/COPD.S109056",Non-OADS,/arxiv_data1/oa_pdf/ac/8d/copd-11-1615.PMC4958354.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ac/8d/copd-11-1615.PMC4958354.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/8d/copd-11-1615.PMC4958354.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/38/dddt-10-2323.PMC4958355.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2323–2331Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2323Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11060 3 Prediction of selective estrogen receptor beta  agonist using open data and machine learning  approach ai-qin niu1 liang-jun Xie2 hui Wang1 Bing Zhu1 sheng-qi Wang3 1Department of gynecology, the  First People’s hospital of shangqiu,   shangqiu, henan, People’s republic  of china; 2Department of image  Diagnoses, the Third hospital of Jinan,   Jinan, shandong, People’s republic  of china; 3Department of Mammary  Disease, guangdong Provincial  hospital of chinese Medicine, the  second clinical college of guangzhou  University of chinese Medicine,   guangzhou, People’s republic of  chinaBackground:  Estrogen receptors (ERs) are nuclear transcription factors that are involved in  the regulation of many complex physiological processes in humans.",Non-OADS,/arxiv_data1/oa_pdf/4c/38/dddt-10-2323.PMC4958355.pdf
"ER- β is mainly expressed in correspondence: sheng-qi Wang Department of Mammary Disease,  guangdong Provincial hospital of  chinese Medicine, the second clinical  college of guangzhou University of  chinese Medicine, Dade road no 111,  guangzhou 510120, People’s republic  of china email wsq2011@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Niu et al Running head recto: Prediction of selective estrogen receptor beta agonist using open data DOI: http://dx.doi.org/10.2147/DDDT.S110603",Non-OADS,/arxiv_data1/oa_pdf/4c/38/dddt-10-2323.PMC4958355.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/38/dddt-10-2323.PMC4958355.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/38/dddt-10-2323.PMC4958355.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 287–293International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  287OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9994 3 One-year assessment of physical activity level  in adult Qatari females: a pedometer-based  longitudinal study suzan sayegh Mercia Van Der Walt Mohamed ghaith al-Kuwari exercise is Medicine Department,   aspetar Orthopedic and sports  Medicine Hospital, Doha, QatarBackground:  Physical inactivity is a growing health concern and has been identified as the  fourth leading risk factor for global mortality.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
"Recently, it has been  identified as the fourth leading risk factor for global mortality, contributing to 6% of  deaths around the world.1 Physical inactivity is associated with noncommunicable  chronic diseases such as obesity, hypertension, and diabetes.2 This is mainly caused  by the global lifestyle changes, specifically the spread of Western lifestyle, which is  characterized by reduced physical activity and unhealthy diet.3,4 The prevalence of  insufficient physical activity is high in the World Health Organization (WHO) region  of the US (32%) and the Eastern Mediterranean Region (31%).5 Moreover, the Arab  region includes countries with some of the world’s highest physical inactivity levels.6  Statistics show that physical inactivity is highly prevalent in Qatar and the countries correspondence: suzan sayegh exercise is Medicine Department,  aspetar Orthopedic and sports Medicine  Hospital, PO Box 29222, Doha, Qatar email souzan.alsayegh@aspetar.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Sayegh et al Running head recto: Assessment of physical activity level in adult Qatari females DOI: http://dx.doi.org/10.2147/IJWH.S99943",Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Registered members were encouraged to frequently upload  their pedometer readings onto their account on the program  website ( http://www.stepintohealth.qa /) by providing them  with instructions about the device utilization and data upload.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Available from: http://www.who.int/dietphysicalactivity/pa/en /.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Available from: http://www.who.int/hpr/physactiv/sedentary.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Available from: http://www.who.int/chp/steps/Qatar_2012_   STEPwise_Report.pdf?ua= 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
"Available from: http://www.bhfactive.org.uk/sites/ Exercise-Referral-Toolkit/downloads/resources/cmos-report-at-least- five-a-week.pd f. Accessed May 30, 2015.",OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
"Available from:  http://www.namat.qa/NamatImages/Publications/75/QATAR%20 PA%20GUIDLINE%20ENGLISH.PD F. Accessed May 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Available from: http://apps.who.int/iris/bitstream/10665/42330/1/ WHO_TRS_894.pdf?ua=1&ua= 1.,OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/ijwh-8-287.PMC4958356.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 125–140Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 125 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S110461 A systematic review and meta-analysis  of Harmonic technology compared with  conventional techniques in mastectomy and  breast-conserving surgery with lymphadenectomy for breast cancer Hang Cheng1  Jeffrey W Clymer1  Nicole C Ferko2  Leena Patel2  Ireena M Soleas2  Chris G Cameron2  Piet Hinoul1 1Ethicon Inc., Cincinnati, OH, USA;   2Cornerstone Research Group,   Burlington, ON, CanadaBackground: Mastectomy and breast-conserving surgery (BCS) are important treatment options  for breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"The occurrence of Correspondence: Jeffrey W Clymer   Ethicon Inc., 4545 Creek Road,  Cincinnati, OH 45242, USA   Tel +1 513 337 3318   Email jclymer@its.jnj.comJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Cheng et alRunning head recto: Harmonic technology in breast cancer surgeryDOI: http://dx.doi.org/10.2147/BCTT.S110461",Non-OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 140 Cheng et al Supplementary materials Literature search strategy The following search strategy was used in MEDLINE, where  “MeSH” indicates Medical subject headings: 1.",Non-OADS,/arxiv_data1/oa_pdf/13/e3/bctt-8-125.PMC4958357.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2263–2270Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2263Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9307 6 Sitagliptin/metformin fixed-dose combination  in type 2 diabetes mellitus: an evidence-based  review of its place in therapy Jennifer Hayes1 Rosie Anderson1 Jeffrey w Stephens1,2 1Department of Diabetes and  endocrinology, Morriston Hospital,   ABM University NHS Trust, 2Diabetes  Research Group, institute of Life  Sciences, Swansea University,   Swansea, UKAbstract:  Type 2 diabetes mellitus is a progressive disease associated with significant morbidity  and mortality.",Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
"The accepted mechanism of action is a reduction in  hepatic glucose output, but it also increases peripheral glucose utilization, increases  peripheral tissue sensitivity to insulin, decreases fatty acid oxygenation, and reduces  intestinal carbohydrate absorption.4 It is the most widely prescribed first-line therapy Correspondence: Jeffrey w Stephens Department of Diabetes and  endocrinology, Morriston Hospital,  ABM University NHS Trust, Heol Maes  eglwys, Swansea SA6 6NL, UK Tel +44 1792 704 078 Fax +44 1792 703 214 email j.w.stephens@swansea.ac.u k Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Hayes et al Running head recto: Fixed dose of sitagliptin/metformin DOI: http://dx.doi.org/10.2147/DDDT.S93076",Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
Available from:  http://www.nice.org.uk/guidance/ng28?unlid=9428993482016126103 832.,Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
Available from: http://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
Available from: http://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
Available from: http://www.merck.com/product/usa/ pi_circulars/j/januvia/januvia_pi.pdf.,OADS,/arxiv_data1/oa_pdf/35/d1/dddt-10-2263.PMC4958358.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/df/ott-9-4317.PMC4958359.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4317–4322OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4317Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11080 2 ectopic micronodular thymoma with lymphoid  stroma in the cervical region: a rare case  associated with Langerhans cells proliferation Min Yu1 Yuan Meng2 Bin Xu2 Lin Zhao3 Qingfu Zhang4 1Department of Cell Biology, Key  Laboratory of Cell Biology, Ministry  of public Health, and Key Laboratory  of Medical Cell Biology, Ministry of  education, China Medical University,   shenyang, people’s republic of  China; 2Department of p athology,   Fushun Central Hospital, Fushun,   people’s republic of China; 3second  Department of Medical Oncology, The  General Hospital of Fushun Mining  Bureau, Fushun, people’s republic  of China; 4Department of p athology,   College of Basic Medical sciences,   China Medical University, shenyang,   people’s republic of ChinaAbstract:  Micronodular thymoma (MNT) with lymphoid stroma is a rare thymic epithelial  neoplasm with the characteristics of multiple nodules separated by abundant lymphoid stroma.",Non-OADS,/arxiv_data1/oa_pdf/fd/df/ott-9-4317.PMC4958359.pdf
"The tumor cells within the Correspondence: Qingfu Zhang Department of pathology, College of  Basic Medical sciences, China Medical  University, No 77 puhe road, shenyang  North New area, shenyang 110122,  Liaoning province, people’s republic  of China email qfzhang@cmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Yu et al Running head recto: Ectopic micronodular thymoma with lymphoid stroma DOI: http://dx.doi.org/10.2147/OTT.S110802",Non-OADS,/arxiv_data1/oa_pdf/fd/df/ott-9-4317.PMC4958359.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/df/ott-9-4317.PMC4958359.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/df/ott-9-4317.PMC4958359.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/90/ott-9-4323.PMC4958360.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4323–4336OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4323Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10694 4 endocannabinoid system as a regulator of tumor  cell malignancy – biological pathways and clinical  significance Maria Pyszniak1–3 Jacek Tabarkiewicz1,2 Jarogniew J Łuszczki4,5 1Centre for innovative Research  in Medical and Natural Sciences,   Faculty of Medicine, 2Department  of immunology, Faculty of Medicine,   University of Rzeszów, Rzeszów,   3Postgraduate School of Molecular  Medicine, Medical University of  warsaw, warszawa, 4Department of  Pathophysiology, Medical University  of Lublin, 5isobolographic Analysis  Laboratory, institute of Agricultural  Medicine, Lublin, PolandAbstract:  The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs),  endogenous cannabinoids, and enzymes responsible for their synthesis, transport, and degradation  of (endo)cannabinoids.",Non-OADS,/arxiv_data1/oa_pdf/a3/90/ott-9-4323.PMC4958360.pdf
"CB1 receptors are found mainly in the  central nervous system, particularly in those regions of the brain that are involved in  the control of memory (hippocampus), emotions (amygdala), motor activity (basal  ganglia and cerebellum), cognition (cortex), and appetite (hypothalamus).5 CB1 recep - tors are also present in peripheral tissues, such as uterus, testes, ovaries, and prostate.1,6  In contrast, CB2 receptors predominate in the immune system, both in cells such as  lymphocytes and macrophages and in tissues such as spleen, tonsils, and lymph nodes.1,6  Recently, it has been reported that some effects of cannabinoids are non-CB1/CB2  mediated.7,8 Orphan GPR GPR55 has been suggested to be the third CB according to  some reports.9,10 The expression of genes encoding a CB3 receptor has been shown  in several peripheral tissues, such as spleen, tonsils, and mammae, and in endothelial Correspondence: Maria Pyszniak Centre for innovative Research in  Medical and Natural Sciences, Faculty  of Medicine, University of Rzeszów,  warzywna 1a, PL 35-310 Rzeszów,  Poland email pyszniakmaria@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Pyszniak et al Running head recto: Endocannabinoid system as a regulator of tumor cell malignancy DOI: http://dx.doi.org/10.2147/OTT.S106944",Non-OADS,/arxiv_data1/oa_pdf/a3/90/ott-9-4323.PMC4958360.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/90/ott-9-4323.PMC4958360.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/90/ott-9-4323.PMC4958360.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 85–93Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  85 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S71325Vasectomy and prostate cancer risk: a historical  synopsis of undulating false causality Max Nutt   Zachary Reed   T obias S Köhler Division of Urology, Southern Illinois  University School of Medicine,  Urology, Springfield, IL, USAAbstract:  The potential influence of vasectomy being a risk factor for the development of  prostate cancer is not a new concept, with more than 30 publications addressing the topic.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
"Ultimately, after reviewing  Correspondence: Tobias S Köhler   Southern Illinois University School of  Medicine, Urology, 301 North Eighth Street, Fourth Floor, Springfield, IL 62701, USA Tel +1 217 545 7443   Email tkohler@siumed.eduJournal name: Research and Reports in Urology Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Nutt et alRunning head recto: Vasectomy and prostate cancer riskDOI: http://dx.doi.org/10.2147/RRU.S71325",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 93 Vasectomy and prostate cancer risk 19.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/rru-8-085.PMC4958361.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/5d/opth-10-1315.PMC4958362.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1315–1321Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1315Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9652 9 inter-eye comparison of retinal oximetry and  vessel caliber between eyes with asymmetrical  glaucoma severity in different glaucoma subtypes Clarissa shu Ming Cheng1,2 Yi Fang lee2 Charles Ong3 Zhu li Yap2 andrew Tsai2 aditi Mohla2 Monisha e nongpiur4 Tin aung2,4 shamira a Perera2,4 1Department of Ophthalmology, Tan  T ock seng hospital, 2Department of  Ophthalmology, singapore national  eye Centre, 3Yong loo lin school  of Medicine, national University of  singapore, 4singapore eye research  institute, singapore national eye  Centre, singaporeBackground:  To compare retinal vessel oxygenation and vessel caliber in primary angle-closure  glaucoma (PACG), primary open-angle glaucoma (POAG), normal-tension glaucoma (NTG),  and normal controls, as well as between eyes of asymmetrical glaucoma severity.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/opth-10-1315.PMC4958362.pdf
"The vascular theory proposes  hypoperfusion and subsequent ischemia, hypoxia, inflammation, and tissue damage in Correspondence: shamira a Perera singapore national eye Centre, 11 Third  hospital avenue, singapore 168751 Tel +65 6322 4584 Fax +65 6323 1903 email shamira.perera@snec.com.s g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cheng et al Running head recto: Retinal oximetry and vessel caliber comparison in glaucoma subtypes DOI: http://dx.doi.org/10.2147/OPTH.S96529",Non-OADS,/arxiv_data1/oa_pdf/71/5d/opth-10-1315.PMC4958362.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/71/5d/opth-10-1315.PMC4958362.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/5d/opth-10-1315.PMC4958362.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1259–1270Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1259OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10820 3 cardiovascular risk prediction: a comparative  study of Framingham and quantum neural  network based approach renu narain1 sanjai saxena1 Achal Kumar goyal2 1Department of Biotechnology,   Thapar University, Punjab, india;   2University computer center,   gurukul Kangri University, haridwar,   Uttarakhand,  indiaPurpose:  Currently cardiovascular diseases (CVDs) are the main cause of death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"Correct and timely diagnosis of correspondence: sanjai saxena Department of Biotechnology, Thapar  University, Bhadson road, Patiala,  Punjab 147004, india email sanjaibiotech@yahoo.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Narain et al Running head recto: Cardiovascular risk prediction DOI: http://dx.doi.org/10.2147/PPA.S108203",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"The dataset  of 5,209 CVD patients of the Framingham study has been  taken from the University of Washington, Seattle, WA,  USA ( http://courses.washington.edu/b513/datasets/datasets.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs317/en/index.htm l.  Accessed May 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
Available from: http://courses.washington.edu/b513/ datasets/datasets.php?class =513.,Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"Available from: http://cvrisk.mvm.ed.ac.uk/calculator/ calc.as p. Accessed May 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"Available from: https://escol.escardio.org/heartscore/download.asp x.  Accessed May 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2d/5d/ppa-10-1259.PMC4958363.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/2f/ott-9-4343.PMC4958364.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4343–4349OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4343Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9958 0 evaluation of MMP-9 and MMP-2 and their  suppressor TiMP-1 and TiMP-2 in adenocarcinoma  of esophagogastric junction Xiaofei lu1,2 lingling Duan3 hongqin Xie4 Xiaoxia lu5 Daolin lu6 Daopeng lu7 nan Jiang8 Yuxin chen1 1Department of general surgery,   Qilu hospital of shandong University,   2Department of general surgery,   Jinan central hospital of shandong  University, 3Department of Preventive  Medicine, Jinan central hospital  affiliated to shandong University,   4Department of gynecology and  Obstetrics, Third People’s hospital  of Jinan, 5Department of Physical  examination, second hospital of  shandong University of Traditional  chinese Medicine, 6health T echnology  exchange center of Jinan, 7emergency  center of Jinan, 8Department of  Pathology, shandong University  Medical school, Jinan, People’s  republic of chinaObjective:  Adenocarcinoma of esophagogastric junction (AEG) is a lethal malignancy featured  with early metastasis, poor prognosis, and few treatment options.",Non-OADS,/arxiv_data1/oa_pdf/01/2f/ott-9-4343.PMC4958364.pdf
"Keywords:  adenocarcinoma of esophagogastric junction, MMP-9, MMP-2, TIMP-1, TIMP-2,  metastasis, prognosis Introduction Adenocarcinoma of esophagogastric junction (AEG) is a kind of malignant tumor  originated from the distal esophagus and the esophagogastric junction.1,2 During the  past 2 decades, the morbidity of AEG increased rapidly.3,4 AEG is characterized by  poor prognosis because of extensive locoregional invasion and distant metastasis at  the time of diagnosis.5,6 Tumor progression is a multistep process, in which many  genes and proteins are involved.7 The function of extracellular matrix (ECM) in  many kinds of cancers have been revealed, but the clinical significance in AEG is  still in mist.correspondence: Yuxin chen Department of general surgery,   Qilu hospital of shandong University,  no 107 Wenhua Xi road, Jinan,  shandong Province 250012,  People’s republic of china Tel +86 531 8690 7588 Fax +86 531 8690 7588 email yxchen@sdu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lu et al Running head recto: MMP-9 +/TIMP-1–predicts poor prognosis of AEG DOI: http://dx.doi.org/10.2147/OTT.S99580",Non-OADS,/arxiv_data1/oa_pdf/01/2f/ott-9-4343.PMC4958364.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/01/2f/ott-9-4343.PMC4958364.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/2f/ott-9-4343.PMC4958364.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 967–976Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  967RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10928 5 Colorectal cancer development and advances in  screening Karen Simon ventura County Gastroenterology  Medical Group, Inc., Camarillo,   CA, USAAbstract:  Most colon tumors develop via a multistep process involving a series of  histological, morphological, and genetic changes that accumulate over time.",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
"It is estimated that achieving this goal  will avert 280,000 new cases of CRC and save 200,000 lives in the US by 2030.8,9  Discussions of CRC screening with patients that lead to successful screenings will be  of vital importance to achieving this goal.7 This review provides a concise overview Correspondence: Karen Simon ventura County Gastroenterology  Medical Group, Inc., 2486 Ponderosa  Drive North D-206, Camarillo,  CA 93010, USA Tel +1 805 484 7921 Fax +1 805 388 5404 email drkarensimon@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Simon Running head recto: Colorectal cancer development and advances in screening DOI: http://dx.doi.org/10.2147/CIA.S109285",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
"Available from: http://seer.cancer.gov/statfacts/ html/colorect.htm l. Accessed March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
"Available from: http://www.cancer.org/cancer/ colonandrectumcancer/detailedguide/colorectal-cancer-survival-rate s;  http://tinyurl.com/grrozt x. Accessed March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
Available from: http://nccrt.org/tools/80-percent-by-2018/80- by-2018-press-kit /.,Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK1562/.,Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/aa/5a/cia-11-967.PMC4958365.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 95–103Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  95 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S109319Prevalence, psychological impact, and risk factors  of erectile dysfunction in patients with Peyronie’s  disease: a retrospective analysis of 309 cases Gianni Paulis1,2  Gennaro Romano3  Andrea Paulis4 1Department of Surgical Sciences,   Andrology Center, Regina  Apostolorum Hospital, Albano L.,  Italy;  2Department of Uro-Andrology,   Peyronie’s Disease Care Center,  Rome, Italy;  3Department of Urologic  Oncology, Section of Avellino, Italian League Against Cancer, Avellino,  Italy;   4Section of Psycho-Sexology,   Peyronie’s Disease Care Center,  Rome, ItalyAbstract: Peyronie’ s disease (PD) is a chronic inflammatory disease involving the tunica  albuginea of the penis.",Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
"The initial stage is followed by a chronic Correspondence: Gianni Paulis  Peyronie’s Disease Care Center, Via Castefidardo 34, 00185   Rome, Italy Tel +39 06 4281 4211Email paulisg@libero.itJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Paulis et alRunning head recto: Erectile dysfunction in patients with PD DOI: http://dx.doi.org/10.2147/RRU.S109319",Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 103 Erectile dysfunction in patients with PD   30.,Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
Available from: http://www.baus.org.uk/_userfiles/pages/files/professionals/sections/EAU2015-Extended-Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/1b/rru-8-095.PMC4958366.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/94/ndt-12-1761.PMC4958367.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1761–1767Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1761Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10030 7 A clinician’s guide to recurrent isolated sleep  paralysis Brian A Sharpless Clinical Psychology Program,   American School of Professional  Psychology at Argosy University,   washington DC, Arlington, vA, USAAbstract:  This review summarizes the empirical and clinical literature on sleep paralysis most  relevant to practitioners.",Non-OADS,/arxiv_data1/oa_pdf/8e/94/ndt-12-1761.PMC4958367.pdf
"However, due to several factors, the clinical ramifications of SP remain  relatively unknown to many practitioners, and it is neither routinely assessed Correspondence: Brian A Sharpless Clinical Psychology Program, American  School of Professional Psychology  at Argosy University, 1550 wilson  Boulevard, Suite 724, Arlington,  vA 22209, USA Tel +1 703 526 5833 email basharpless@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Sharpless Running head recto: Sleep paralysis DOI: http://dx.doi.org/10.2147/NDT.S100307",Non-OADS,/arxiv_data1/oa_pdf/8e/94/ndt-12-1761.PMC4958367.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8e/94/ndt-12-1761.PMC4958367.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/94/ndt-12-1761.PMC4958367.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/73/dddt-10-2311.PMC4958368.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2311–2321Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2311Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9132 1sPOcK1 promotes tumor growth and metastasis  in human prostate cancer Qi chen1,* Yuan-ting Yao2,* huan Xu1 Yan-bo chen1 Meng gu1 Zhi-kang cai1 Zhong Wang1 1Department of Urology, shanghai  9th People’s hospital, shanghai Jiao  T ong University school of Medicine,   2institute of Plant Physiology and  ecology, chinese academy of sciences,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  Prostate cancer is the most diagnosed noncutaneous cancer and ranks as the second  leading cause of cancer-related deaths in American males.",Non-OADS,/arxiv_data1/oa_pdf/a9/73/dddt-10-2311.PMC4958368.pdf
"SPARC/osteonectin, cwcv, and kazal-like domain proteoglycan 1 (SPOCK1,  also known as testican-1) is a proteoglycan that belongs to a novel Ca2+-binding correspondence: Zhong Wang;   Zhi-kang cai Department of Urology, shanghai 9th  People’s hospital, shanghai Jiao Tong  University school of Medicine, no 639   Zhizaoju road, shanghai 200011,  People’s republic of china Tel +86 21 2327 1699 Fax +86 21 6313 6856 email zhongwang2010@sina.co m;  13311630565@189.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chen et al Running head recto: SPOCK1 promotes tumor growth and metastasis in human prostate cancer DOI: http://dx.doi.org/10.2147/DDDT.S91321",Non-OADS,/arxiv_data1/oa_pdf/a9/73/dddt-10-2311.PMC4958368.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a9/73/dddt-10-2311.PMC4958368.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/73/dddt-10-2311.PMC4958368.pdf
"http://informahealthcare.com/mby ISSN: 1040-841X (print), 1549-7828 (electronic) Crit Rev Microbiol, 2016; 42(6): 928–941 !2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-com-mercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited, and is not altered, transformed, orbuilt upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from: http://www.cdc.gov/drugresistance/threat- report-2013/pdf/ar-threats-2013-508.pdf [last accessed 7 Mar 2014].,OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from: http://www.cdc.gov/std/stats13/default.htm [last accessed 7 Mar 2014].,OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from: http://neisseria.org/ipnc/ history.shtml [last accessed 7 Mar 2014].,Non-OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from: http://www9.health.gov.au/cda/source/rpt_3_sel.cfm [last accessed 1 Oct 2015].,OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from http://www.who.int/reproductivehealth/publications/ rtis/9789241502450/en/ [last accessed 7 Mar 2014].,Non-OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
Available from: http://www.who.int/reproducti- vehealth/publications/rtis/9789241503501/en/ [last accessed 7 Mar2014].,Non-OADS,/arxiv_data1/oa_pdf/4b/a4/imby-42-928.PMC4958600.pdf
"Received: 14 February 2016, Accepted: 6 April 2016 Published online in J-STAGE: 24 April 2016 *Corresponding author: A Sugiyama  (e-mail: sugiyama@muses.tottori-u.ac.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/0e/5b/tox-29-173.PMC4958615.pdf
"For electron microscopy, small pieces of for - malin-fixed samples of the intra-abdominal mass were fixed in 2% phosphate-buffered glutaraldehyde, postfixed in 1% Received: 25 January 2016, Accepted: 8 March 2016 Published online in J-STAGE: 25 March 2016 *Corresponding Author: A Inomata  (e-mail: a-inomata@hhc.eisai.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/05/3d/tox-29-185.PMC4958616.pdf
"For histological microscopy, 4 µm paraffin sections of  each organ were stained with hematoxylin and eosin (HE) Received: 7 October 2015, Accepted: 5 April 2016 Published online in J-STAGE: 24 April 2016 *Corresponding authors: S Sutjarit (e-mail: cvtsms@ku.ac.th), A Poapolathep (e-mail: fvetamp@hotmail.com, fvetamp@ku.ac.th) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/ca/c3/tox-29-207.PMC4958617.pdf
"Nutrition Research and Practice 2016;10(4):371-376 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Adenophora remotiflora  protects human skin keratinocytes against  UVB-induced photo-damage by regulating antioxidative activity  and MMP-1 expression Hye Kyung Kim§ Department of Food & Biotechnology, Hanseo University, 46, Hanseo 1-ro, Haemi-Myun, Seosan, Chungnam 31962, Korea BACKGROUND/OBJECTIVES: Chronic ultraviolet (UV) exposure-induced reactive oxygen species (ROS) are commonly involved  in the pathogenesis of skin damage by activating the metalloproteinases (MMP) that break down type I collagen.",Non-OADS,/arxiv_data1/oa_pdf/88/87/nrp-10-371.PMC4958638.pdf
"Nutrition Research and Practice 2016;10(4):377-384 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Involvement of miR-Let7A in inflammatory response and cell  survival/apoptosis regulated by resveratrol in THP-1 macrophage Juhyun Song1,2, Mira Jun3, Mok-Ryeon Ahn3 and Oh Yoen Kim3§ 1Department of Biomedical Engineering, Dongguk University, Gyeonggi 10326, Korea 2Department of Biology, York University, Toronto, Ontario, Canada 3Department of Food Science and Nutrition, Dong-A Universi ty, 37 Nakdong-daero 550beon-gil, Saha-gu, Busan 49315, Korea BACKGROUND/OBJECTIVES:  Resveratrol, a natural polyphenol, has multiple functions in cellular responses including apoptosis,  survival, and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/34/76/nrp-10-377.PMC4958639.pdf
"Nutrition Research and Practice 2016;10(4):386-392 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Effects of disturbed liver growth and oxidative stress of high-fat  diet-fed dams on cholesterol metabolism in offspring mice Juyoung Kim1, Juhae Kim1 and Young Hye Kwon1,2§ 1Department of Food and Nutrition, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea 2Research Institute of Human Ecology, Seoul National University, Seoul 08826, Korea BACKGROUND/OBJECTIVES:  Changes in nutritional status during gestation and lactation have detrimental effects on offspring  metabolism.",Non-OADS,/arxiv_data1/oa_pdf/2d/57/nrp-10-386.PMC4958640.pdf
"Nutrition Research and Practice 2016;10(4):393-397 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Therapeutic effects of dihydroartemisinin and transferrin against  glioblastoma Suk Hee Kim1, Seong Hee Kang2 and Bo Sun Kang2§ 1Department of Food and Nutrition, Hyejeon College, Chungnam 32244, Korea 2Department of Radiological Science, College of Medical Scienc e, Konyang University, 158 Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea  BACKGROUND/OBJECFTIVES:  Artemisinin, a natural product isolated from Gaeddongssuk ( artemisia annua L.) and its main active  derivative, dihydroartemisinin (DHA), have long been used as antimalarial drugs.",Non-OADS,/arxiv_data1/oa_pdf/54/6a/nrp-10-393.PMC4958641.pdf
"Nutrition Research and Practice 2016;10(4):398-403 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Associations among plasma vitamin C, epidermal ceramide and  clinical severity of atopic dermatitis Jihye Shin1, You Jin Kim2, Oran Kwon2, Nack-In Kim3 and Yunhi Cho1§ 1Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi 17104, Ko rea  2Department of Nutritional Science and Food Management, College of Health Sciences, Ewha Womans University, Seoul 03760, Korea 3Department of Dermatology, College of Medicine, Kyung Hee University, Seoul 02447, Korea BACKGROUND/OBJECTIVES:  Atopic dermatitis (AD), a chronic inflammatory skin disease, is accompanied by disruption of the  epidermal lipid barrier, of which ceramide (Cer) is the major component.",Non-OADS,/arxiv_data1/oa_pdf/38/94/nrp-10-398.PMC4958642.pdf
"Nutrition Research and Practice 2016;10(4):404-410 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Dietary inflammatory index is associated with serum C-reactive  protein and protein energy wasting in hemodialysis patients: A cross-sectional study Mevlude Kizil1§, M. Merve Tengilimoglu-Metin1, Damla Gumus1, Sumeyra Sevim1, İnci Turkoglu1 and Fahri Mandiroglu2 1Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06100 S ıhhiye, Ankara, Turkey 2RFM Hemodialysis Units, Ankara, Turkey BACKGROUND/OBJECTIVE:  Malnutrition and inflammation are reported as the most powerful predictors of mortality and morbidity  in hemodialysis (HD) patients.",Non-OADS,/arxiv_data1/oa_pdf/96/86/nrp-10-404.PMC4958643.pdf
"Nutrition Research and Practice 2016;10(4):411-417 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Leptin and uric acid as predictors of metabolic syndrome in  jordanian adults Ahmad A. Obeidat1§, Mousa N. Ahmad2, Fares H. Haddad3 and Firas S. Azzeh4 1Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Taibah University, Yanbu Street, Yanbu 21911, Saudi Arab ia 2Department of Nutrition, Faculty of Agricu lture, University of Jordan, Amman, Jordan 3Department of Endocrinology, King Hussein Medical Center, Amman, Jordan 4Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia BACKGROUND/OBJECTIVES:  Metabolic syndrome (MetS) is a set of interrelated metabolic risk factors that increase the risk of  cardiovascular morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/nrp-10-411.PMC4958644.pdf
Available from: http://www.idf.org/webdata/docs/IDF_  Meta_def_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/5c/nrp-10-411.PMC4958644.pdf
Available from: http://www.cdc.gov/nchs/data/nhanes/ nhanes_  05_06/BM.pdf.,OADS,/arxiv_data1/oa_pdf/10/5c/nrp-10-411.PMC4958644.pdf
"Nutrition Research and Practice 2016;10(4):418-423 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The influence of obesity on the effects of spirulina supplementation  in the human metabolic response of Korean elderly Hee-Jung Park1 and Hyun-Sook Lee2§  1Food and Nutrition, Kookmin University, Seoul 02707, Korea 2Food Science and Nutrition, Dongseo University, 47 Jurye-ro, Sasang-gu, Busan 47011, Korea BACKGROUND/OBJECTIVES: Spirulina, a blue-green alga, is widely produced and commercialized as a dietary supplement with  bio- and immune-modulatory functions.",Non-OADS,/arxiv_data1/oa_pdf/af/2d/nrp-10-418.PMC4958645.pdf
"Nutrition Research and Practice 2016;10(4):424-432 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Perception and practice regarding allergen labeling: focus on  food-related employees Si-Eun Park1, Yong-Seok Kwon2, Jin-Kyoung Paik1, Tong-Kyung Kwak3* and Wan-Soo Hong1*§ 1Department of Foodservice Management and Nutrition, Sangmyung University, 20 Hongjimun 2-gil, Jongno-gu, Seoul 03016, Korea  2Research Institute of Natural Science, Sangmyung University, Seoul 03016, Korea 3Department of Food and Nutrition, Yo nsei University, Seoul 03722, Korea BACKGROUND/OBJECTIVES:  Most consumers are able to recognize allergenic foods.",Non-OADS,/arxiv_data1/oa_pdf/2e/4f/nrp-10-424.PMC4958646.pdf
"Nutrition Research and Practice 2016;10(4):433-441 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Development and evaluation of a dish-based semiquantitative food  frequency questionnaire for Korean adolescents Jinhee Yum and Seungmin Lee§ Department of Food and Nutrition, Sungshin Women’s University, 55, Dobong-ro 76 ga-gil, Gangbuk-gu, Seoul 01133, Korea BACKGROUND/OBJECTIVES: The purpose of this study was to develop a dish-based semiquantitative food frequency questionnaire  (FFQ) for Korean adolescents and evaluate its reproducibility and validity.SUBJECTS/METHODS: Based on 24-hour dietary recall data from the 4th Korean National Health and Nutrition Examination  Survey (KNHANES), we developed a FFQ with 71 items.",Non-OADS,/arxiv_data1/oa_pdf/a9/20/nrp-10-433.PMC4958647.pdf
"Nutrition Research and Practice 2016;10(4):442-447 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   A study on blood lipid profiles, aluminum and mercury levels in  college students Eunim Jung1,5, Whajin Hyun2, Yoona Ro3, Hongmie Lee4 and Kyunghee Song5,6§ 1Department of Nutrition Team, Soonchunhyang University Bucheon Hospital, Gyeonggi 14584, Korea 2Department of Food and Nutrition, Jo ongbu University, Chungnam 32713, Korea 3Columbia University, 116th Street and Broadway, New York, NY10027, USA  4Department of Food and Nutrition, Da ejin University, Gyeonggi 11159, Korea 5Department of Food and Nutrition, Myongji University, 116,  Myongji-ro, Cheoin-gu, Yongin-si, Gyeonggi 17058, Korea 6Graduate School of Education, Myongji University, Seoul 03674, Korea BACKGROUND/OBJECTIVES: College students are in a period of transition from adolescence to adulthood, in which proper  dietary habits and balanced nutritional intake are very important.",Non-OADS,/arxiv_data1/oa_pdf/c6/20/nrp-10-442.PMC4958648.pdf
"Nutrition Research and Practice 2016;10(4):448-455 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Nutritional aspects of night eating and its association with weight  status among Korean adolescents Emely Hernandez1, Meeyoung Kim1, Won Gyoung Kim1 and Jihyun Yoon1,2§ 1Department of Food and Nutrition, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea 2Research Institute of Human Ecology, Seoul National University, Seoul 08826, Korea BACKGROUND/OBJECTIVES: A growing body of research has indicated that night eating could be associated with poor diet  quality and negative health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d7/8c/nrp-10-448.PMC4958649.pdf
Available from: http://www.index.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/d7/8c/nrp-10-448.PMC4958649.pdf
"Nutrition Research and Practice 2016;10(4):456-463 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Evaluation of emotion-based messages designed to motivate  Hispanic and Asian parents of early adolescents to engage in  calcium-rich food and beverage parenting practices Jinan Corinne Banna1§, Marla Reicks2, Carolyn Gunther3, Rickelle Richards4, Christine Bruhn5, Mary Cluskey6, Siew Sun Wong6,  Scottie Misner7, Nobuko Hongu7 and N Paul Johnston8 1Department of Human Nutrition, Food and Animal Sciences, 1955 East West Road, Agricultural Sciences 216, University of Hawaii a t Manoa, Honolulu, HI 96822, USA 2Food Science and Nutrition, University of Minnesota, Minneapolis, MN 55455, USA 3Department of Human Nutrition, The Ohio State University, Columbus, OH 43210, USA 4Department of Nutrition, Dietetics and Food Scienc e, Brigham Young University, Provo, UT 84602, USA 5Center for Consumer Research, Food Science and Technology, University of California-Davis, Davis, CA 95616, USA 6Nutrition, School of Biological and Population Health Sc iences, Oregon State University, Corvallis, OR 97331, USA 7Department of Nutritional Sciences, University of Arizona, Tucson, AZ 85721, USA 8Department of Nutrition, Dietetics and Food Scienc e, Brigham Young University, Provo, UT 84602, USA  BACKGROUND/OBJECTIVES:  Setting healthful beverage expectations, making calcium-rich foods and beverages (CRF/B) available,  and role modeling are parenting practices promoting calcium intake among early adolescents.",Non-OADS,/arxiv_data1/oa_pdf/51/fa/nrp-10-456.PMC4958650.pdf
Available from: http://ncsu.edu/ffci/publications/2008/v13-n3-2008-winter/  cluskey-auld-adlefsen-zaghloul -bock-bouskey-bruhn-goldberg-  nisner-olson-reicks.php.,Non-OADS,/arxiv_data1/oa_pdf/51/fa/nrp-10-456.PMC4958650.pdf
"Nutrition Research and Practice 2016;10(4):464-470 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The Effects of industrial workers' food choice attribute on sugar  intake pattern and job satisfaction with Structural Equcation Model Young Il Park and Nami Joo§ Department of Food and Nutrition, Sookmyung Women’s University, Chungpa-ro 47-gil, Yongsan-gu, Seoul 04310, Korea BACKGROUND/OBJECTIVES:  This research analyzes the effects of the food choices of industrial workers according to their sugar  intake pattern on their job satisfaction through the construction of a model on the relationship between sugar intake pattern and job satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/ae/2e/nrp-10-464.PMC4958651.pdf
"Nutrition Research and Practice 2016;10(4):471 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Erratum: Health Blief Model-based intervention to improve nutritional  behavior among elderly women Jamileh Amirzadeh Iranagh1, Hejar Abdul Rahman2 and Seyedeh Ameneh Motalebi3 1Faculty of Public Health, Urmia University of Medical Sciences, 5714783734, Urmia, Iran 2Faculty of Medical and Health Sciences, Uneversiti Putr a Malaysia (UPM), 43400, Serdang, Selangor, Malaysia 3Faculty of Public Health, Urmia University of Medical Sciences, 5714783734, Urmia, Iran Nutrition Research and Practice 2016;10(4):471; doi:10.4162/nrp.2016.10.4.471; pISSN 1976-1457 eISSN 2005-6168 To the Editor, There was an error in our published article titled “Health Blief Model-based intervention to improve nutritional behavior among   elderly women” Nutrition Research and Practice 2016 May 11; pISSN 1976-1457 eISSN 2005-6168 We made a mistake in presenting author affiliations.",Non-OADS,/arxiv_data1/oa_pdf/05/c8/nrp-10-471.PMC4958652.pdf
"Review Article Obstet Gynecol Sci 2016;59(4):253-260 http://dx.doi.org/10.5468/ogs.2016.59.4.253 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 253Introduction Pelvic organ prolapse (POP) is a common condition, affecting  approximately half of parous women, and correlates with in - creasing age [1].",Non-OADS,/arxiv_data1/oa_pdf/d7/02/ogs-59-253.PMC4958670.pdf
"Corresponding author: Sang Wook Bai Department of Obstetrics and Gynecology, Institute of Women’s Life  Medical Science, Y onsei University College of Medicine, 50-1 Y onsei-ro,  Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2230  Fax: +82-2-313-8350 E-mail: swbai@yuhs.ac http://orcid.org/ 0000-0001-7724-7552",Non-OADS,/arxiv_data1/oa_pdf/d7/02/ogs-59-253.PMC4958670.pdf
Original  Article Obstet Gynecol Sci 2016;59(4):261-268 http://dx.doi.org/10.5468/ogs.2016.59.4.261 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 261Introduction Ovarian cancer is the most lethal malignancy of the female  reproductive system.,Non-OADS,/arxiv_data1/oa_pdf/46/25/ogs-59-261.PMC4958671.pdf
"Corresponding author: Chi-Heum Cho Department of Obstetrics and Gynecology, Keimyung University School  of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea Tel: +82-53-250-7518  Fax: +82-53-250-7599  E-mail: chcho@kmu.ac.kr http://orcid.org/ 0000-0002-0437-4099",Non-OADS,/arxiv_data1/oa_pdf/46/25/ogs-59-261.PMC4958671.pdf
"Original  Article Obstet Gynecol Sci 2016;59(4):269-278 http://dx.doi.org/10.5468/ogs.2016.59.4.269 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 269Introduction Cervical cancer is a malignant disease that develops in the  cervix; with increasing use of the Pap smear for screening,  the incidence and mortality rate have decreased significantly.",Non-OADS,/arxiv_data1/oa_pdf/4d/d8/ogs-59-269.PMC4958672.pdf
"Corresponding author: Y oun Seok Choi  Department of Obstetrics and Gynecology, Catholic University of  Daegu School of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu,  Daegu 42472, Korea Tel: +82-53-650-4087  Fax: +82-53-650-4078 E-mail: drcys@cu.ac.kr http://orcid.org/ 0000-0001-8901-9434",Non-OADS,/arxiv_data1/oa_pdf/4d/d8/ogs-59-269.PMC4958672.pdf
"Original  Article Obstet Gynecol Sci 2016;59(4):279-285 http://dx.doi.org/10.5468/ogs.2016.59.4.279 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 279Introduction Ovarian cancer is a malignant gynecological disease, with  >70% of patients diagnosed at an advanced stage [1].",Non-OADS,/arxiv_data1/oa_pdf/c0/c7/ogs-59-279.PMC4958673.pdf
"Corresponding author: Seung Cheol Kim Department of Obstetrics and Gynecology, Ewha Womans  University Mokdong Hospital, Ewha Womans University School  of Medicine, 1071 Anyangcheon-ro, Y angcheon-gu, Seoul 07985,  Korea Tel: +82-2-2650-5587  Fax: +82-2-2650-5963 E-mail: onco@ewha.ac.kr http://orcid.org/ 0000-0002-5000-9914",Non-OADS,/arxiv_data1/oa_pdf/c0/c7/ogs-59-279.PMC4958673.pdf
http://dx.doi.org/10.1111/ pedi.12276 .,Non-OADS,/arxiv_data1/oa_pdf/c0/c7/ogs-59-279.PMC4958673.pdf
Original  Article Obstet Gynecol Sci 2016;59(4):286-294 http://dx.doi.org/10.5468/ogs.2016.59.4.286 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 286Introduction Endometriosis is a common gynecological disorder caused by  ectopic implantation of endometrial glandular and stromal  cells outside the uterine cavity [1-3].,Non-OADS,/arxiv_data1/oa_pdf/79/d1/ogs-59-286.PMC4958674.pdf
"Corresponding author: Ji Sung Lee Department of Obstetrics and Gynecology, Gachon University College  of Medicine, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon  21565, Korea Tel: +82-32-460-3254  Fax: +82-32-460-3290 E-mail: dongwook@gilhospital.com http://orcid.org/ 0000-0002-2076-7634",Non-OADS,/arxiv_data1/oa_pdf/79/d1/ogs-59-286.PMC4958674.pdf
"Original  Article Obstet Gynecol Sci 2016;59(4):295-302 http://dx.doi.org/10.5468/ogs.2016.59.4.295 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 295Introduction For women with ovarian tumors, a number of diagnostic in - dexes are combined with different variables.",Non-OADS,/arxiv_data1/oa_pdf/4f/8c/ogs-59-295.PMC4958675.pdf
"Corresponding author: Byung Chul Jee Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7254  Fax: +82-31-787-4054 E-mail: blasto@snubh.org http://orcid.org/ 0000-0003-2289-6090",Non-OADS,/arxiv_data1/oa_pdf/4f/8c/ogs-59-295.PMC4958675.pdf
Short Communication Obstet Gynecol Sci 2016;59(4):303-306 http://dx.doi.org/10.5468/ogs.2016.59.4.303 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 303Introduction Preterm delivery <37 weeks is a great problem of public health  in worldwide with high rates of neonatal morbidity and mor - tality [1].,Non-OADS,/arxiv_data1/oa_pdf/59/07/ogs-59-303.PMC4958676.pdf
"111 Torre Vitoria, São  Paulo-SP , CEP 05089-030, Brazil  Tel: +55-11-37965944  Fax: +55-11-37965944  E-mail: araujojred@terra.com.br  http://orcid.org/ 0000-0002-6145-2532",Non-OADS,/arxiv_data1/oa_pdf/59/07/ogs-59-303.PMC4958676.pdf
"Short Communication Obstet Gynecol Sci 2016;59(4):307-310 http://dx.doi.org/10.5468/ogs.2016.59.4.307 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 307Introduction Accidental exposure of oocyte to endometriotic fluid is an  uncommon but possible event during oocyte retrieval with an  incidence of 2.8% to 6.1% [1,2].",Non-OADS,/arxiv_data1/oa_pdf/16/dd/ogs-59-307.PMC4958677.pdf
"Corresponding author: Byung Chul Jee Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7254  Fax: +82-31-787-4054 E-mail: blasto@snubh.org http://orcid.org/ 0000-0003-2289-6090",Non-OADS,/arxiv_data1/oa_pdf/16/dd/ogs-59-307.PMC4958677.pdf
"Case Report Obstet Gynecol Sci 2016;59(4):311-315 http://dx.doi.org/10.5468/ogs.2016.59.4.311 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 311Introduction Adenomyosis, is characterized by heterotopic endometrial  glands and stroma in the myometrium, and is an established  cause of menorrhagia, dysmenorrhea and pelvic pressure  symptoms [1].",Non-OADS,/arxiv_data1/oa_pdf/cf/6c/ogs-59-311.PMC4958678.pdf
"Corresponding author: Yong  Soon Kwon Department of Obstetrics and Gynecology, Ulsan University Hospital,  University of Ulsan College of Medicine, 877 Bangeojinsunwhan-doro,  Dong-gu, Ulsan 44033, Korea Tel: +82-52-250-8786  Fax: +82-52-250-7168 E-mail: kbongchun@hanmail.net http://orcid.org/ 0000-0002-5754-6018",Non-OADS,/arxiv_data1/oa_pdf/cf/6c/ogs-59-311.PMC4958678.pdf
Case Report Obstet Gynecol Sci 2016;59(4):316-318 http://dx.doi.org/10.5468/ogs.2016.59.4.316 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 316Introduction Heterotopic pregnancy (HP) is a rare and fatal condition.,Non-OADS,/arxiv_data1/oa_pdf/5f/08/ogs-59-316.PMC4958679.pdf
"Corresponding author: Won Joon Seong Department of Obstetrics and Gynecology, Kyungpook National  University Hospital, Kyungpook National University School of Medicine,  130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea  Tel: +82-53-420-5724  Fax: +82-53-423-7905 E-mail: wjseong@knu.ac.kr  http://orcid.org/ 0000-0002-8088-2554",Non-OADS,/arxiv_data1/oa_pdf/5f/08/ogs-59-316.PMC4958679.pdf
Case Report Obstet Gynecol Sci 2016;59(4):319-322 http://dx.doi.org/10.5468/ogs.2016.59.4.319 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 319Introduction Cervical incompetence causes repeated painless mid-trimester  losses or preterm deliveries [1].,Non-OADS,/arxiv_data1/oa_pdf/74/15/ogs-59-319.PMC4958680.pdf
"Corresponding author: Yong Soon Kwon Department of Obstetrics and Gynecology, Ulsan University Hospital,  University of Ulsan College of Medicine, 877 Bangeojinsunwhan-doro,  Dong-gu, Ulsan 44033, Korea Tel: +82-52-250-8786  Fax: +82-52-250-7168 E-mail: kbongchun@hanmail.net http://orcid.org/ 0000-0002-5754-6018",Non-OADS,/arxiv_data1/oa_pdf/74/15/ogs-59-319.PMC4958680.pdf
Case Report Obstet Gynecol Sci 2016;59(4):323-327 http://dx.doi.org/10.5468/ogs.2016.59.4.323 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 323Introduction Endometrial stromal sarcoma (ESS) is a rare form of uterine  sarcoma.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/ogs-59-323.PMC4958681.pdf
"Accepted: 2016.2.8 Corresponding author: Seok Mo Kim Department of Obstetrics and Gynecology, Chonnam National  University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-61-379-7687  Fax: +82-62-227-1637 E-mail: Seokmo2001@hanmail.net http://orcid.org/ 0000-0003-2318-0334",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/ogs-59-323.PMC4958681.pdf
Case Report Obstet Gynecol Sci 2016;59(4):328-332 http://dx.doi.org/10.5468/ogs.2016.59.4.328 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 328Introduction Few studies have been published on female adnexal tumors  of probable Wolffian origin (FATWO) since the first report in  1973 by Kariminejad and Scully [ 1].,Non-OADS,/arxiv_data1/oa_pdf/4b/94/ogs-59-328.PMC4958682.pdf
"Corresponding author: Min Kyu Kim Department of Obstetrics and Gynecology, Samsung Changwon  Hospital, Sungkyunkwan University School of Medicine, 158  Paryong-ro, Masanhoewon-gu, Changwon 51353, Korea Tel: +82-55-290-6040  Fax: +82-2-6442-9285 E-mail: minkyukim@skku.edu http://orcid.org/ 0000-0002-1937-3611",Non-OADS,/arxiv_data1/oa_pdf/4b/94/ogs-59-328.PMC4958682.pdf
Case Report Obstet Gynecol Sci 2016;59(4):333-336 http://dx.doi.org/10.5468/ogs.2016.59.4.333 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 333Introduction Ovarian tumors are rare in children and adolescents.,Non-OADS,/arxiv_data1/oa_pdf/a7/24/ogs-59-333.PMC4958683.pdf
"Corresponding author: Ki Heon Lee Department of Obstetrics and Gynecology, Cheil General Hospital &  Women’s Healthcare Center, Dankook University College of Medicine,   17 Seoae-ro 1-gil, Jung-gu, Seoul 04619, Korea Tel: +82-2-2000-7283  Fax: +82-2-2000-7183 E-mail: 1103khl@hanmail.net http://orcid.org/ 0000-0002-4079-9035",Non-OADS,/arxiv_data1/oa_pdf/a7/24/ogs-59-333.PMC4958683.pdf
"Case Report Obstet Gynecol Sci 2016;59(4):337-341 http://dx.doi.org/10.5468/ogs.2016.59.4.337 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 337Introduction Several tubal occlusion methods are now available for per - manent female contraception, using either a transcervical or  transabdominal approach.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/ogs-59-337.PMC4958684.pdf
"Corresponding author: E. Scott Sills  Reproductive Research Section, Center for Advanced Genetics,   3144 El Camino Real, Suite 106, Carlsbad, CA 92008, USA    Tel: +1-760-994-0156  Fax: +1-760-994-0159 E-mail: drsills@CAGivf.com http://orcid.org/0000-0001-7334-1031",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/ogs-59-337.PMC4958684.pdf
Available from: https://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=4531887 .,OADS,/arxiv_data1/oa_pdf/9b/1e/ogs-59-337.PMC4958684.pdf
"Case Report Obstet Gynecol Sci 2016;59(4):342-345 http://dx.doi.org/10.5468/ogs.2016.59.4.342 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 342Introduction Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a mal - formation of the female genitals characterized by normal  female phenotype, vaginal agenesis, a rudimentary or absent  uterus and normal ovaries [1].",Non-OADS,/arxiv_data1/oa_pdf/20/d9/ogs-59-342.PMC4958685.pdf
"Corresponding author: Miran Kim Department of Obstetrics and Gynecology, Ajou University School of  Medicine, 164 World cup-ro, Y eongtong-gu, Suwon 16499, Korea Tel: +82-31-219-5300  Fax: +82-31-219-5245 E-mail: kmr5300@ajou.ac http://orcid.org/ 0000-0001-5553-5334",Non-OADS,/arxiv_data1/oa_pdf/20/d9/ogs-59-342.PMC4958685.pdf
http://dx.doi.org/10.1016/j.jpedsurg.2015.09.014.,OADS,/arxiv_data1/oa_pdf/20/d9/ogs-59-342.PMC4958685.pdf
"247 http://dx.doi.org/10.3345/kjp.2016.59.6.247Korean J Pediatr 2016;59(6):247-251 Nutritional concerns in pediatric inflammatory  bowel disease Yong Joo Kim, MD, PhD Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea The pathophysiology and fundamental etiologic mechanism of inflammatory bowel disease (IBD) is  not well understood even though therapeutic regimens and drugs are rapidly evolutionary.",Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
"Cytokines Retardation of growth and delayed pubertal development are one of the major nutri -Corresponding author: Yong Joo Kim, MD, PhD Department of Pediatrics, Hanyang University  College of Medicine, 222-1 Wangsimni-ro, Seong - dong-gu, Seoul 04763, Korea Tel: +82-2-2290-8390 Fax: +82-2-2297-2380 E-mail: kyjoo@hanyang.ac.kr Received: 14 October, 2015 Revised: 15 December, 2015 Accepted: 16 December, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrReview article Korean J Pediatr 2016;59(6):247-251 http://dx.doi.org/10.3345/kjp.2016.59.6.247 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.247Kim YJ  • Nutritional concerns in pediatric inflammatory bowel disease 248tional issues in the children and adolescents with IBD, especially  with CD.",Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
"249 http://dx.doi.org/10.3345/kjp.2016.59.6.247Korean J Pediatr 2016;59(6):247-251 Important nutritional concerns in pediatric IBD are (1) enteral  nutrition (elemental nutrition), (2) total parenteral nutrition, (3)  supplement of deficient nutrients-protein, vitamins (A, D, E, K,  B12, folate), minerals (iron, zinc, calcium, phosphorus, magnesium,  kalium), (4) avoidance of symptom-aggravating foods17-20).",Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.247Kim YJ  • Nutritional concerns in pediatric inflammatory bowel disease 250by deficiencies of vitamin B1, vitamin B2, and pantothenic acid.",Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
251 http://dx.doi.org/10.3345/kjp.2016.59.6.247Korean J Pediatr 2016;59(6):247-251  5.,Non-OADS,/arxiv_data1/oa_pdf/58/2e/kjped-59-247.PMC4958701.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.252Kim KR, et al.",OADS,/arxiv_data1/oa_pdf/b2/01/kjped-59-252.PMC4958702.pdf
"It has been reported that Corresponding author: Yae-Jean Kim, MD, PhD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 16351, Korea  Tel: +82-2-3410-3539 Fax: +82-2-3410-0043 E-mail: yaejeankim@skku.edu  Received: 18 July, 2015 Revised: 25 December, 2015 Accepted: 29 December, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(6):252-255 http://dx.doi.org/10.3345/kjp.2016.59.6.252 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/b2/01/kjped-59-252.PMC4958702.pdf
253 http://dx.doi.org/10.3345/kjp.2016.59.6.252Korean J Pediatr 2016;59(6):252-255 up to 43% of children with cancer developed PCP before the  era of trimethoprim/sulfamethoxazole (TMP/SMX) prophylaxis  and nowadays its occurrence is much less with prophylaxis3).,Non-OADS,/arxiv_data1/oa_pdf/b2/01/kjped-59-252.PMC4958702.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.252Kim KR, et al.",OADS,/arxiv_data1/oa_pdf/b2/01/kjped-59-252.PMC4958702.pdf
"255 http://dx.doi.org/10.3345/kjp.2016.59.6.252Korean J Pediatr 2016;59(6):252-255 traditional medication, newer option would be needed.",Non-OADS,/arxiv_data1/oa_pdf/b2/01/kjped-59-252.PMC4958702.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.256Yun KW, et al.",OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
"Until the early 2000’s, the only test available for LTBI was the tuberculin skin Corresponding author: Ki Wook Yun, MD, PhD Department of Pediatrics, Seoul National University  Children’s Hospital, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea Tel: +82-2-2072-4909 Fax: +82-2-766-7283 E-mail: pedwilly@snu.ac.kr Received: 15 October, 2015 Revised: 27 February, 2016 Accepted: 13 March, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(6):256-261 http://dx.doi.org/10.3345/kjp.2016.59.6.256 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
257 http://dx.doi.org/10.3345/kjp.2016.59.6.256Korean J Pediatr 2016;59(6):256-261 test (TST)2).,OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
Docu - mentation of bacillus Calmette-Guérin (BCG) vaccination was  confirmed using records from immunization diaries or an online  site of Korean national immunization program (https://nip.cdc.,Non-OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.256Yun KW, et al.",OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
"259 http://dx.doi.org/10.3345/kjp.2016.59.6.256Korean J Pediatr 2016;59(6):256-261 antigen was significantly increased, resulting in the increased  IGRA value (Fig.",OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.256Yun KW, et al.",OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
261 http://dx.doi.org/10.3345/kjp.2016.59.6.256Korean J Pediatr 2016;59(6):256-261 Conflict of interest No potential conflict of interest relevant to this article was  reported.,OADS,/arxiv_data1/oa_pdf/ad/59/kjped-59-256.PMC4958703.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.262Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"Increased myocyte number, dimension and myocardial Corresponding author: Young Mi Hong, MD Department of Pediatrics, Ewha Womans Univer - sity School of Medicine, 1071 Anyangcheon-ro,  Yangcheon-gu, Seoul 07985, Korea Tel: +82-2-2650-2841 Fax: +82-2-2653-3718 E-mail:ymhong@ewha.ac.kr  Received: 14 March, 2016 Revised: 25 April, 2016 Accepted: 10 May, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(6):262­270 http://dx.doi.org/10.3345/kjp.2016.59.6.262 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
263 http://dx.doi.org/10.3345/kjp.2016.59.6.262Korean J Pediatr 2016;59(6):262-270 extracellular matrix can also be noted4).,OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.262Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"265 http://dx.doi.org/10.3345/kjp.2016.59.6.262Korean J Pediatr 2016;59(6):262-270 group, 0.75 ±0.06 g vs. 0.32 ±0.03 g, P<0.05) after MCT injection.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.262Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
267 http://dx.doi.org/10.3345/kjp.2016.59.6.262Korean J Pediatr 2016;59(6):262-270 eNOS   1w  2w  4w C M S  00.10.20.30.40.50.60.70.80.9 1wk 2wk 4wkC M SeNOS   ET-1  1w  2w  4w C M S ET-1  00.20.40.60.811.2 1wk 2wk 4wkC M S †  † MMP -2  1w  2w  4w C M S  00.20.40.60.811.21.4 1wk 2wk 4wkC M SMMP -2  †  G H I  †  1w  2w  4w C M S ERA  00.10.20.30.40.50.60.70.80.91 1wk 2wk 4wkC M S †  1w  2w  4w C M S  C  M  S  050100150200250 1w 2w 4w β-actin  J K BNP Troponin -I  1w  2w  4w 1w  2w  4w C M S C M S  00.20.40.60.811.21.4 1wk 2wk 4wkC M S 00.20.40.60.811.21.41.61.8 1wk 2wk 4wkC M S BNP Troponin -I  †  † Caspase -3  1w  2w  4w C M S  00.10.20.30.40.50.60.70.80.9 1wk 2wk 4wkC M SCaspase -3  †  † A B C  Bcl-2  1w  2w  4w C M S  00.10.20.30.40.50.60.70.8 1wk 2wk 4wkC M SBcl-2  † TNF-α  1w  2w  4w C M S  00.20.40.60.811.2 1wk 2wk 4wkC M STNF-a †  IL-6  1w  2w  4w C M S IL-6  00.10.20.30.40.50.60.70.80.9 1wk 2wk 4wkC M S †  D E F  ERA  β-actin   Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.262Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
269 http://dx.doi.org/10.3345/kjp.2016.59.6.262Korean J Pediatr 2016;59(6):262-270 cGMP and calcium signaling28).,OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.262Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/d9/aa/kjped-59-262.PMC4958704.pdf
"271 http://dx.doi.org/10.3345/kjp.2016.59.6.271Korean J Pediatr 2016;59(6):271-275 Clinical importance of F-waves as a prognostic  factor in Guillain-Barré syndrome in children Eung-Bin Lee, MD1, Yun Young Lee, MD1, Jae Min Lee, MD1, Su Min Son, MD2, Su-Kyeong Hwang, MD3, Soonhak Kwon, MD3, Sae Yoon  Kim, MD1 Departments of 1Pediatrics and 2Physical Medicine and Rehabilitation, Yeungnam University College of Medicine, Daegu, 3Department of Pediatrics, Kyungpook  National University Children's Hospital, Kyungpook National University School of Medicine, Daegu, Korea Purpose: A limited number of studies have examined the link between F-wave abnormalities and  clinical presentation in pediatric Guillain-Barré syndrome (GBS).",Non-OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
"An F-wave study is often used to measure nerve conduction velocity and is particularly Corresponding author: Sae Yoon Kim, MD Department of Pediatrics, Yeungnam University  Medical Center, 170 Hyeonchung-ro, Nam-gu,  Daegu 42415, Korea Tel: +82-53-620-3533 Fax: +82-53-629-2252 E-mail: sysnow88@hanmail.net Received: 1 September, 2015 Revised: 22 October, 2015 Accepted: 9 November, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(6):271-275 http://dx.doi.org/10.3345/kjp.2016.59.6.271 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.271Lee EB, et al.",OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
273 http://dx.doi.org/10.3345/kjp.2016.59.6.271Korean J Pediatr 2016;59(6):271-275 autoantibody tests.,OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.271Lee EB, et al.",OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
275 http://dx.doi.org/10.3345/kjp.2016.59.6.271Korean J Pediatr 2016;59(6):271-275 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/29/91/kjped-59-271.PMC4958705.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.276Tavasoli A, et al.",OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
"Corresponding author: Shirin Sayyahfar, MD Department of Pediatrics, Iran University of Medical  Sciences, Ali Asghar Children Hospital, Vahid Dast - gerdi Street, Shariati Street, Tehran 1919816766,  Iran Tel: +98 -21-22255218 Fax: +98-21-22220063 E-mail: sayyahfar.sh@iums.ac.ir Received: 19 January, 2014 Revised: 7 May, 2014 Accepted: 15 August, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(6):276-279 http://dx.doi.org/10.3345/kjp.2016.59.6.276 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
"277 http://dx.doi.org/10.3345/kjp.2016.59.6.276Korean J Pediatr 2016;59(6):276-279 Case report A 2-year-old boy was referred to our hospital due to develop - mental delay, ichthyosis, asthma, and recurrent pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.276Tavasoli A, et al.",OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
279 http://dx.doi.org/10.3345/kjp.2016.59.6.276Korean J Pediatr 2016;59(6):276-279 [cited 2013 Jun 2].,OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
Available from: http://emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
Available from:  http://www.ginasthma.org/documents/5/documents_variants/37.,OADS,/arxiv_data1/oa_pdf/81/1f/kjped-59-276.PMC4958706.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.280Yang IY, et al.",OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
"Case 1 A 5­year­old boy presented with headache, vomiting, and seizure­like motion, although Corresponding author: Tae-Sung Ko, MD, PhD Department of Pediatrics, Asan Medical Center  Children’s Hospital, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul  05505, Korea Tel: +82-2-3010-3386 Fax: +82-2-473-3725 E-mail: tsko@amc.seoul.kr Received: 9 July, 2014 Revised: 7 August, 2014 Accepted: 22 August, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(6):280­284 http://dx.doi.org/10.3345/kjp.2016.59.6.280 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
281 http://dx.doi.org/10.3345/kjp.2016.59.6.280Korean J Pediatr 2016;59(6):280-284 he was without a history of trauma.,Non-OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.280Yang IY, et al.",OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
"283 http://dx.doi.org/10.3345/kjp.2016.59.6.280Korean J Pediatr 2016;59(6):280-284 and neuroradiological features, and after which the recent  development of genetic linkage analysis has allowed the full  description of CCMs.",OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.6.280Yang IY, et al.",OADS,/arxiv_data1/oa_pdf/ab/1d/kjped-59-280.PMC4958707.pdf
This was achieved byfocusing on splicing and exonic variants (excludingsynonymous) and removing the variants that werepresent with a frequency higher than 1% in the 1000Genomes project (http://www.1000genomes.org/; data from April 2012) and/or in the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/;data from January 2013) because they are more likelyto be germline.,Non-OADS,/arxiv_data1/oa_pdf/bc/4f/CJP2-2-166.PMC4958737.pdf
[Online] Available: http://physics.nist.gov/XrayTrans.,OADS,/arxiv_data1/oa_pdf/06/30/CJP2-2-175.PMC4958738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/0d/aww130.PMC4958899.pdf
"Data were then ﬁltered to include only low frequency coding variants present in 41% of the control population, ExAC database (http://exac.broadinstitute.org/), and compatible with an autosomal recessive mode of inheritance as this ﬁts with both pedigrees analysed.",OADS,/arxiv_data1/oa_pdf/e7/0d/aww130.PMC4958899.pdf
Available from: http://exac.broadinstitute.org.,OADS,/arxiv_data1/oa_pdf/e7/0d/aww130.PMC4958899.pdf
The medial primary motor cortex was extracted from the Neurosynth atlas (http://neuro-synth.org/; Yarkoni et al.,OADS,/arxiv_data1/oa_pdf/11/ed/aww140.PMC4958903.pdf
"Voxel-based morphometry Images were processed with the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm/), of SPM8 software (http://www.ﬁl.",OADS,/arxiv_data1/oa_pdf/11/ed/aww140.PMC4958903.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/92/aww145.PMC4958905.pdf
"Functional MRI processing Functional MRI data were preprocessed and analysed usingAFNI (Analysis of Functional NeuroImages; http://afni.nimh.nih.gov) software packages (Cox, 1996).",OADS,/arxiv_data1/oa_pdf/82/92/aww145.PMC4958905.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32758 - http://dx.doi.org/10.3402/pba.v6.32758 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9e/29/PBA-6-32758.PMC4958916.pdf
"Primate species are shaded in gray.Adam B. Salmon 2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32758 - http://dx.doi.org/10.3402/pba.v6.32758",Non-OADS,/arxiv_data1/oa_pdf/9e/29/PBA-6-32758.PMC4958916.pdf
"Pathobiol Aging Age Relat Dis 2016; 6:31793.Common marmosets as aging primate model Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32758 - http://dx.doi.org/10.3402/pba.v6.32758 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9e/29/PBA-6-32758.PMC4958916.pdf
"Lupus (2016) 25, 699–709 http://lup.sagepub.com PAPER Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care IN Bruce1,2, M Urowitz3, R van Vollenhoven4, C Aranow5, J Fettiplace6, M Oldham7, B Wilson8,*, C Molta9,*, D Roth9and D Gordon9 1Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK;2The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK;3University of Toronto and Toronto Western Hospital, Toronto, ON, Canada;4Karolinska Institute, Stockholm, Sweden;5The Feinstein Institute for Medical Research, Manhasset, NY, USA;6GSK, Uxbridge, Middlesex, UK;7GSK, Stevenage, Hertfordshire, UK;8GSK, Research Triangle Park, NC, USA; and9GSK, Philadelphia, PA, USA Objective: To examine long-term organ damage and safety following treatment with belimumab plus standard of care (SoC) in patients with systemic lupus erythematosus (SLE).",Non-OADS,/arxiv_data1/oa_pdf/cc/19/10.1177_0961203315625119.PMC4958991.pdf
Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav 10.1177/0961203315625119,Non-OADS,/arxiv_data1/oa_pdf/cc/19/10.1177_0961203315625119.PMC4958991.pdf
"Cells 2016; 39(7): 515-523  http://dx.doi.org/10.14348/molcells.2016.0089                    The Role of Lymphatic Niches in T Cell  Differentiation     Tara Capece and Minsoo Kim*      Long-term immunity to many viral and bacterial pathogens  requires CD8+ memory T cell development, and the induc- tion of long-lasting CD8+ memory T cells from a naïve, un- differentiated state is a major goal of vaccine design.",Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
"Below this layer is the cortex, which can be divided Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
Cells http://molcells.org     into two regions – the follicular cortex (outer cortex) and the  paracortex (inner cortex).,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
The Role of Lymphatic Niches in T Cell Differentiation  Tara Capece & Minsoo Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
Cells http://molcells.org      B  A                       C     E               D           Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
The Role of Lymphatic Niches in T Cell Differentiation  Tara Capece & Minsoo Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
Cells http://molcells.org     intact organs to be chemically processed and stained with dif- ferent antibodies up to 22 times.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
The Role of Lymphatic Niches in T Cell Differentiation  Tara Capece & Minsoo Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
Cells http://molcells.org     and function of the stem cell niche.,OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
The Role of Lymphatic Niches in T Cell Differentiation  Tara Capece & Minsoo Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a8/9e/molce-39-7-515.PMC4959015.pdf
"Cells 2016; 39(7): 524-529  http://dx.doi.org/10.14348/molcells.2016.0105                    Control of Asymmetric Cell Divisions during Root  Ground Tissue Maturation     Ji Won Choi, and Jun Lim *      Controlling the production of diverse cell/tissue types is  essential for the development of multicellular organisms such as animals and plants.",OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
"Since the production of the MC layer during root GT matura- tion was first reported (Baum et al., 2002), accumulating evi-   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
Regulation of Root Ground Tissue Maturation  Ji Won Choi & Jun Lim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
"Cells http://molcells.org     cent studies have shown that the root endodermis acts as a hub  for ABA and GA responses (Dinneny, 2014; Duan et al., 2013;  Heo et al., 2011; Lee et al., 2016; Miyashima and Nakajima,  2011; Shani et al., 2013; Ubeda-Tomás et al., 2008; 2009).",OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
Regulation of Root Ground Tissue Maturation  Ji Won Choi & Jun Lim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
"Cells http://molcells.org     et al., 2014).",OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
Regulation of Root Ground Tissue Maturation  Ji Won Choi & Jun Lim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/89/ee/molce-39-7-524.PMC4959016.pdf
"Cells 2016; 39(7): 530-535  http://dx.doi.org/10.14348/molcells.2016.0033                    BK Knockout by TALEN-Mediated Gene Targeting   in Osteoblasts: KCNMA1 Determines the Proliferation and Differentiation of Osteoblasts    Hongya Hei1,5, Jianjun Gao2,5, Jibin Dong1, Jie Tao3, Lulu Tian1, Wanma Pan1, Hongyu Wang4, and  Xuemei Zhang1,*     Large conductance calcium-activated potassium (BK)  channels participate in many important physiological func- tions in excitable tissues such as neurons, cardiac and smooth muscles, whereas the knowledge of BK channels  in bone tissues and osteoblasts remains elusive.",Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
"Considering the possible role of osteoblasts in bone formation and bone related diseases (Long, 2012), we  intended to investigate the function of BK channels in osteo- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
"Briefly, the left arm and right arm of TALENs that target  KCNMA1 gene were designed on the website (https://tale-nt.cac.cornell.edu/).",OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
Cells http://molcells.org      Table 2.,OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/63/molce-39-7-530.PMC4959017.pdf
"Cells 2016; 39(7): 536-542  http://dx.doi.org/10.14348/molcells.2016.0048                    The Membrane-Bound Form of IL-17A Promotes   the Growth and Tumorigenicity of Colon Cancer  Cells     Do Thi Van Anh1,3, Sang Min Park1,3, Hayyoung Lee2,*, and Young Sang Kim1,*      Interleukin-17A is a member of the IL-17 family, and is  known as CTLA8 in the mouse.",Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
In present study we  investigated whether expression of the membrane-bound form of IL-17A on CT26 colon cancer cells promotes or inhibits their Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
"Cells http://molcells.org      RESULTS    Expression of secretory and membrane-bound IL-17A in  CT26 colon cancer cells  To define the role of IL-17A in cancer cells we used murine CT26 colorectal carcinoma cells, which are derived from  BALB/c mice.",OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
Cells http://molcells.org     expression.,OADS,/arxiv_data1/oa_pdf/9a/6c/molce-39-7-536.PMC4959018.pdf
"Cells 2016; 39(7): 543-549  http://dx.doi.org/10.14348/molcells.2016.0050                    MiR-144-3p and Its Target Gene β-Amyloid  Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial  Dysfunction     Kuo Li1, Junling Zhang1, Chunxue Ji1, and Lixuan Wang*      MicroRNAs (miRNAs) have been reported to be involved in  many neurodegenerative diseases.",OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
"MicroRNAs (miRNAs) are a group of small, single-stranded  and non-coding RNAs which have been identified as post- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
"Cells http://molcells.org     transcriptional regulators of gene expression (Graves and Zeng,  2012).",OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
MiR-144-3p target prediction  The putative target gene of miR-144-3p was predicted using  TargetScan (http://www.targetscan.org/) and microRNA.org (http://www.microrna.org/microrna /home.do/).,OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
The interaction  between the mRNA 3 ′-untranslated region (UTR) of the pre- dicted gene and miR-144-3p was analyzed by RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/).,OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/ee/molce-39-7-543.PMC4959019.pdf
"Cells 2016; 39(7): 550-556  http://dx.doi.org/10.14348/molcells.2016.0069                    Hop2 and Sae3 Are Required for Dmc1-Mediated  Double-Strand Break Repair via Homolog Bias during Meiosis     Hong-Rae Cho1,2, Yoon-Ju Kong1,2, Soo-Gil Hong1,2, and Keun Pil Kim1,*      During meiosis, exchange of DNA segments occurs be- tween paired homologous chromosomes in order to pro-duce recombinant chromosomes, helping to increase ge- netic diversity within a species.",OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
"Therefore,  the Hop2-Mnd1 and Mei5-Sae3 complexes may be essential for homolog bias mediated by Dmc1-dependent recombination Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
Cells http://molcells.org     Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
Cells http://molcells.org      A              B                                                          Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
"Cells http://molcells.org     and Sung, P. (2008).",OADS,/arxiv_data1/oa_pdf/ae/3f/molce-39-7-550.PMC4959020.pdf
"Cells 2016; 39(7): 557-565  http://dx.doi.org/10.14348/molcells.2016.0079                    Paired Ig-Like Type 2 Receptor-Derived Agonist  Ligands Ameliorate Inflammatory Reactions by Downregulating β1 Integrin Activity     Kyoung-Jin Lee, Dongyoung Lim, Yeon Ho Yoo, Eun-Ji Park, Sun-Hee Lee, Birendra Kumar Yadav,  Yong-Ki Lee, Jeong Hyun Park, Daejoong Kim, Kyeong Han Park*, and Jang-Hee Hahn*     The paired immunoglobulin-like type 2 receptor (PILR)  family consists of two functionally opposite members,  inhibitory PILR α and activating PILR β receptors.",Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
"A previous in vivo  study demon- strated that anti-CD99 antibody inhibited transmigration of acti-vated lymphocytes into inflammatory sites, but did not affect the   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
"Cells http://molcells.org     homing of naïve lymphocytes (Bixel et al., 2004).",Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
Cells http://molcells.org     Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
Cells http://molcells.org     PLA with PILRpep3 treatment.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
Cells http://molcells.org      A                          B                           Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d1/59/molce-39-7-557.PMC4959021.pdf
"Cells 2016; 39(7): 566-572  http://dx.doi.org/10.14348/molcells.2016.0112                    LAMP-3 (Lysosome-Associated Membrane Protein 3)  Promotes the Intracellular Proliferation of Salmonella typhimurium     Eun-Ju Lee1,5, Kwan-Sik Park1,4,5, In-Sook Jeon1, Jae-Woon Choi2, Sang-Jeon Lee2, Hyun E. Choy3,  Ki-Duk Song4, Hak-Kyo Lee4,*, and Joong-Kook Choi1,*     Lysosomes are cellular organelles containing diverse  classes of catabolic enzymes that are implicated in diverse  cellular processes including phagocytosis, autophagy, lipid transport, and aging.",OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
Expression  of LAMP-2 on the cell surface has been implicated in cancer  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
Cells http://molcells.org     Sci.,OADS,/arxiv_data1/oa_pdf/2d/37/molce-39-7-566.PMC4959022.pdf
"Cells 2016; 39(7): 573-579  http://dx.doi.org/10.14348/molcells.2016.0121                    A Pair of Oviduct-Born Pickpocket  Neurons  Important for Egg-Laying in Drosophila melanogaster     Hyunjin Lee1,2, Hyun Woo Choi1,2, Chen Zhang1, Zee-Yong Park1,*, and Young-Joon Kim1,*      During copulation, male Drosophila  transfers Sex Peptide  (SP) to females where it acts on internal sensory neurons expressing pickpocket  (ppk).",Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
"Cells http://molcells.org     MATERIALS AND METHODS     Phosphoprotein analysis  BG2 cells were obtained from Drosophila Genome Resource  Center (Cell line stock number, 51), and cultured according to the protocol form the provider  (https://dgrc.bio.indiana.edu/  include/file/general_maintenance.pdf).",OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3a/fd/molce-39-7-573.PMC4959023.pdf
"1521-0103/358/2/164 –172$25.00 http://dx.doi.org/10.1124/jpet.116.232702 THEJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 358:164 –172, August 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/68/21/jpet.116.232702.PMC4959095.pdf
"1, 12 –28 http://dx.doi.org/10.1080/1750399X.2016.1154340 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3d/79/ritt-10-012.PMC4959122.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/ licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/79/ritt-10-012.PMC4959122.pdf
"ORCID Hanna Risku http://orcid.org/0000-0003-2165-6669 References Abdallah, K. 2011 .“Empowering Translators.",Non-OADS,/arxiv_data1/oa_pdf/3d/79/ritt-10-012.PMC4959122.pdf
"Accessed March 10, 2015 http://www.t21n.com/homepage/articles/T21N-2010-01-Stewart,Orban,Kornelius.pdf Suchman, L. 2007 .Human-Machine Recon ﬁgurations .",Non-OADS,/arxiv_data1/oa_pdf/3d/79/ritt-10-012.PMC4959122.pdf
"NUMERICALFUNCTIONALANALYSISANDOPTIMIZATION 2016, VOL.37,NO.5,521–540 http://dx.doi.org/10.1080/01630563.2016.1144070 OptimalConvergenceRatesResultsforLinearInverse Pr oblemsinHilbertSpaces V.Albania,P.Elbaua,M.V.deHoopb,andO.Scherzera,c aComputationalScienceCenter,UniversityofVienna,Vienna,Austria;bDepartmentofComputationaland Applied Mathematics and Department of Earth Science, Rice University, Houston, Texas, USA;cJohann RadonInstituteforComputationalandAppliedMathematics(RICAM),Linz,Austria ABSTRACT In this article, we prove optimal convergence rates results for regular izationmethodsforsolvinglinearill-posedoperatorequa- tions in Hilbert spaces.",Non-OADS,/arxiv_data1/oa_pdf/bd/f5/lnfa-37-521.PMC4959128.pdf
"This is explained partly by the creation of a network of Employment Promotion Centres in the early 2000s, which flagged the labour market activation agenda of Greek governments in the background of the Lisbon 1 http://ec.europa.eu/eurostat/statistics-explained/index.php/Unemployment_statistics 2 Greek Labour Force Survey data have structural difficulties in capturing immigrant respondents (Kasimis and Papadopoulos, 2013).Maroukis 181",Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
"Contact public employment officeContact private employment officeApply to employers directlyAsk friends, relatives, trade unions 1999 34.8 5.6 80.2 87.1 2000 43.8 6.1 83.0 86.4 2001 48.8 8.2 83.4 86.9 2002 51.1 11.4 82.0 84.4 2003 51.9 11.4 84.6 87.5 2004 56.2 10.6 82.9 86.8 2005 61.7 10.5 84.5 86.5 2006 61.5 8.7 84.9 86.7 2007 60.8 9.4 82.6 85.0 2008 58.1 9.2 80.3 84.5 2009 58.4 8.5 84.4 87.6 2010 62.9 8.3 87.5 89.9 2011 65.9 8.6 89.1 92.4 2012 65.1 8.2 90.0 94.0 2013 64.1 5.4 89.7 94.1 Source: Eurostat, Labour Force Survey (available at http://ec.europa.eu/eurostat/web/products-datasets/-/lfsa_ugmsw).",Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
3 http://ec.europa.eu/eurostat/statistics-explained/index.php/Employment_statistics182 Transfer 22(2),Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
4 See: http://www.simaxiagiatinergasia.gr/%CE%B5%CF%84%CE%B1%CE%B9%CF%81%CE%B5%- CE%AF%CE%B5%CF%82/; http://www.enet.gr/?i ¼news.el.article&id ¼340463; http://espaergasia.gr/?,Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
6 https://www.ika.gr/gr/infopages/downloads/apokleistikh.pdf/Maroukis 189,Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
Website references http://ec.europa.eu/eurostat/web/products-datasets/-/lfsa_ugmsw http://ec.europa.eu/eurostat/statistics-explained/index.php/Unemployment_statistics http://ec.europa.eu/eurostat/statistics-explained/index.php/Employment_statistics http://www.simaxiagiatinergasia.gr/%C E%B5%CF%84%CE%B1%CE%B9%CF%81%CE%B5% CE%AF%CE%B5%CF%82/; http://www.enet.gr/?i ¼news.el.article&id ¼340463; http://espaergasia.gr/?cat ¼6; https://www.ika.gr/gr/infopages/downloads/apokleistikh.pdf/192 Transfer 22(2),Non-OADS,/arxiv_data1/oa_pdf/9c/e7/10.1177_1024258916634620.PMC4959133.pdf
"The term ’asthma endotype’ is not synonymousEnhanced Content To view enhanced content for this article, go to http://www.medengine.com/Redeem/48D 4F06023BDDEA2 .",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/41030_2016_Article_17.PMC4959136.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/41030_2016_Article_17.PMC4959136.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(7) 1–5 DOI: 10.1177/2054270416632706",Non-OADS,/arxiv_data1/oa_pdf/aa/ef/10.1177_2054270416632706.PMC4959143.pdf
"Primary care work- force commission, http://hee.nhs.uk/work-programmes/primary-and-community-care-programme/primary-care-workforce-commission/ (2014, accessed 5 April2016).",Non-OADS,/arxiv_data1/oa_pdf/aa/ef/10.1177_2054270416632706.PMC4959143.pdf
"GP task- force final report, http://hee.nhs.uk/wp-content/uploads/sites/321/2014/07/GP-Taskforce-report.pdf(2014, accessed 5 April 2016).",Non-OADS,/arxiv_data1/oa_pdf/aa/ef/10.1177_2054270416632706.PMC4959143.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–8 DOI: 10.1177/2054270416648043",Non-OADS,/arxiv_data1/oa_pdf/82/6b/10.1177_2054270416648043.PMC4959144.pdf
"J Interprof Care, http://informahealthcare.com/jic (2014, accessed 11 May 2016).13.",Non-OADS,/arxiv_data1/oa_pdf/82/6b/10.1177_2054270416648043.PMC4959144.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(7) 1–4 DOI: 10.1177/2054270416643890",Non-OADS,/arxiv_data1/oa_pdf/52/c1/10.1177_2054270416643890.PMC4959145.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(7) 1–8 DOI: 10.1177/2054270416639785",Non-OADS,/arxiv_data1/oa_pdf/e4/11/10.1177_2054270416639785.PMC4959146.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(7) 1–9 DOI: 10.1177/2054270416639481",Non-OADS,/arxiv_data1/oa_pdf/7b/97/10.1177_2054270416639481.PMC4959148.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–10 DOI: 10.1177/2054270416649282",Non-OADS,/arxiv_data1/oa_pdf/08/a0/10.1177_2054270416649282.PMC4959149.pdf
"London: Department of Health, 2012, https://www.gov.uk/government/ publications/long-term-conditions-compendium-of-information-third-edition (accessed 28 April 2016).",Non-OADS,/arxiv_data1/oa_pdf/08/a0/10.1177_2054270416649282.PMC4959149.pdf
Available from: http://www.prisonstudiesorg/publications/ list/40‑world‑prison‑population‑list‑8th‑edition.html.,Non-OADS,/arxiv_data1/oa_pdf/6d/70/JEHP-5-5.PMC4959254.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs103/en [Last  accessed on 2014 Sep 04].,Non-OADS,/arxiv_data1/oa_pdf/25/d1/JEHP-5-4.PMC4959259.pdf
Available from: http://www.sciencedaily.com/ releases/2014/08/140822094238.htm [Last accessed on 2014 Sep 02].,Non-OADS,/arxiv_data1/oa_pdf/25/d1/JEHP-5-4.PMC4959259.pdf
Available from: http://www.uniteforsight.org/ health‑communication‑course/module5.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/JEHP-5-3.PMC4959262.pdf
Available from: http://www.wan‑ifra.org/press‑releases/2011/10/12/ world‑press‑ trends‑newspapers‑still‑reach‑more‑than‑internet.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/JEHP-5-3.PMC4959262.pdf
Available from:  http://www.mxmindia.com/2011/12/registered‑publications‑  show‑6‑25‑per‑cent‑growth‑rni‑report/.,OADS,/arxiv_data1/oa_pdf/75/d8/JEHP-5-3.PMC4959262.pdf
Available from: http://www.academia.edu/351767/ Media_usage_habits_of_the_youths_and_adults_in_MAnipur.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/JEHP-5-3.PMC4959262.pdf
Available from: http://www.rni.nic.in/pin1314.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/JEHP-5-3.PMC4959262.pdf
Available  from: http://www.nursingplanet.com/research/qualitative_research.,Non-OADS,/arxiv_data1/oa_pdf/ca/41/JEHP-5-7.PMC4959263.pdf
"Mobile technology fact sheet, http://www.pewinternet.org/ fact-sheets/mobile-technology-fact-sheet/ (accessed 1 March 2014).",Non-OADS,/arxiv_data1/oa_pdf/ac/1d/10.1177_2050312116659089.PMC4959300.pdf
"Weinburg I. Vascular Medicine, http://www.angiologist.com/ vascular-laboratory/pulse-volume-recording/ (2010, accessed  27 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/10.1177_2050312116659088.PMC4959301.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/aa/49/10.1177_2048004016658142.PMC4959304.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/37/03/10.1177_2048004016657475.PMC4959305.pdf
Available from: http://www.who.int/mediacentre/factsheets/  fs282/en/.,Non-OADS,/arxiv_data1/oa_pdf/45/da/IJY-9-114.PMC4959321.pdf
Available from: http://www.who.int/ classifications/icd/ en/icdonlineversions/en/index.html.,OADS,/arxiv_data1/oa_pdf/45/da/IJY-9-114.PMC4959321.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/45/da/IJY-9-114.PMC4959321.pdf
"Design This is a randomized, waitlist control, single‑blind clinical  trial in which 81 participants were assigned to two groups  (yoga and control) using a computer generated random  number table obtained from http://www.randomizer.org.",Non-OADS,/arxiv_data1/oa_pdf/b7/c6/IJY-9-137.PMC4959324.pdf
Available from: http://www.goldcopd.org/ uploads/users/files/GOLD_Report_2015.pdf.,OADS,/arxiv_data1/oa_pdf/b7/c6/IJY-9-137.PMC4959324.pdf
Available from:  http://www.lympho.org/mod_turbolead/upload/file/Lympho/Programme%20 basse%20d%C3%A9f.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/fb/IJY-9-145.PMC4959325.pdf
Available from: http://www.lympho.org/mod_turbolead/upload/ file/Programme_2011_BD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/fb/IJY-9-145.PMC4959325.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed.,OADS,/arxiv_data1/oa_pdf/92/fb/IJY-9-145.PMC4959325.pdf
Available from: http://www.sonimafoundation.org/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http://www.yogaed.com/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http://www.yogainschools.org/index.php/ about/our‑story/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http://g1.globo.com/sc/ santa ‑catarina/jornal ‑do‑almoco/videos/v/escola ‑no‑sul ‑da‑ilha ‑trabalha ‑ tecnicas‑de‑meditacao‑e‑yoga‑com‑alunos/4307114/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http://www.ryedabahia.blogspot.com.br/.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http://www.oei.es/congreso2014/memoriactei/1519.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/d5/IJY-9-156.PMC4959326.pdf
Available from: http:// jeksite.org/yoga/resp.pdf and http://jeksite.org/yoga/resp.htm.,Non-OADS,/arxiv_data1/oa_pdf/06/fe/IJY-9-163.PMC4959327.pdf
Available from: http://news.harvard.edu/gazette/2002/04.18/09‑ tummo.html.,Non-OADS,/arxiv_data1/oa_pdf/8f/45/IJY-9-97.PMC4959333.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/8f/45/IJY-9-97.PMC4959333.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/8f/45/IJY-9-97.PMC4959333.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/01/1f/JSTCR-7-4.PMC4959409.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/01/1f/JSTCR-7-4.PMC4959409.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/94/74/JSTCR-7-7.PMC4959410.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/b5/ott-9-4387.PMC4959411.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4387–4396OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4387Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10630 3 MK-2206 co-treatment with 5-fluorouracil  or doxorubicin enhances chemosensitivity  and apoptosis in gastric cancer by attenuation  of akt phosphorylation Piaopiao Jin1,2 chi chun Wong3 sibin Mei1 Xingkang he4 Yun Qian4 leimin sun1 1Department of gastroenterology,   sir run run shaw hospital, Zhejiang  University school of Medicine,   hangzhou, 2Department of  gastroenterology, The First affiliated  hospital, Wenzhou Medical University,   Wenzhou, Zhejiang, 3Department of  Medicine and Therapeutics, chinese  University of hong Kong, hong  Kong, 4institute of gastroenterology,   Zhejiang University, hangzhou,   Zhejiang, People’s republic of chinaAbstract:  The anticancer effect of MK-2206, an Akt inhibitor, has been explored in some types  of cancers, but its effect on gastric cancer is unclear.",Non-OADS,/arxiv_data1/oa_pdf/34/b5/ott-9-4387.PMC4959411.pdf
"However,  except for trastuzumab, which targets gastric cancer with ERBB2 amplification, no  other targeted therapy has been approved for gastric cancer thus far.correspondence: leimin sun Department of gastroenterology, sir run  run shaw hospital, Zhejiang University  school of Medicine, 3 east Qingchun  road, hangzhou 310016, Zhejiang,  People’s republic of china Tel +86 571 8609 0073 email sunleimin@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jin et al Running head recto: MK-2206 inhibits gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S106303",Non-OADS,/arxiv_data1/oa_pdf/34/b5/ott-9-4387.PMC4959411.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/34/b5/ott-9-4387.PMC4959411.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/b5/ott-9-4387.PMC4959411.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/e9/ott-9-4377.PMC4959412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4377–4385OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4377Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9470 3The expression status of TrX, ar, and cyclin D1  correlates with clinicopathological characteristics  and er status in breast cancer Weisun huang1 Weiwei nie1 Wenwen Zhang2 Yanru Wang1 aiyu Zhu1 Xiaoxiang guan1,2 1Department of Medical Oncology,   Jinling hospital, school of Medicine,   southern Medical University,   guangzhou, People’s republic of  china; 2Department of Medical  Oncology, Jinling hospital, Medical  school of n anjing University, nanjing,   People’s republic of chinaBackground:  The ER signaling pathway plays a critical role in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4e/e9/ott-9-4377.PMC4959412.pdf
"TRX was first identified in Escherichia coli as a dithiol hydrogen donor for ribonucle - otide reductase and acts as a key molecule in protein redox regulation in cooperation  with TRX reductase and nicotinamide adenine dinucleotide phosphate (NADPH).3,4 TRX  influences tumor proliferation and progression by activating transcription factors such as  AP-1, NF- kB, and p53 by redox regulation and by regulating the cell cycle via the ERK1/2- cyclin D1 pathway.5–8 Recently, TRX was revealed to enhance the transcription activity of correspondence: Xiaoxiang guan Department of Medical Oncology, Jinling  hospital, southern Medical University,  guangzhou, 210002, People’s republic  of china email xguan@nju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Huang et al Running head recto: TRX, AR, and cyclin D1 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S94703",Non-OADS,/arxiv_data1/oa_pdf/4e/e9/ott-9-4377.PMC4959412.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4e/e9/ott-9-4377.PMC4959412.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/e9/ott-9-4377.PMC4959412.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/ae/ott-9-4369.PMC4959413.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4369–4375OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4369Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10965 6 coffee consumption and risk of hepatocellular  carcinoma: a meta-analysis of eleven epidemiological  studies Kai Bai* Qiucheng cai* Yi Jiang lizhi lv Department of hepatobiliary surgery,   Fuzong clinical college, Fujian  Medical University, Fuzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Growing evidence has shown that coffee consumption is inversely related with the  risk of hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/4d/ae/ott-9-4369.PMC4959413.pdf
"It is generally acknowledged that chronic hepatitis B virus infection is the major  risk factor for primary liver cancer and the prevalence of it can largely reflect the occur - rence of cancer.2 To be more accurate, hepatitis B virus infection may be responsible correspondence: lizhi lv Department of hepatobiliary surgery,  Fuzong clinical college, Fujian Medical  University, 156 north Xi-er huan  road, Fuzhou 350025, People’s  republic of china Tel +86 158 6095 7758 email lvlizhi_fz@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Bai et al Running head recto: Coffee intake and HCC risk DOI: http://dx.doi.org/10.2147/OTT.S109656",Non-OADS,/arxiv_data1/oa_pdf/4d/ae/ott-9-4369.PMC4959413.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4d/ae/ott-9-4369.PMC4959413.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/ae/ott-9-4369.PMC4959413.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/d4/ott-9-4357.PMC4959414.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4357–4367OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4357Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10651 3 inhibition of microrna-126 promotes the  expression of spred1 to inhibit angiogenesis in  hepatocellular carcinoma after transcatheter  arterial chemoembolization: in vivo study Jian-song Ji1,2,* Min Xu1,* Jing-Jing song1,* Zhong-Wei Zhao1,* Min-Jiang chen1 Wei-Qian chen1 Jian-Fei T u1 Xiao-Ming Yang2 1Department of radiology, affiliated  lishui hospital of Zhejiang University,   Fifth affiliated hospital of Wenzhou  Medical University, central hospital  of Zhejiang lishui, lishui, People’s  republic of china; 2Department of  radiology, lab-Yang, University of  Washington, seattle, W a, Usa *These authors contributed equally  to this workAbstract:  MicroRNA-126 (miR-126) has been found to promote angiogenesis, but the  underlying mechanisms are still unclear.",Non-OADS,/arxiv_data1/oa_pdf/97/d4/ott-9-4357.PMC4959414.pdf
"Keywords:  microRNA-126, sprouty-related, EVH1 domain containing protein 1, hepatocellular  carcinoma, transcatheter hepatic arterial chemoembolization, animal modeling, angiogenesis,  vascular endothelial growth factor, microvessel density Introduction Hepatocellular carcinoma (HCC) is currently regarded as one of the most malignant  cancers with a high incidence.1 In the People’s Republic of China, the annual HCC  incidence is over 300,000, comprising 60% of the world’s HCC incidence.2 The cur - rent research suggested that the joint reactions between telomere shortening, chro - mosomal instability, and p21WAF1/CIP1 inactivation play important roles in HCC  formation.3 There are some histologic changes in this process, including changes correspondence: Xiao-Ming Yang Department of radiology, lab-Yang,  University of Washington, Box 358056,  815 Mercer street, room s470,  seattle 98109, Wa, Usa Tel +1 206 685 6967 Fax +1 206 685 6967 email y_xyxiao6309@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ji et al Running head recto: miR-126 inhibits angiogenesis after TACE DOI: http://dx.doi.org/10.2147/OTT.S106513",Non-OADS,/arxiv_data1/oa_pdf/97/d4/ott-9-4357.PMC4959414.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/97/d4/ott-9-4357.PMC4959414.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/d4/ott-9-4357.PMC4959414.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/02/ott-9-4397.PMC4959415.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4397–4409OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4397Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9841 0 FaT10 is associated with the malignancy and drug  resistance of non-small-cell lung cancer Feng Xue1,2,* lin Zhu3,* Qing-wei Meng1 liyan Wang2 Xue-song chen1 Yan-bin Zhao1 Ying Xing1 Xiao-yun Wang1 li cai1 1The Fourth Department of Medical  Oncology, harbin Medical University  cancer hospital, 2Department of  Medical Oncology, heilongjiang  Provincial hospital, 3Department  of radiotherapy, harbin Medical  University cancer hospital, harbin,   People’s republic of china *These authors contributed equally  to this workAbstract:  Lung cancer has become one of the leading causes of cancer mortality worldwide,  and non-small-cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases.",Non-OADS,/arxiv_data1/oa_pdf/8d/02/ott-9-4397.PMC4959415.pdf
"This resistance is mediated through multiple  mechanisms, and extensive evidence has demonstrated that during this process, modu - lation in pathways supporting cell survival, including cell growth and proliferation,  apoptosis, DNA damage repair, and endocytosis, is frequently observed.5 FAT10, originally identified through mapping the HLA-F genomic locus, is an 18  kDa  protein composed of 165 amino acid residues.6 It belongs to the ubiquitin-like (UBL) correspondence: li cai The Fourth Department of Medical  Oncology, harbin Medical University  cancer hospital, 150 haping road,  harbin 150040, People’s republic  of china Tel +86 0451 8629 8283 Fax +86 0451 8629 8735 email caili@ems.hrbmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xue et al Running head recto: Malignancy and drug resistance of NSCLC DOI: http://dx.doi.org/10.2147/OTT.S98410",Non-OADS,/arxiv_data1/oa_pdf/8d/02/ott-9-4397.PMC4959415.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8d/02/ott-9-4397.PMC4959415.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/02/ott-9-4397.PMC4959415.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: June 22, 2016 EXTRA  William Reginold, MD   Department of Medical Imaging, University of Toronto   4th Floor, 263 McCaul St.   Toronto, ON M5T 1W7 (Canada)   E-Mail wreginold   @   qmed.ca www.karger.com/dee DOI: 10.1159/000446770  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/02/a4/dee-0006-0233.PMC4959429.pdf
"Published online: June 25, 2016 EXTRA  Leo Boelaarts, MD, MSc   Department of Geriatric Medicine, Medical Center Alkmaar   PO Box 501   NL–1800 AM Alkmaar (The Netherlands)   E-Mail l.boelaarts   @   nwz.nl www.karger.com/dee DOI: 10.1159/000445711  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f7/d2/dee-0006-0242.PMC4959430.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: June 25, 2016 EXTRA  Dr. Chin Yee Cheong   Department of Geriatric Medicine   90 Yishun Central, Khoo Teck Puat Hospital   Singapore 768828 (Singapore)   E-Mail chinyee.cheong   @   mohh.com.sg www.karger.com/dee DOI: 10.1159/000445883  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/42/88/dee-0006-0268.PMC4959431.pdf
"https://www.abramsoncenter.org/ media/1199/observed-emotion-rating-scale.pdf (accessed January 6, 2014).",Non-OADS,/arxiv_data1/oa_pdf/42/88/dee-0006-0268.PMC4959431.pdf
"With the growing  elderly population, the number  Published online: June 25, 2016 EXTRA  Miguel F. Gago   Neurology Department, Hospital da Senhora da Oliveira, EPE   Rua dos Cutileiros, Creixomil   PT–4835-044 Guimarães (Portugal)   E-Mail miguelfgago   @   yahoo.com www.karger.com/dee DOI: 10.1159/000447124  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a3/d2/dee-0006-0252.PMC4959436.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/iew049.PMC4959459.pdf
"To identify P5AP homologues, we used the HMMER online server ( http://www.ebi.ac.uk/Tools/hmmer/ search/phmmer ) to search for proteins with the DUF4097 and DUF4098 domains.",OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
J Gen Microbiol 129: 813– 822. http://dx.doi.org/10.1099/ 00221287-129-3-813 .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/ JB.01834-08 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/AAC.45.5.1480-1486.2001 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/ 10.1128/JB.186.5.1221-1228.2004 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/JB.185.24.7184 -7192.2003 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/mBio.00199-11 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/mBio.01446-14 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/AAC.05984-11 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/JB.00084-07 11.,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
Mol Microbiol 75: 874 – 885. http://dx.doi.org/10.1111/j.1365-2958.2009.07014.x .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/MMBR.00042-10 .13.,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
Antimicrob Agents Chemother 57:6179 – 6186. http://dx.doi.org/ 10.1128/AAC.01472-13 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/AAC.22.2.295 .,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
BMC Genomics 14:466. http://dx.doi.org/ 10.1186/1471-2164-14-466 .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1128/JB.00259 -12.,Non-OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
Proteomics5:4684 – 4688. http://dx.doi.org/10.1002/pmic.200500021 .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1006/meth.2001.1183 .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1093/sysbio/syq010 .,OADS,/arxiv_data1/oa_pdf/ea/01/mBio.02188-15.PMC4959515.pdf
http://dx.doi.org/10.1016/0169 -4758(86)90011-6 .,OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1371/journal.pntd.0001287 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Nature 422:83– 87. http://dx.doi.org/10.1038/nature01461 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.4161/viru.3.1.18295 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1038/nrmicro3298 .,OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Science 320: 677– 681. http://dx.doi.org/10.1126/science.1156296 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Nature 501: 430 – 434. http://dx.doi.org/10.1038/nature12516 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1000685 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Science 329:841– 845. http://dx.doi.org/10.1126/science.1193032 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1126/science.7516579 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1371/journal.pntd.0001728 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Am J Hum Genet93:54 – 66. http://dx.doi.org/10.1016/j.ajhg.2013.05.014 .,OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/ 10.1038/ki.2015.151 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
NatCommun 6:8078. http://dx.doi.org/10.1038/ncomms9078 .,OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1038/nmeth.1923 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1371/ journal.pntd.0000658 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1093/gbe/evu222 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1371/journal.pntd.0003404 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1093/bioinformatics/btp352 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/ 10.1093/molbev/msj030 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/10.1038/nbt.1754 .,Non-OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
Proc NatlAcad Sc iUSA 86:6196 – 6200. http://dx.doi.org/10.1073/ pnas.86.16.6196 .,OADS,/arxiv_data1/oa_pdf/b0/23/mBio.02198-15.PMC4959518.pdf
http://dx.doi.org/ 10.1016/0140-6736(93)90480-5 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1016/S0140-6736(03)15328-7 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/ 10.1099/00221287-148-11-3681 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Mol Microbiol 57:420 – 433. http://dx.doi.org/ 10.1111/j.1365-2958.2005.04700.x .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Infect Immun 74:6547– 6556. http://dx.doi.org/10.1128/IAI.00695-06 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Nature 449:804 – 810. http://dx.doi.org/10.1038/nature06244 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
EnvironMicrobiol 9:3– 4. http://dx.doi.org/10.1111/j.1462-2920.2006.01222_3.x .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1126/science.1124234 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
J Infect Dis 110: 38 – 46. http://dx.doi.org/10.1093/infdis/110.1.38 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/ 10.1016/j.mib.2010.10.003 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
